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Osteoarthritis (OA) is a debilitating degenerative joint disease affecting 27 million Americans
over the age of 25. OA is characterized by total joint changes including the degradation of artic-
ular cartilage and inflammation of the synovium, a specialized lining that envelops the knee joint.
Whereas OA is a disease of the entire joint organ, the contribution of the synovium in OA and to
cartilage degeneration has been underappreciated. Synovial inflammation often precedes the devel-
opment of cartilage damage and is observed in early and late stage OA. The onset of synovitis is
driven by both elevated concentrations of pro-inflammatory cytokines and tissue debris in the joint
space resulting from trauma, such as meniscal or anterior cruciate ligament tears. Accordingly, sur-
geons have observed cartilaginous debris embedded within the synovial membrane of OA patients
presenting with severe capsular synovial hyperplasia and metaplasia. It has been hypothesized that
the fibrotic shortening of the synovial capsule results in pain and stiffness often associated with
OA and contributes to further joint destruction through the release of degradative enzymes. Cur-
rent strategies to treat synovial inflammation and joint pain, such as intra-articular injections and
synovectomy, have had limited and variable success.
To this end, cell culture and tissue engineering culture models provide a versatile platform to
study the tissues and cells involved in OA. Our lab has typically employed mechanical overload or
cytokine insult of chondrocytes and cartilage explants to study cartilage degradation. Alternatively,
using cells derived from the pathologic joint provides the opportunity to study these within their
de novo extracellular matrix (ECM). Increasingly more physiologic models of OA have cultured
synovial explants with injured cartilage tissue. Within synovial explants, the inflammatory response
of fibroblast-like synoviocytes (FLS) cannot be separated from the response of synovial macrophages.
To isolate the role of FLS in the progression of OA, FLS can be exposed to chemical (e.g. cytokines)
or physical (e.g. fluid shear) OA stimuli. Although often overlooked as an instigator of OA, cartilage
wear particles have been reported to induce synovial inflammation and OA-like joint changes in
various animal models. As opposed to non-biological (metal or plastic) wear particles, small (sub-
10μm) cartilage wear particles are comprised of ECM constituents that are degradable and may
interact with cells beyond just being internalized. The work presented in this dissertation aims to
combine knowledge from basic science and pre-clinical models of OA to develop a clinically relevant
disease model using cells derived from clinical samples.
Previous studies have shown that synovial explants produce increased concentrations of degen-
erative enzymes in response to cytokines. To better understand the effects of these cytokines on the
synovium, we looked at how cytokines regulate the cellular and ECM composition of the synovium
in a physiologic co-culture system. In support of clinical observations, synovial explants were able
to engulf large cartilage particles. To study the contribution of FLS only to synovial inflammation,
we developed a high-density monolayer culture model of the synovium. Using this model allowed
for the characterization of the interaction of FLS with cartilage wear particles. The resulting FLS
proliferation and inflammation was determined to be caused by both phagocytosis and cell attach-
ment to the particles. Using small latex particles and large collagen coated beads, we determined
that this response was likely due to cell-attachment and activation of integrins. Cartilage particles
also reduced the mechanosensitivity of FLS to fluid shear, implicating additional deleterious effects
of cartilage particulates within the synovium and in the joint space.
Cells isolated from pathologic tissue provide another approach to studying OA. Using cells
derived from an animal model of OA allowed us to make direct comparisons between synovial fluid
and media concentrations of OA biomarkers. These tissues had different media concentrations of
MMPs, chemokines and cytokines for up to two weeks of culture. This confirmed that disease cells
can be used for the development of pathologic culture models.
As has been shown in the literature, the observed behavior of cells isolated from other species
(bovine or canine) may not be a direct comparison to findings in human cells. For the final studies,
we sought to translate our finding from a synovium disease model using juvenile bovine FLS and a
chondrocyte disease model using canine chondrocytes to a clinically relevant cell source. Specifically,
we compared the response of normal (healthy, non-diseased) and diseased (OA) FLS to different
OA stimuli to model synovial inflammation in early and late stage OA. These results show that
diseased cells are much more sensitive to inflammatory stimuli and that cytokines stimulate a larger
inflammatory response than particles alone. Taken together, the sum of this work can provide a
new research platform to study disease progression and identify new diagnostics and therapeutics
that target joint inflammation and pain.
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Chapter 1 Introduction
While osteoarthritis (OA) has long been considered a disease of cartilage, there is a growing appreci-
ation for the role of synovium in total joint health and in disease. It remains unknown if the changes
in the synovial membrane cause or are the result of joint inflammation and cartilage degradation.
In order to better understand synovial inflammation in OA, this dissertation looks to (1) develop
and characterize a biofidelic and versatile culture model of OA using both pro-inflammatory stimuli
and cartilage debris and (2) apply these finding to clinically-relevant human tissues. The global
hypothesis and specific aims are presented below, followed by the significance of the work and an
overview of literature related to the synovium, models of OA and cartilage wear particles.
1.1 Global hypothesis and specific aims
The work in this dissertation looks at the development of biologically relevant in vitro models of
osteoarthritis (OA) using a combination of chemical and physical stimuli, and pathologic cells. In
developing a biofidelic culture model of OA, model systems were developed and tested in basic
science (bovine) and pre-clinical model (canine) systems using fibroblast-like synoviocytes (FLS)
and chondrocytes and ultimately combines them in a clinical model with human FLS (Figure 1.1),
guiding the following global hypothesis.
Global Hypothesis: Cells derived from a pathologic environment can retain their
diseased phenotype in vitro under permissive culture conditions. Moreover, within
their de novo matrix, healthy and OA FLS will respond differentially to applied
chemical and physical OA stimuli, including cartilage wear particles. The behavior of
healthy and OA FLS in these OA-like conditions will provide insights to the role of
the synovium in disease progression and cartilage degeneration.
To guide the research to investigate this global hypothesis, the following specific aims were devel-
oped.
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Figure 1.1: Schematic overview of the specific aims guiding the work in the dissertation.
Specific Aim 1A (SA1A): Create a 2D in vitro synovium model using juvenile bovine
FLS via culture in media supplemented with pro-inflammatory cytokines. Validate
that synovium model expresses key synovial markers and interacts with cartilage in a
manner similar to native synovium.
The synovial membrane is comprised of densely packed cells (FLS and macrophages) within a
collagenous ECM (Kiener et al. , 2010; Smith, 2011). FLS are not only responsible for the synthesis
of key synovial fluid constituents but also the maintenance of the synovial ECM (Smith, 2011;
Valencia et al. , 2004). Along with macrophages, FLS release degenerative factors in response to
pro-inflammatory mediators (Sellam & Berenbaum, 2010; Scanzello & Goldring, 2012; Manferdini
et al. , 2016). Studies of explant tissues can be unreliable due to the variability of synovial ECM
composition and cellularity by region (Smith, 2011)(Kjelgaard-Petersen et al. , 2015). Further,
explant culture does not allow for the isolation of the FLS response from the macrophage response
to pro-inflammatory cytokines. Previous studies on both explants and OA FLS alone have ignored
how these inflammatory mediators can modulate FLS biosynthesis of ECM components (Gitter et al.
, 1989; Blewis et al. , 2010b; Hamilton et al. , 1994; Kjelgaard-Petersen et al. , 2015). A versatile
model system that can study FLS in the absence of macrophages will allow for the isolation of the
effects of pro-inflammatory mediators on FLS.
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Specific Aim 1B (SA1B): Extend this model to include the interaction of cartilage
particulates in the presence and absence of pro-inflammatory cytokines. Identify the
optimal dose of cartilage wear particulates that results in the greatest response by
utilizing a previously established sensitive system that was developed for
quantification of cartilage wear particles. Characterize the particulate-induced
inflammatory response.
Specific Aim 1C (SA1C): To elucidate underlying mechanisms that mediate FLS
behavior in the OA model developed in SA1A,B, investigate the role of integrins and
gap junction communication. Utilize a non-biologic particle (control) to further
identify if the observed cartilage particulate response is driven by phagocytosis or
ECM attachment.
Within the OA joint, cartilage particles are observed at the surface of and embedded within the
synovial membrane (Lloyd-Roberts, 1953; Myers et al. , 1992). Injections of cartilage particles into
healthy knees alone are capable of inducing synovitis, fibrotic thickening of the synovial capsule, and
OA-like joint changes to the cartilage and sub-chondral bone (Chrisman et al. , 1965; Evans et al. ,
1984; Hurtig, 1988). Previous in vitro studies with cartilage particles have used a single mass based
dosage (Cameron-Donaldson et al. , 2004; Evans et al. , 1981b), ignoring potential dosage effects.
However, the exact mechanism governing the inflammatory response of the synovium remains poorly
understood. It has been previously demonstrated that FLS are capable of phagocytosing <15μm
non-biologic wear particulates (Greis et al. , 1994; Olson et al. , 1988) and attaching to cartilage
ECM proteins via integrins (Sarkissian & Lafyatis, 1999). The use of the Coulter Counter Multisizer
4 allows for the quantification of cartilage particle size and number (Oungoulian et al. , 2013;
Oungoulian et al. , 2014; Oungoulian et al. , 2015), creating a new precise method to dose cells with
cartilage particles that has previously been use in studies of non-biologic particles only. Additionally,
OA synovium have increased expression of gap junction (Marino et al. , 2004) and activated integrins
(Attur et al. , 2010; Schedel et al. , 2004). Using the model system developed in SA1A, this
work aims to characterize how cartilage particles are capable of inducing synovial inflammation
through phagocytosis and cell surface constant, including integrin activation and increased cell-cell
communication.
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Specific Aim 1D: Adopting the particulate conditions of SA1B that yields the most
robust response, repeat study in the presence of engineered cartilage that is
physically separated from the FLS, where FLS are cultured ± cartilage particulates.
Co-culture models of OA involving cartilage and the synovium investigate the effects of mechanically
injured and/or chemically insulted cartilage with healthy or cytokine treated synovium (Cook et al.
, 2007; Patwari et al. , 2009a; Beekhuizen et al. , 2011; Lee et al. , 2009; Swärd et al. , 2017).
However, the effects of cartilage on the synovium or FLS remains unknown. Using the synovium
model developed and characterized in SA1A, this aim will adapt the particle-mediated model of
synovial inflammation developed in SA1B,C to a co-culture system with cartilage. A synovitis
driven co-culture model will provide key insights in how FLS driven synovial inflammation interacts
with cartilage.
Specific Aim 2: Develop an in vitro model of OA cartilage using chondrocytes
isolated from a large animal preclinical OA model (dog) to allow for age and donor
matched normal controls. Cartilage pellets will be characterized by their biochemical
composition as well as release of matrix metalloproteinases (MMPs), chemokines and
cytokines into the culture media.
Ideally, OA tissue cartilage explants would be studied in vitro, as this culture system provides an
opportunity to study diseased chondrocytes within their own native ECM. However, depending on
the severity of OA, only fragile, irregular cartilage fragments can be harvested from the pathologic
joint. Thus, the ability to study OA chondrocytes within their own elaborated matrix provides
a more realistic and clinically relevant alternative. Previous studies of OA chondrocytes fail to
provide healthy chondrocyte controls (Hsieh-Bonassera et al. , 2009; Dehne et al. , 2009; Tallheden
et al. , 2005), as healthy cartilage can typically only be harvested from cadaver donors (Cigan et al.
, 2016; Li et al. , 2012). The outcomes of these studies are limited by statistical matching power
(age and gender) (Li et al. , 2012; Dorotka et al. , 2005). Chondrocytes from a pre-clinical canine
model provide an alternative system to study OA chondrocytes in vitro, wherein healthy and OA
chondrocytes can be isolated from the same donor.
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Specific Aim 3A: Isolate and characterize human FLS from healthy and OA samples
using FACS and create a 2D in vitro model of the synovium using methods described
in SA1A.
Specific Aim 3B: Using the model system in SA3A culture normal and OA FLS ±
cartilage particulates. Measure biochemical content including biochemical
composition, synthesis of lubrication molecules (e.g. hyaluronan) as well as
inflammatory factors (e.g. MMPs, chemokines and cytokines).
The translation of tissue-engineering approaches from basic science (bovine) to pre-clinical (canine)
to human cells sources does not always correlate (Ng et al. , 2010; Giannoni et al. , 2005). There-
fore, the studies proposed in this aim seek to translate the OA culture model developed using canine
chondrocytes in SA2 and the particulate mediated model of synovitis developed in SA1 to clinically
relevant human cell sources derived from normal (non-diseased) and diseased (OA) synovium. Pre-
vious studies of human FLS have been limited to treating OA FLS with pro-inflammatory cytokines
(Blewis et al. , 2010b; Gitter et al. , 1989; Furuzawa-Carballeda et al. , 2008; Hamilton et al. ,
1994). These studies provide no comparison to the response of healthy FLS to the same stimuli. It
is a challenge to find patients undergoing surgery with healthy synovium. However, healthy syn-
ovium can be harvested arthroscopically during surgery or from patients undergoing total knee/hip
arthroplasty after fracture. Further none of these previous studies have evaluated the effects of
alternative inflammatory stimuli, such as cartilage wear particles. A clinically relevant synovium
OA model will provide a new understanding of how the response of FLS to cytokines and cartilage




Healthy articular cartilage allows for proper joint lubrication and load distribution resulting from
normal motion. While some tissue wear occurs naturally as the result of the interaction between two
distinct moving surfaces, it is typically minimal (Jay et al. , 2007; Griffin & Guilak, 2005). However,
aging, overuse, obesity and traumatic injury can disrupt knee joint mechanics, preventing smooth
articulation and resulting in the development of OA (Griffin & Guilak, 2005; Buckwalter & Mankin,
1998a). OA is one of the most common joint diseases affecting an estimated 27 million Americans
over the age of 25 and representing a substantial financial burden for both patients and insurers
(Kotlarz et al. , 2009). OA is characterized by the degeneration of the cartilage matrix leading
to the formation of loose cartilage particles in the joint space (Goldring et al. , 2011; Blasioli &
Kaplan, 2014). Risk factors for OA can contribute to increased cartilage degradation and production
of cartilage debris (Griffin & Guilak, 2005; Griffin et al. , 2010; Felson et al. , 2000). Clinically,
these cartilage wear particles become bound to the surface or embedded within the synovium, the
specialized lining that surrounds the knee joint (Lloyd-Roberts, 1953; Myers et al. , 1992).
While the role of the synovium in OA and cartilage degradation has typically been underappre-
ciated, OA is an inflammatory disease of the total joint organ (Loeser et al. , 2012). OA symptoms
typically include joint pain, swelling and stiffness, which suggests that the inflammation of the syn-
ovium is a key feature of OA (Pelletier et al. , 2001). Specifically, it has been hypothesized that
synovitis and the fibrotic shortening of the synovial capsule results in the pain associated with OA
(Scanzello & Goldring, 2012; Attur et al. , 2010). Further, pro-inflammatory cytokines released by
the inflamed synovium, elevate levels of degenerative enzymes in synovial fluid that result in further
cartilage degradation and inhibit repair and regeneration (Sutton et al. , 2009; Smith et al. , 1997).
To manage pain and joint swelling, patients can be injected with corticosteroid injections or
viscosupplementation. Clinicians have reported that in the earlier stages of disease, some patients
will experience no pain for hours, days or months while others experience no improvement after
these treatments (Hirsch et al. , 2013; Berthelot et al. , 2013; Boutefnouchet et al. , 2017; Ayhan
et al. , 2014). For more severe cases, surgeons often use lavage with synovectomy to remove tissue
debris from the synovium and the joint space. However, the use of lavage with synovectomy has
been widely debated due to variable success in practice (Felson, 2010; Pitta et al. , 2016). For
6
both early and late stage interventions, the cause of these inconsistent outcomes remains poorly
understood. The variable patient response motivates the need for a better understanding of the
total joint and synovial changes that occur at different stages of disease.
Using tissue-engineering strategies, the work described in this dissertation develops physiologic
culture models of OA that evaluate inherent changes to OA cells (FLS and chondrocytes) within their
own de novo ECM and characterize their response to pathologic stimuli. This work complements
ongoing work to develop patient specific models of OA (Willard et al. , 2014). Based on clinical
observations and the results of early animal models, it has long been hypothesized that cartilage
particulates play a key role in the activation of synovial cells, resulting in the early pathogenesis
of synovitis and ultimately OA (Sellam & Berenbaum, 2010; Attur et al. , 2010; Mathiessen &
Conaghan, 2017). Concurrently, the results described in this dissertation characterize the interaction
between small (sub-10μm) and large (>40 μm) cartilage wear particles and the synovium to provide
a more complete understanding of the role of the synovium in OA and disease progression. Together,
these strategies can be combined to develop clinically relevant therapeutic interventions to address
joint pain and inflammation.
The studies in Part I of this dissertation investigate the role of clinically relevant pro-inflammatory
stimuli on the synovium using a basic science model (bovine tissue explants and cells). Chapter 2
utilizes an explant model system to study structural and biochemical changes to the synovium after
pro-inflammatory cytokine insult in the presence and absence of cartilage. While similar explants
models have been used previously, these studies only looked at the effects of co-culture on cartilage
tissue (Cook et al. , 2007; Patwari et al. , 2009a). Chapter 3 explores effects of both chemical
(cytokine) and physical (cartilage wear particles) OA stimuli on FLS to understand how FLS alone
can drive the inflammatory response of the synovium. Chapter 4 builds off the work in Chapter 3
to better characterize the drivers behind the response of FLS to cartilage wear particles and how
these particulates interact with the entire synovium.
In Part II, we develop a culture model for OA using cells derived from canine OA cartilgae. Using
cells derived from a pre-clinical animal model of OA, Chapter 5 outlines the use of the Luminex®
assay system to detect multiple OA biomarkers in small sample volumes to confirm that cells from
the pathologic joint retain their disease phenotype in culture.
Part III combines the work in Part I and Part II and applies it the results to human FLS derived
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from the synovium of healthy and OA patients (Chapter 6). The cumulative results of this work
can be used to develop biofidelic culture models of OA that can be used for therapeutic screening
of new OA interventions.
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Figure 1.2: Schematic of the (A) diarthrodial joint and (B) structure of the synovium. Image
adapted from (Tiwari et al. , 2010)
1.3 Background
1.3.1 Diarthrodial joint structure and osteoarthritis
1.3.1.1 Synovial structure and function The synovium is a thin specialized connective tis-
sue that surrounds the diarthrodial joint, acting as a semipermeable membrane that mediates the
composition of synovial fluid through the production of lubricin and hyaluronan as well as through
its filtration function (Figure 1.2A) (Smith, 2011; Scanzello & Goldring, 2012; Blewis et al. , 2010a;
Blewis et al. , 2010b; O’Connell, 2000). The synovium is comprised of two layers: the intima and
the sub-intima (Figure 1.2B).
The intima, which is closest to the joint cavity, is 1-4 cells thick (10-40 μm). Within the
intima, fibroblast-like synoviocytes (FLS) or type B synoviocytes are the predominant cell type.
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In the healthy tissue, these cells make up 70-90% of the resident cell type) (Smith, 2011; Tiwari
et al. , 2010; Wilkinson et al. , 1992; Smith et al. , 2003a). In additional to expressing common
mesenchymal stem cell (MSC) markers (Shirasawa et al. , 2006), these cells can also be identified
by the surface expression of decay accelerating factor (CD55), vascular cell adhesion molecule-1
(VCAM-1), and calcium-dependent adhesion molecule-11 (cadherin-11). The lining structure of the
synovium is mediated by the unique self-assembly properties of FLS and cadherin-11. FLS interact
with the extracellular matrix (ECM) and the sub-intima through integrins, such as the α1β1, α2β1,
α4β1 integrins and intercellular adhesion molecule (ICAM-1) (Kiener et al. , 2010; Valencia et al. ,
2004; Agarwal & Brenner, 2006; Bartok & Firestein, 2010).
The other resident cell type of the intima is type A macrophages or synovial macrophages
(SM). These cells are identifiable by positive expression of CD11b, CD14, CD45, CD68 and CD163
(Bartok & Firestein, 2010; Smith, 2011). These cells may also be found within the sub-intimal
layer. In healthy synovium, the macrophages remove waste and pathogens from the joint (Sellam
& Berenbaum, 2010). These cells reside in a collagenous matrix (primarily type I and IV) (Smith,
2011).
The sub-intima layer (~5mm) is fairly acellular and heterogeneous. In addition to synovial
macrophages and FLS, the sub-intima contains a number of other cell types including: endothelial,
immune and hematopoietic cells. Depending on the depth, the tissue can consist of fibrous collagen
(type I, III, IV, V and VI), fat or vasculature. The tissue is also highly innervated and the nerves
are collocated to the vascular network throughout the tissue (Smith, 2011; Mathiessen & Conaghan,
2017; Price et al. , 1996; Levick & McDonald, 1995).
1.3.1.2 Synovium and osteoarthritis The synovium is involved in a number of inflammatory
conditions, including spondyloarthritis, rheumatoid arthritis (RA) and OA. Synovial inflammation
can be triggered by a number of different traumas, such as meniscal or anterior cruciate ligament
tears (Scanzello et al. , 2011). Synovial changes in tissue morphology, cellular composition and
molecular synthesis are observed in most patients with OA. These dramatic changes are poorly
understood and likely stem from a number of factors including activation by cartilage fragments,
or crystals (Attur et al. , 2010; Scanzello & Goldring, 2012; Wenham & Conaghan, 2010). These
changes to the synovial lining often precede the presence of cartilage damage (Hugle & Geurts,
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2016).
In OA, the synovium undergoes a pannus-like thickening (Furuzawa-Carballeda et al. , 2008;
Shibakawa et al. , 2003; Yuan et al. , 2004). The tissue itself shows an increase in cellularity,
fibrosis, vascularity and innervation (Mathiessen & Conaghan, 2017; Wenham & Conaghan, 2010).
Patients suffering from synovial inflammation show signs such as redness, swelling, pain and heat.
Synovial inflammation can be detected through imaging modalities such as MRI and ultrasound as
these patients also have a greater amount of synovial fluid volume with a total increase in lubricant
content (Sellam & Berenbaum, 2010; Blewis et al. , 2010a; Blewis et al. , 2010b; Mathiessen &
Conaghan, 2017). Changes to the synovial composition (both ECM and cell type) can affect the
tissues ability to regulate clearance in and out of the joint space (Myers et al. , 1995).
Histology has shown that changes to the synovium include synovial hyperplasia, driven by
increased lining cells (both FLS and SM) and infiltration of sub-lining cells. With disease, the
ratio of lining cells shifts to favor polarized macrophages, with visual separation between FLS and
macrophages (O’Brien et al. , 2017; Ambarus et al. , 2012). The degree of cellular infiltration
by inflammatory cells including, macrophages, B cells and T lymphocytes has been correlated
with the degree of synovitis and the severity of OA. The development of macrophage clusters
to form multinucleated giant cells for improved phagocytosis has also been reported (Mathiessen
& Conaghan, 2017). It is believed that the activated FLS and invading immune cells produce
increased concentrations of proteases and cytokines, such as IL-1, IL-6, IL-8, TNF-, and matrix
metalloproteinases (MMPs), that contribute to the further degradative cascade of OA (Scanzello &
Goldring, 2012; Attur et al. , 2010; Mathiessen & Conaghan, 2017). Thus, the primary focus of this
dissertation work will be on the role of FLS as these are the primary resident cells of the synovium
at the onset of disease.
1.3.1.3 Cartilage and osteoarthritis The degradation of articular cartilage is a hallmark of
OA. As the tissue degrades, increased fibrillation, collagen damage and loss of proteoglycan content
can occur. This leads increased mechanical wear and cartilage debris (Buckwalter & Mankin,
1998a; Maroudas, 1976; Stockwell, 1979). At the cellular level, these changes in the extracellular
environment lead to a disrupted chondrocyte homeostasis between anabolic and catabolic activities
(Kjelgaard-Petersen et al. , 2015). Increased synovial fluid concentrations of cytokines, such as
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interleukin-1 (IL-1) and tumor necrosis factor (TNF)-α, result in the initiation of a catabolic cycle
in which chondrocytes have increased expression of inflammatory factors (i.e. chemokines, cytokines,
MMPs) and decreased ECM synthesis (Goldring & Goldring, 2007; Goldring & Berenbaum, 2004a).
These factors can also stimulate the cells of the synovial lining, further contributing to the feedback
loop of degradation and loss of cartilage integrity.
1.3.2 Models of osteoarthritis
1.3.2.1 Animal models of osteoarthritis and biomarker discovery In vivo models of OA
have been developed that create biomechanical insults in the knee joint, and lead to accelerated
degeneration of the articular cartilage (Cook et al. , 2007; Pond & Nuki, 1973; Setton et al. , 1995).
OA is induced using arthroscopic guidance and instrumentation so as to avoid the known effects of
open arthrotomy on joint health. Two of the most widely used in animal models in OA research
include the destabilized medial meniscus (DMM) or meniscal release (MR) and cruciate ligament
transection models (Pond & Nuki, 1973). These models are particularly attractive because they
lead to reproducible joint degeneration that mimics many aspects of clinical OA but occurs in weeks
or months, rather than years (Venable et al. , 2008; Gregory et al. , 2012). However, the breakdown
observed in these models is not necessary physiologic and reflects degenerative changes that follow
joint injury in the absence of surgical or non-surgical intervention. Ultimately, these models provide
a platform to study the progression of OA as well as potential chemical and surgical interventions.
In particular, the DMM model in the dog has proven to be an effective pre-clinical tool for study
of cell-based and pharmaceutical therapeutic strategies. Use of this canine model of OA allows the
researcher to address the full spectrum of pathologic changes seen in clinical OA across species,
producing data that correlate strongly with those from the clinical setting (Gregory et al. , 2012;
Le Graverand et al. , 2002; Marshall & Chan, 1996; Kuroki et al. , 2011). Advantages over other
preclinical animal models is that outcomes measures can include quantitative gait analyses that
provides a measure of function and level of pain experienced by the animal (Ng et al. , 2010).
Animal models have led to the development and application of new diagnostic biomarker panels
for the study of OA. In these studies, as with human synovial fluid samples, there is often a limited
volume of sample available for testing. Commonly identified biomarkers of OA include interleukin
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IL-1α, IL-1β, TNF-α, IL-6, IL-8, MCP-1, MMP-1, MMP-2, MMP-3, MMP-9, MMP-10, MMP-13
(Griffin et al. , 2010; Garner et al. , 2013; Garner et al. , 2011; Monibi et al. , 2016; Huebner &
Kraus, 2006). Luminex® Multiplex technology provides a unique platform that can measure up
to 100 different biomarkers in 25μl of sample, compared to more traditional assays such as ELISA
that require upwards of 50μl of sample for a single analyte (Khalifian et al. , 2015; Cuéllar et al. ,
2016). This technology can also be used to measure cytokine concentrations in cell culture media,
serum, urine as well as synovial fluid. More recently, the Luminex platform has been applied to
human synovial fluid samples (Monibi et al. , 2016; Tsuchida et al. , 2014) as well as in vitro cell
culture (Tsuchida et al. , 2014; Steinecker-Frohnwieser et al. , 2014).
1.3.2.2 In vitro models of synovitis Studying the response of synovial explants to pro-
inflammatory stimuli is more complex than studying cartilage explants, as up to 10% of the cells in
the synovium are synovial macrophages. Further, depending on the harvesting site the cellularity
and ECM composition of the synovium is quite variable (Smith, 2011). Thus, it can be challenging
to characterize how inflammatory stimuli differentially affect synovial ECM composition as well as
synthesis of ECM components and inflammatory factors. Human synovial explants treated with
IL-1β or TNF-α express increased concentration of inflammatory mediators such as prostaglandin
E2 (PGE2) (Hardy et al. , 2002), IL-6, and IL-8 (Beekhuizen et al. , 2011). In vitro, synovial
explants from clinical patients are hard to manipulate, thus limiting the types of analyses that can
be performed (Kjelgaard-Petersen et al. , 2015).
To better understand the contribution of FLS to inflammation, FLS can be easily isolated
from their native tissue matrix and neighboring immune cells. In 3D matrigel culture, these cells
have been shown to self-assemble to replicate the unique lining of the synovium that is capable
of supporting macrophages in a way that other fibroblasts cannot (Kiener et al. , 2010). Further,
FLS alone have been shown to play an important role in the regulation of macrophage phenotype
(Donlin et al. , 2014) and will be the focus of this dissertation work. In response to IL-1β and
TNF-α, human OA FLS secrete increased concentrations of lubricant molecules (e.g. hyaluronan
and lubricin), cytokines, nitric oxide (NO), PGE2 and MMPs (Blewis et al. , 2010a; Blewis et al. ,
2010b; Gitter et al. , 1989; Furuzawa-Carballeda et al. , 2008; Hamilton et al. , 1994; Kolomytkin
et al. , 2002; Pulkki, 1986). However, these studies lack healthy human controls and characterization
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of the structural changes to the synovial ECM (Kiener et al. , 2010).
1.3.2.3 In vitro models of cartilage degeneration The simplest models to study OA treat
chondrocyte monolayers with supraphysiologic concentrations of IL-1 or TNF- α, which induce
a shift to the catabolic cycle marked by the release of MMPs, aggrecanases, IL-6 and IL-8 and
accompanied by the decreased expression and synthesis of aggrecan and collagen type II (Blasioli
& Kaplan, 2014; Goldring et al. , 1994). Alternatively, more complex in vitro models have applied
injurious mechanical loading or supraphysiologic cytokine insult to cartilage explants and tissue
engineered cartilage (pellet culture or hydrogels) (Bonassar et al. , 1997; Lima et al. , 2008b; Tan
et al. , 2010a; Patwari et al. , 2001; Kuroki et al. , 2005). However, there has much debate about
the behavior of OA chondrocytes in vitro in two-dimensional (2D) and three-dimensional (3D)
culture. Some groups have reported reduced ECM synthesis by OA chondrocytes (Dorotka et al. ,
2005; Tallheden et al. , 2005), while others have reported comparable or increased levels of ECM
synthesis (Dehne et al. , 2009; Li et al. , 2012) and proliferation (Hsieh-Bonassera et al. , 2009).
1.3.2.4 In vitro co-culture models of osteoarthritis As OA is a disease of the entire joint,
it is important to understand how the various components, such as cartilage, synovium, bone and
other intra-articular tissues contribute to total joint health. There is currently a limited under-
standing of the inter-relationship between the synovium (including FLS and SM) and cartilage in
OA, particularly in the presence of inflammatory mediators. The most common co-culture mod-
els involve physically separating the synovial tissue and cartilaginous sample by a physical barrier
(e.g., Transwell®) and introducing a chemical insult or mechanical insult to the cartilaginous tis-
sue. Co-culture of bovine, canine or human cartilage and synovium explants from healthy and OA
donors exposed to injurious compression or cytokine insult (IL-1 or TNF-α) results in increased tis-
sue degradation (decreased collagen and proteoglycan content) and increased levels of inflammatory
mediators such as MMPs, NO and PGE2 (Cook et al. , 2007; Patwari et al. , 2009a; Beekhuizen
et al. , 2011; Lee et al. , 2009; Swärd et al. , 2017).
Co-culture models can also be used to study the role of FLS or synovial macrophages individually
on cartilage degradation. FLS cultured directly on top of cytokine stimulated cartilage induced
matrix degradation (Pretzel et al. , 2009). Similarly, co-culture of OA synoviocytes with alginate
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encapsulated OA chondrocytes resulted in decreased proteoglycan synthesis and increased PGE2
expression, an effect that was only further magnified by treatment with IL-1β (Huch et al. , 2001). It
has been hypothesized that the crosstalk between the chondrocytes and FLS is regulated by HIF-2α
mediated cytokines (Huh et al. , 2015). However, co-culturing injured cartilage with healthy FLS
appears to have a protective effect on the cartilage (Lee et al. , 2013). On the other hand, culture
of tissue engineered cartilage on silk fibroin scaffolds with macrophage conditioned media (MCM)
containing physiologic concentrations of TNF-α, IL-1β, PGE2 and NO from stimulated human
macrophages, can induce loss of GAG, increased MMP expression, hypertrophy and chondrocyte
apoptosis (Sun et al. , 2011). Similarly, cartilage tissue engineered pellets from human MSCS co-
cultured with human synovial fibroblasts had increased GAG loss and expression of MMPs, IL-8
and MCP-1. This effect was magnified in pellets cultured with both monocytes and FLS together
(to represent the native synovium composition) (Blasioli et al. , 2014). Thus, both cell types of the
synovium can contribute to the progression of cartilage degradation in the presence of OA stimuli.
1.3.3 Cartilage wear particles
1.3.3.1 Clinical characterization of cartilage wear particles Surgeons have observed that
cartilage particles from the synovial fluid become embedded within the synovium of OA patients
presenting with synovial hyperplasia and metaplasia (Lloyd-Roberts, 1953; Myers et al. , 1992). To
better understand the presence of cartilage particle within the OA joint, many have characterized
cartilage particle pathology in synovial fluid aspirates equine and human patients with and without
OA (Table 1).
These studies have found that correlations may exist between the presence or stage of disease
and the concentration or size of cartilage particulates in the joint space (Kuster et al. , 1998; Evans
et al. , 1981a; Mendel et al. , 2010; Hakshur et al. , 2011; Tew & Hackett, 1981). Evans et al.
observed wear particles in OA joints that fell into three different categories: Fibrous wear particles
which are larger in size (up to 400 μm); spherical wear particles of a medium size (20-25 μm);
smaller rod-like wear particles of a few microns up to 100 μm (Evans & Mears, 1981). Kuster et al.
observed smaller spherical wear particles in normal joints (30.6 μm) and particles of up to 66.7 μm in
grade 3 OA joints, and reported an increased concentration of wear particles with OA progression .
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Table 1: Suummary of in vivo observations of cartilage wear particles in OA pathogenesis. *Partic-
ulates below 10 μm in size could not be detected by available technology.
They also observed three major wear particle shapes, which they classified as: lamellar, rod-like and
chunky (Figure 1.3) (Kuster et al. , 1998). Chondrocytes were only observed in large particulates
from patients with the most advance stages of disease (Hotchkiss et al. , 1982). Typically, these
wear particle analyses are done using synovial aspirates coupled with ferrography and SEM imaging
technology (Kuster et al. , 1998; Evans & Mears, 1981). This method, however, limits the ability
to detect smaller wear particles (<10 μm in size). Given that the concentration of MMPs in the
joint space increases with OA grade, it is likely that these larger particles are degraded into smaller
particulates by the time they reach the synovial membrane (Loeser et al. , 2012; Masuhara et al. ,
2002; Goldring & Goldring, 2004). Accordingly, it has been observed that knee joints with grade 2
OA and above had a population of much smaller and much larger wear particles than normal knee
joints (Mendel et al. , 2010; Hakshur et al. , 2011).
1.3.3.2 In vivo effects of cartilage wear Particles A number of animal studies have injected
high concentrations of cartilage particulates into the knee joints of healthy animals to determine
the biological significance of cartilage wear particles on overall synovial joint health and OA disease
progression.
In a canine animal model, 22 μg weekly injections of cartilage wear particles resulted in mild
synovitis after only one injection. After 6 months of injections, the synovium exhibited capsular,
fibrotic thickening with embedded cartilage debris. After 12 months, changes in cartilage thickness
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Figure 1.3: Examples of wear cartilage particle structures from the literature. (A) Lamellar, leaf-
shaped wear particle from a healthy knee joint. (B) Elongated rodshaped cartilage wear particle
from a knee joint with grade 1 OA. (C) Chunky cartilage wear particle from the deep zone in a joint
with OA. Adapted from (Kuster et al. , 1998).
and subchondral bone structure were observed (Chrisman et al. , 1965). In a lapine animal model,
after 2 months of 1 mg injections of cartilage wear particles three times per week, the experimental
rabbit knees were swollen, resulting in decreased use of the affected limb without any signs of
bacterial infection. This response was accompanied by an increased presence of proteolytic enzymes
and infiltration of mononuclear cells. By the end of the 5-month study, the cartilage showed some
degradation accompanied by severe synovitis. Notably, these results also showed that the injected
wear particles were still present and embedded in the synovium (Evans et al. , 1984).
Compared to traditional animal models of OA, such as ACL transection, meniscal release, iodoac-
etate (Elmesiry et al. , 2014) or collagen (Evans et al. , 1984), cartilage particle induced models
of OA are much slower and take several months to develop severe OA symptoms compared to just
12 weeks (Gregory et al. , 2012; Le Graverand et al. , 2002; Marshall & Chan, 1996). A study
comparing a single 25 mg iodoacetate injection and 50 mg weekly cartilage wear particle injections
for 7 weeks in donkey knees showed that significant changes in lameness score, carpal score and
joint flexion angle were much slower to develop in knees treated with cartilage particles compared
to iodoacetate (Elmesiry et al. , 2014). While severe synovitis was present across all cartilage par-
ticulate induced animal models, a high concentration of cartilage particulates over a long period of
time was needed to induce marked cartilage degeneration.
From these animal models, it is believed that two mechanisms separate mechanism contribute
the degeneration of the knee joint. First, it is believed that the cartilage particulates may act as
abrasives on the cartilage resulting in the generation of even more cartilage debris. Second, as these
cartilage particles become embedded within the synovial membrane, they interact with both FLS
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Figure 1.4: A. Particulate size and volume distribution for a representative 24 hour test of cartilage-
on-cartilage surface wear. B. Wear particulate confocal z stack and angled z stack showing quali-
tative agreement between observed size distribution and coulter counter particle measurements for
representative of cartilage on cartilage wear. Image adapted from (Oungoulian et al. , 2013).
and synovial macrophages resulting in hyperplasia, dysregulation of synovial fluid lubricants and
the increased production of pro-inflammatory mediators and MMPs (Evans et al. , 1984; Evans
et al. , 1981b; Evans et al. , 1981a; Elmesiry et al. , 2014). These studies suggest that the presence
of high concentrations of cartilage wear particles alone are capable of causing OA-like changes in
healthy knee joints.
1.3.3.3 In vitro modeling and quantification of cartilage particle generation Loading,
gait and friction studies have confirmed in vivo observations regarding the presence of cartilaginous
wear particles in normal knee joints and their changing sizes and shape with increasing grades
of osteoarthritis. Previous cartilage surface friction studies have shown increased coefficients of
friction on the cartilage surface with increased loading time, accompanied by alterations in surface
topography, cartilage thickness (Forster & Fisher, 1999; Forster & Fisher, 1996) and generation
of debris (Stachowiak et al. , 1997). These findings also complement clinical and experimental
observations showing increased cartilage surface roughness with increased age due to increased wear
over time (Temple et al. , 2007; Temple-Wong et al. , 2009). More recently, it has been found
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Table 2: Overview of in vitro studies on the effect of different types of wear particles on different
cell types of the articular joint.
that the latest generation of particle analyzer are capable of measuring low levels of cartilage wear,
including the generation of micron sized particulates (Figure 1.4) (Oungoulian et al. , 2013).
1.3.3.4 In vitro effects of wear Particles Previous studies have looked at the effects of car-
tilage particles on synovial cells and chondrocytes in vitro. Evans et al. cultured human FLS with
cartilage particles taken from human synovial aspirates resulted in increased enzymatic degradation
(Evans et al. , 1981b). However, this study failed to isolate the importance the concentration of the
wear particles, secondary effects from remaining synovial fluid and particle effects on the FLS phe-
notype. Similarly, Cameron-Donaldson et al. co-cultured chondrocytes with wear particles derived
from homogenized irradiated cartilage and found increased gene expression of TNF-α (Cameron-
Donaldson et al. , 2004). While these studies do show that cartilage particles can result in cellular
changes, future studies, need to be carried out to determine at what concentration these changes
occur as well as how wear particle effect cellular function, phenotype and expression of other OA
chemokines and cytokines.
Monolayer cell culture has long been used to study the effects of biologic and synthetic partic-
ulates on cells. Many of these studies have been performed in the absence of immune cells, such
as monocytes or macrophages, to isolate increases in cytokine and chemokine production by non-
immune cells in vitro. Various cell types across a number of species have been plated in direct
co-culture systems with UHMWPE and titanium wear particles. While the most common method
19
of determining particle-induced effects is to apply a specific number of particles per cell (Chiu et al.
, 2009; Chang et al. , 2008; Haleem-Smith et al. , 2012; Park et al. , 2013), other methods include
mass per number of cells or volume percentage measurements. Across the board, adding wear parti-
cles of any material to each of the cell types resulted in changes to cellular viability and function and
resulted in increased expression of chemokines and cytokines. Other studies have also linked cellu-
lar chemotaxis to wear debris with up-regulation of factors such as monocyte chemotactic protein-1
(MCP-1) and IL-8 (Goodman & Ma, 2010) (Table 2).
Most of the wear particulates studied in the literature, particularly synthetic particles, have
been less than 10 μm in size. As a result, many of these studies observed the potential for cells
such as chondrocytes to become phagocytic and to engulf the wear particles (Chang et al. , 2008;
Castillo & Kouri, 2004). While this may be a physiologically relevant phenomenon, these studies
do not investigate biologic particles (small or large) also observed in situ that may or cannot be
phagocytosed by the cells and must be degraded through other mechanisms to recapitulate the
conditions of the osteoarthritic synovial joint.
20
Part I
Understanding Synovial Inflammation in a
Bovine Culture Model
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Chapter 2 Characterization of the Response of Synovial Explant
Tissues to Pro-inflammatory Insult in a Physiologic
Culture Model
2.1 Introduction
Changes in the synovial structure leading to cartilage degeneration are observed in both osteoarthri-
tis (OA) and rheumatoid arthritis (RA). The healthy synovium is comprised of two cell types: type A
synovial macrophages (SM, ~5-20%) and type B fibroblast-like synoviocytes (FLS,80-95%) (Smith,
2011; Wilkinson et al. , 1992). In both RA and OA, the synovium undergoes a pannus-like thick-
ening as the result of proliferation of both cell types (Yuan et al. , 2004; Shibakawa et al. , 2003;
Furuzawa-Carballeda et al. , 2008). However, this ratio shifts with inflammation due to the invasion
of polarized inflammatory macrophages (O’Brien et al. , 2017; Ambarus et al. , 2012). In the in-
flamed synovium, both activated FLS and invading immune cells produce increased concentrations
of inflammatory factors and degenerative enzymes that break down cartilage and inhibit tissue re-
pair and regeneration (Attur et al. , 2010; Mathiessen & Conaghan, 2017; Scanzello & Goldring,
2012; Bartok & Firestein, 2010).
Stimulation of synovial explants with interleukin-1 or TNF-α has been shown to increase cellu-
larity (Cook et al. , 2007) and production of MMPs (Kjelgaard-Petersen et al. , 2015), prostaglandin
E2 (PGE2) (Hardy et al. , 2002), IL-6, and IL-8 (Beekhuizen et al. , 2011). While it is believed that
the increase in cellularity stems from both FLS proliferation and SM proliferation, the stability of
the healthy ratio and changes after cytokine treatment are unknown. Given that these cell types
are responsible for regulating the composition of the synovium, alteration in the cellular make-up
of the synovium may also translate to changes in extracellular matrix (ECM) composition.
Dexamethasone (DEX) has been shown as a critical compound for the maintenance of cartilage
explant properties (Bian et al. , 2010) and engineered tissue growth (Byers et al. , 2008; Lima et al.
, 2007) as well as for chondroprotection from pro-inflammatory mediators (Roach et al. , 2016; Lima
et al. , 2008b). The effects of DEX on the synovium have not been thoroughly characterized. It has
been previously been shown that DEX can modulate human FLS proliferation, prostaglandin E2
production (Gitter et al. , 1989)and B-cell activating factor (Reyes et al. , 2008). DEX has also been
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shown to induce chrondrogenic and osteogenic changes in mesenchymal stem cells (MSCs) such as
FLS (also known as synovium derived stem cells) (Sampat et al. , 2011; Langenbach & Handschel,
2013; Beane & Darling, 2012). Therefore, while chondroprotective to cartilage, DEX could also
cause dramatic changes to the ECM composition of the synovium.
Previous explant co-culture studies have looked at the contribution of the synovium to the
continued degradation of healthy, injured or cytokine treated cartilage. These results have all found
that synovial tissue is capable of producing factors that contribute to the the breakdown of cartilage
and inhibition of chondrocyte biosynthesis. Co-culture of the two tissues also led to an increase in
MMPs and aggrecanases (Cook et al. , 2007; Lee et al. , 2009; Patwari et al. , 2009a; Fell & Jubb,
1977). Additionally, the culture of OA synovium with OA knee cartilage resulted in the GAG loss
due to inhibition of total proteoglycan synthesis due to the release of cytokines and MMPs by the
OA synovial tissue (Beekhuizen et al. , 2011). Yet these studies are focused on the effects of the
synovium on cartilage and do not look at changes that occur to the synovium itself after cytokine
stimulation or co-culture.
In this present study, we investigate the effect of pro-inflammatory and anti-inflammatory me-
diators on the synovium, specifically the ECM composition, surface markers and ratio of FLS to
macrophages. Co-culture with cartilage provide a physiologic culture environment to see if cartilage
explants can modulate the response of the synovium to in the presence of absence pro-inflammatory
or anti-inflammatory factors. We hypothesize that the synovium alone could induce inflammatory
changes in the cartilage and that pro-inflammatory or anti-inflammatory factors would increase or
decrease the inflammatory response in both tissues.
2.2 Materials and methods
2.2.1 Sample preparation and culture
Synovium and articular cartilage were harvested from juvenile bovine knees (2-4 weeks old). Synovial
tissue was cut into equal size pieces (~1mm x 1mm). Middle zone explants were obtained using a
4mm biopsy punch and by removing both the superficial and deep zone layers. Synovial tissue and
cartilage tissue samples were cultured alone or together in a Transwell® co-culture system (Figure
2.1 for two weeks in chemically defined serum-free medium comprised of: Dulbecco’s Modified Eagle
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Figure 2.1: Schematic of explant co-culture system. Cartilage explants were place in the top chamber
of the Transwell® (I). Synovial explants were placed in the bottom chamger (II). Both top and
bottom chambers of the Transwell® were filled will CM 100 nM DEX 10 ng/mL IL-1.
Medium (DMEM, Life Technologies, Carlsbad, CA), 1% ITS + premix (BD Biosciences, San Jose,
CA), 50mg/ml L-proline, 0.9mM sodium pyruvate, 50 ug/mL ascorbic 2-phospate (Sigma-Aldrich,
St. Louis, MO) (Byers et al. , 2008; Lima et al. , 2008b; Bian et al. , 2010; Bian et al. , 2008). To
study the effects of pro-inflammatory media and chondroprotective mediators on the synovial joint
tissue alone and in co-culture, 10ng/mL of interleukin-1α (IL-1), 100 nM dexamethasone (DEX) or
10ng/mL IL-1 and 100 nM DEX (ILDEX) were added to each tissue combination.
2.2.2 Mechanical testing
Mechanical properties of cartilage explants were characterized using a custom unconfined compres-
sion testing device with rigid-impermeable platens. Samples were equilibrated under a creep load
of 10 grams and stressed to 10% of the thickness at a strain rate of 0.05%/second to determine
the equilibrium Young’s Modulus (EY). To determine the dynamic modulus (G*) a 1% sinusoidal
strain in either direction was applied at 0.01Hz (Soltz & Ateshian, 1998; Mauck et al. , 2000).
2.2.3 Determination of CD14 positive cells
To determine the percentage of macrophages (CD14 positive cells) or FLS in explants cultured
with or without IL-1 or DEX, after 2 weeks of culture synovial explants were digested with type II
collagenase (Worthington Biochemical Corporation, Carlsbad, CA). The resulting number of cells
was counted. A negative isolation was performed using CD14 Dynabeads (Invitrogen, Carlsbad,
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CA) (Sampat et al. , 2011) Briefly, the cells were suspended in phosphate-buffered saline (PBS)
with 0.1% bovine serum albumin (BSA) and 2 mM EDTA (Sigma-Aldrich) at a concentration of
10x106 cells/mL. The Dynabeads were suspended in PBS with 0.1% BSA, and then mixed with the
cell suspension (50 mL of beads per 1x109 cells) for 30 min at 4°C. The synovial fibroblasts and the
CD14 cells bound to the Dynabeads were separated using the DynaMag-15 magnet (Invitrogen).
The isolated FLS were counted and used to determine the percent FLS in the explant tissues.
2.2.4 Biochemical analysis
Cartilage tissues were weighed wet prior to lyophilization. All tissues were frozen, lyophilized,
weighed dry and digested 0.5 mg/mL of proteinase K (MP Biomedicals, Santa Ana, CA, USA) in
50 mM Tris buffered saline containing 1 mM EDTA, 1 mM iodoacetamide and 10 μg/ml pepstatin
A for 16 hours at 56°C (Riesle et al. , 1998). Aliquots were analyzed for DNA, glycosaminoglycan
(GAG) and collagen (COL) using the picogreen (Invitrogen) (McGowan et al. , 2002), 1,9 dimethyl-
methylene blue (DMMB) (Sigma Aldrich) dye-binding (pH=1.5) (Farndale et al. , 1982; Farndale
et al. , 1986; Zheng & Levenston, 2015), and orthohydroxyproline () assays. In the OHP assay,
the proteinase K digested sample was hydrolyzed with 12 N HCl at 110°C overnight, dried, and
re-suspended in assay buffer. OHP content was determined using a colorimetric assay in which
chloramine T was reacted with dimethylaminobenzaldehyde and quantified using a 1:7.64 OHP-to-
collagen mass ratio (Riesle et al. , 1998; Hollander et al. , 1994).
2.2.5 Media analysis
Media samples were collected at each feeding as well as at the terminal (day 14) time point. All
media samples were analyzed for GAG released to the media using the DMMB assay and for nitric
oxide (NO) using the Griess Reagent Kit for nitrite quantification (Life Technologies). The total
GAG released and total NO produced by the tissues was computed as the sum of the intermediate
and final media collections.
2.2.6 Immunohistochemical analysis
Synovial tissue was fixed in 4% paraformaldehyde (PFA) for up to 24 hours. After fixation, tissues
were dehydrated and paraffin embedded. Tissues were sectioned at 8μm thickness. Immunohis-
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Figure 2.2: Gross morphology image of cartilage explants and synovial explants. Scalebar for all
samples except day 0 is the same. Scalebar = 5mm.
tochemistry was performed to detect distribution and expression of lubricin and VCAM-1 (rabbit
polyclonoal, Abcam, Cambridge, MA). Prior to immunohistochemical staining tissues were deparaf-
finized, rehydrated and subjected to antigen retrieval prior to application of primary antibodies.
Primary antibodies were incubated with samples overnight at 4°C. Samples were washed and devel-
oped using a horseradish peroxidase detection kit (AbCam).
2.2.7 Statistical analysis
GraphPad Prism 7 was used to perform statistical analysis. The results of a pilot study were used to
determine the number of samples needed to at least 80% power with G*power (α=0.05) (Faul et al.
, 2007). Data was checked for normality and homogeneity Kolmogorov-Smirnov Test and Levene’s
test in R (version 3.3.2). Data that did not satisfy these conditions for analysis with Analysis
of Variance (ANOVA) were adjusted using a log transformation. The percent of FLS in synovial
explant tissues was analyzed using a one-way ANOVA with Tukey’s honest significant difference
(HSD) post-hoc test. For both synovial and cartilage tissue samples, a two-way ANOVA with post-
hoc Tukey’s HSD test (n=11-12, α=0.05) was used with culture condition (alone or co-culture) and
treatment as the main factors.
2.3 Results
2.3.1 Cartilage tissue mechanical and biochemical characterization
Cartilage explants cultured in the absence of DEX experienced swelling (Figure 2.2) accompanied by
a significant increase in water content (data not shown). No differences in swelling or water content
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Figure 2.3: Equilibrium Young’s (A) and dynamic modulus of cartilage explants. (C) Dry weight
(DW), (D) GAG/DW and (E) COL/DW of cartilage explants. Data presented as mean and standard
deviation (n=10-12). Groups with different letters indicate significant differences (p<0.05).
were observed between cartilage samples cultured with and without synovium. Accordingly, the
equilibrium Young’s modulus and dynamic modulus were significantly decreased in control (CTL)
and IL treated cartilage explants after 14 days, regardless of culture conditions. DEX and ILDEX
treated explants demonstrated increased stiffness with time in culture, as increases were observed
in both the equilibrium modulus and dynamic modulus (Figure 2.3A,B). CTL, DEX and ILDEX
treated cartilage explants retained their day 0 ECM composition, as there were no significant dif-
ferences observed in tissue dry weight (DW), GAG/DW (%) and COL/DW (%) (Figure 2.3C,D,E).
CTL and IL had significantly higher DNA content than DEX and ILDEX treated cartilage samples
in both cartilage only and co-culture groups. DNA content was significantly lower in all co-culture
groups compared to cartilage only controls (data not shown). GAG/DW (%) of IL treated samples
dropped from 36.49 ± 5.86% at day 0 to 15.95 ± 8.28% and 18.53 ± 11.28% for cartilage only and
co-culture groups (Figure 2.3D). Collagen content was significantly greater than day 0 composition
in IL treated sample treated alone (41.96 ± 4.31% vs. 64.49 ± 20.30%, Figure 2.3E). Across all
measured factors for cartilage tissues, co-culture had no effect (pEY= 0.63, pG*=0.92, pDW= 0.47,
pGAG= 0.91, pCOL= 0.076).
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Figure 2.4: Biochemical analysis of synovial explants as determined by dry weight (DW) (A),
DNA/DW (B), GAG/DW (C) and COL/DW (D). Data presented as mean and standard deviation
(n=10-12). Groups with different letters indicate significant differences (p<0.05).
2.3.2 Synovial tissue cellular and matrix composition
Synovial gross tissue morphology and cellular composition was modulated by experimental treat-
ments. CTL, IL and ILDEX treated tissue samples contracted into pellet-like structures with time
in culture, while DEX treated explants retained their initial sheet-like morphology. Additional con-
traction was observed in in all co-cultured synovial tissues (Figure 2.2). However, the change in
gross tissue morphology was not accompanied by a change in sample dry weight (Figure 2.4A).
Tissue treatment (p<0.0001) and co-culture (p= 0.004) as well as the interaction of the two
factors (p=0.0125) had a significant effect on overall DNA content of synovial tissue explants (Fig-
ure 2.4B). In synovial tissue only cultures, DNA content increased significantly in IL and ILDEX
treated synovial explants, compared to day 0 and CTL tissues. Only IL treated tissues had signifi-
cantly higher DNA content than DEX treated samples. In terms of cellularity, day 0 explants were
determined to contain 94.38 2.89% FLS. The percent of FLS cells in the synovial explants dropped
from day 0 values to 30.25 ± 11.95% in CTL, 66.27 ± 6.96 % in DEX and 13.00 ± 2.828 % in IL
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Figure 2.5: Dynabead determination of CD14 positive cells in synovial explant cultures. FLS =
Fibroblast-like synoviocytes. SM = Synovial Macrophages. Data presented as mean and standard
deviation (n=2-4). * p<0.05 vs. day 0, ** p<0.05 vs. CTL and IL.
treated explant tissues (Figure 2.5).
The GAG content of CTL (1.36 ± 0.34% and 1.29 ± 0.28%) and IL treated ( 1.34 ± 0.33%
and 1.415 ± 0.21% ) synovial tissues was significantly higher than day 0 explants (0.94 ± 0.24%)
regardless of culture condition (Figure 2.4C). Collagen content was significantly lower in IL treated
synovial explants in the absence of cartilage (39.55 ± 11.68%), compared to day 0 (54.25 ± 12.35%)
values only (Figure 2.4D). Co-culture treatment had no effect on GAG (p=0.67) or collagen content
(p=0.21) of synovial explant tissues.
No differences in expression of VCAM-1 or lubricin were observed between synovial explants
cultured with or without cartilage (not shown). IL treated synovium had increased expression of
both markers at the intimal surface of the synovial tissue and throughout the tissue. Meanwhile,
DEX treated synovial samples had decreased expression of lubricin as little positive stain was
observered throughout the tissue. Synovium samples treated with ILDEX had similar VCAM-1
and lubricin expression at the intimal surface as synovial explant controls (Figure 2.6).
2.3.3 Media composition
Culture (pmGAG=0.007, pNO<0.0001) and cytokine treatment (pmGAG<0.0001, pNO<0.0001) and
the interaction of the two factors (pmGAG<0.0001, pNO<0.0001) had significant effects on GAG loss
to the media as well as the production of NO. Synovial tissue explants released no measurable GAG
into the media. In cartilage explant only culture, GAG release was the least in samples treated
with DEX and the greatest in samples treated with IL. No difference in % GAG loss was detected
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Figure 2.6: Representative images of staining for VCAM-1 (Top) and lubricin (Bottom) expression
in synovial explants. Scalebar = 200μm.
between CTL and ILDEX cartilage explants. In co-culture samples, GAG loss was also greatest
after IL treatment, however there were no differences in total GAG lost between IL treated cartilage
only and co-culture samples (55.10 ± 21.04% vs 56.52 ± 19.13%). On the contrary, no differences in
% GAG were detected between DEX and ILDEX co-culture groups. However, the percent of GAG
lost to the media was greater in CTL co-culture samples (15.48 ± 5.68%) compared to untreated
cartilage only explants (7.92 ± 1.14%, p<0.0001, Figure 2.7A).
Significant differences in NO in the media were observed between all synovium treatments. IL
treated synovium had the greatest concentration of NO (33.61 ± 3.12μM), followed by CTL (28.07
± 2.64μM), ILDEX (21.15 ± 2.81 μM) and DEX (15.66 ± 2.44 μM, Figure 2.7B)). The difference
between DEX and ILDEX synovium NO synthesis was likely due to a 2-fold increase in NO after
the first feeding only. Similar trends in NO production were observed in cartilage explants, except
for a 5-fold difference in NO between DEX and ILDEX treated samples was observed after the first
feeding.
Co-culture with synovium induced a synergistic increase in total NO production, with all treat-
ments resulting in higher media NO concentrations than the sum of NO media concentrations of
the individual tissue samples. CTL (159 ± 18.9 M) and IL (395 ± 26.77 μM) co-culture samples
had a significantly higher concentration of NO in the media than DEX (106 ± 3.02M) and ILDEX
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Figure 2.7: % GAG lost to the media (A) and total media nitric oxide (NO) of cartilage and synovial
explants. % GAG loss was calculated at GAG in the media divided by the total amount of GAG in
both explants and media Data presented as mean and standard deviation (n=10-12). Groups with
different letters indicate significant differences (p<0.05).
samples (109 ± 8.59 μM) (Figure 2.7).
2.4 Discussion
Here, we employ the use of an explant co-culture model to investigate regulation of the synovium
by pro-inflammatory cytokines and corticosteroids as well as the combination of the two factors.
As has been shown previously by our lab, IL treatment of cartilage explants results in decreased
mechanical properties and GAG content (and thus an artificial increase in collagen content) (Lima
et al. , 2008b; Bian et al. , 2009). The degradative effects of IL can be overcome by the addition of a
chondroprotective corticosteroid, such as DEX (Lima et al. , 2008b; Roach et al. , 2016; DeRijk et al.
, 1997; Huebner et al. , 2013; Huebner et al. , 2014). While previous studies observed significant
cartilage degradation after co-culture with synovium, the present study in serum-free media found
that co-culture with synovium alone had no effect on cartilage explant mechanical properties or
ECM composition. These previous studies were cultured in media containing FBS, which has been
shown by our lab to induce degenerative changes (loss of mechanical properties and decrease ECM
composition) in cartilage explants with time in culture compared to serum-free media (Bian et al. ,
2010; Bian et al. , 2008). Thus, we suspect that the combination of FBS with synovial macrophages
and cytokines magnified the degradative effects of FBS on the cartilage explants.
The cellular composition of the synovium was determined by culture conditions (Figure 2.5).
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Macrophage composition has been identified as key regulator in activation of FLS and of response
of synovial tissues to cytokine stimulation(Fichadiya et al. , 2016). In all culture groups, the
percentage of macrophages increased with time in culture. However, groups cultured in the absence
of DEX had the highest percentages of SM. Based off the percent increases in SM and total DNA
content in IL treated synovial explants, we can postulate that IL stimulates proliferation of both
FLS and SM (Figure 2.4B). Based on the total percent increase in DNA in DEX treated synovial
explants, we can infer that the increase in DNA content resulted simply from the proliferation of SM
(Figure 2.4B). However, DEX may polarize SM to an anti-inflammatory state, such that this shift
is chondroprotective to the joint (Kennedy et al. , 2011). As such, the observed increase in SM may
lead to the production of anti-inflammatory factors. Lastly, given that untreated synovial explants
tissues resulted in an increase in the percentage of SM and no change in total DNA (Figure 2.4B),
these tissues likely released FLS to the media (Katagiri et al. , 2017). In all cases, co-culture with
cartilage seems to slightly modulate the magnitude of this shift, although not significantly. Future
work will further characterize this cellular phenotype shift in co-culture and with ILDEX.
The ECM composition of the synovium was also regulated by IL, which caused a significant
increase in GAG and decrease in collagen content (Figure 2.4). This is surprising since interleukin-1
and TNF- have been shown to inhibit chondrogenesis of MSCs. These ECM effects were mitigated
slightly by co-culture with cartilage, again suggesting a beneficial effect of cartilage on the synovium
(Ousema et al. , 2012; Wehling et al. , 2009). However, this maybe a niche dependent phenomenon
as TNF-α has been shown to promote proliferation and chrondrogenic potential in stem cells derived
from the synovium (Shioda et al. , 2017), explain the increase in GAG content. Since IL stimu-
lates MMP production by both FLS and SM, it is expected that collagen content of the synovium
decreased as a result of the elevated media concentration of MMPs (Furuzawa-Carballeda et al. ,
2008; Attur et al. , 2010; Mathiessen & Conaghan, 2017; Scanzello & Goldring, 2012; Kolomytkin
et al. , 2002).
While VCAM-1 is expressed by FLS cells residing within the synovial intima (Smith, 2011;
Bartok & Firestein, 2010), VCAM-1 expression has been shown to be upregulated in synovial tissue
and in FLS collected from OA patients (Schett et al. , 2009; Kalichman et al. , 2011). It is also
believed that in the inflamed synovium, VCAM-1 may be involved with the initiation of mononuclear
infiltration, although the exact mechanism remains poorly understood (Liu et al. , 2013). Thus,
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VCAM-1 has emerged as a marker of synovial inflammation. Here, positive VCAM-1 expression was
present in the intimal layer of all tissues. However, the area of positive staining was greatest in the
IL treated synovial tissues, indicative of a greater inflammatory response. Some additional VCAM-1
staining was also observed in the vasculature of the sub-intima (Figure 2.6) (Smith, 2011; Smith
et al. , 2003b). Similarly, CTL, IL and ILDEX treated synovial explants had increased lubricin
staining compared to DEX treated synovial explants (Figure 2.6). While lubricin expression is
decreased in OA cartilage, concentrations of lubricin in OA synovial fluid and within OA synovium
are elevated compared to healthy levels (Reesink et al. , 2017; Alquraini et al. , 2015). Further, it
has been previously shown by our lab and others that IL stimulated FLS secreted increased amounts
of lubricin (Blewis et al. , 2010b; Stefani et al. , 2015).
Loss of GAG to the media was greatest after IL treatment in both cartilage and co-culture
groups. No significant difference was observed between the two groups, likely due to magnitude
of the drop in GAG content in the cartilage samples for both groups. In cartilage only samples,
GAG loss was reduced only in the DEX only groups. However, in the co-culture groups, GAG was
significantly greater in the controls compared to DEX and ILDEX. While GAG content was not
changed by the synovium, the overall biosynthesis was shifted by factors released by the SM as
demonstrated by increase GAG loss in co-culture groups (Figure 2.7A). Similarly, DEX modulated
NO production by FLS and SM in the synovium and chondrocytes in the cartilage explants in the
presence and absence of DEX, indicative of its anti-inflammatory effects (Li et al. , 1995; Abramson,
2008; Scher et al. , 2007). The inflammatory factors released by unstimulated SM and IL stimulated
FLS and SM also increased NO in co-culture groups. However, while DEX was able to reduce NO
even after IL stimulation, the overall NO in the media was greater than the sum of synovium and
cartilage alone for each group (Figure 2.7B) . Thus, there is still some underlying cross talk between
the two tissues that promotes NO (Olson & van der Vliet, 2011; Huh et al. , 2015).
DEX successfully modulated the inflammatory effects of IL on synovial joint tissues and pro-
moted a healthier phenotype of synovial tissue in serum-free culture. While this study utilized a
low dose of DEX over two weeks, DEX is often administered at high concentrations over multiple
injections due to rapid clearance from the joint space, which can have harmful effects on joint health
(Gerwin et al. , 2006). Current therapeutic approaches utilizing DEX are considering intra-articular
injections (Huebner et al. , 2013; Huebner et al. , 2014) or slow release from within polymer micro-
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spheres (Roach et al. , 2016). Future work is needed to characterize the long-term effects of DEX
on the synovium, including regulation of synovial transport and the secretion of lubricants that
are required for normal joint articulation. Inflamed synovium and activated FLS produce increased
volumes of hylauronan and lubricin(Blewis et al. , 2010b). DEX may be able to counteract this
increased biosynthesis by blocking the synovial activation by IL-1 or TNF-α (Henderson et al. ,
1991; Arend & Dayer, 1995).
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Chapter 3 Development and Characterization of a Synovium
Model to Study the Chemical and Physical Mediators
of Synovial Inflammation
3.1 Introduction
Tissue wear occurs as the result of articulation between load bearing surfaces (Jay et al. , 2007).
Increased cartilage wear, leading to formation of loose particles in the joint space, has been linked
to aging, overuse and obesity (Griffin & Guilak, 2005), often leading to osteoarthritis (OA). Several
studies have investigated using synovial fluid aspirates to diagnose OA by characterizing cartilage
wear particles in the synovial joint (Kuster et al. , 1998; Hakshur et al. , 2011; Evans et al. , 1981a).
Clinically, it has been observed that cartilage and bone debris are bound to the surface or embedded
deep within the synovial membrane of patients suffering from capsular synovial hyperplasia and
metaplasia6. It has been hypothesized that the fibrotic shortening of the synovial capsule and
synovitis result in OA-associated pain and contribute to further degradation of cartilage (Lloyd-
Roberts, 1953; Attur et al. , 2010). To provide pain relief to patients with OA, surgeons often
use arthroscopy with lavage and synovectomy to remove tissue debris from the joint space and
the synovium, however its success as a preventative measure has been widely debated (Felson,
2010; Pitta et al. , 2016). Characterizing the interaction between cartilage particulates and the
synovium is important for understanding why lavage is successful in some but not all patients; it
may also explain how increased concentrations of cartilage debris may contribute to the progression
of osteoarthritic changes via the synovium. Despite mounting in vitro and in vivo evidence of
the deleterious effects of cartilage particulates on joint health, the mechanisms that mediate their
negative interactions with synovial cells remain poorly understood.
In vivo studies have investigated the biological effects of cartilage wear particles on synovial joint
health and disease progression in animal models (Chrisman et al. , 1965; Hurtig, 1988; Evans et al.
, 1984). For the latter, animals developed synovitis shortly after joint injection with particulates,
which persisted and was accompanied by the infiltration of mononuclear cells and capsular, fibrotic
thickening of the synovium (Evans et al. , 1984). Notably, the injected particles were still present
and embedded within the synovium months later (Chrisman et al. , 1965; Evans et al. , 1984).
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Monolayer cell and particulate co-cultures have previously been used to study the effects of
biologic and synthetic particles on cells. While the most common method of determining particle-
induced effects is to apply a specific number of particles per cell (Chang et al. , 2008; Haleem-Smith
et al. , 2012; Park et al. , 2013), measuring particulate mass per number of cells is also commonly
used (Evans et al. , 1981b; Cameron-Donaldson et al. , 2004). Adding wear particles of any material
to cells can change cellular viability, metabolic activity, function and expression of OA specific
markers. Specifically, treatment of human fibroblast-like synoviocytes (FLS) or chondrocytes with
cartilage particles results in increased proteinase activity (Evans et al. , 1981b) and tumor necrosis
factor- α (TNF-α) gene expression (Cameron-Donaldson et al. , 2004). Lacking the availability of
techniques to measure precisely the number or size of particles being used for treatment, previous
studies examined biologic wear particles by mass, with an undefined size distribution. As such, it
has been difficult to determine if the mechanism involved in driving the response of FLS to cartilage
particulates is mediated by phagocytosis, cell surface contact or a combination of both.
Studies typically use synthetic particles that are 0.2-7μm in size (Chang et al. , 2008; Haleem-
Smith et al. , 2012; Park et al. , 2013; Okafor et al. , 2006; Chiu et al. , 2009), as particles <15μm
in diameter, are readily phagocytosed by chondrocytes, macrophages, FLS and mesenchymal stem
cells (MSCs) (Greis et al. , 1994; Olson et al. , 1988). Compared to these non-biologic (metal or
plastic) wear particles, biologic (cartilage) wear particles are more complex to study because they
are composed of extracellular matrix (ECM) proteins that can be phagocytosed or degraded by, or
bound to cells. This study aims to better understand the interplay of cartilage particulates with
cytokines on cells of the synovium to foster the development of effective strategies to mitigate the
inflammatory effect of cartilage particulates in OA.
3.2 Materials and methods
3.2.1 Experimental design
Three studies are discussed in this paper (outlined in Figure 3.1). Study 1 optimized the treatment
dosage of sub-10μm cartilage or 1μm latex particles. Particle concentrations up to 1000 particles
per cell were cultured for 5 days with confluent FLS monolayers to determine a dose that would
elicit a cellular response without compromising cell viability (n=3-4/group). The lowest particle
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Figure 3.1: Schematic of the experimental study design. In study 1, FLS were cultured for 5 days
with increasing concentrations of latex or cartilage particulates (up to 1000:1 particles:cells). In
study 2, FLS were cultured for 5 days in the presence or absence of 250 latex or cartilage particles
per cell and 10 ng/mL IL-1α or TNF-α. In study 3, FLS were cultured in the presence (FLS + CART)
or absence (FLS) of 250 cartilage wear particles per cell for 5 days. Concurrently, media alone and
particles alone were also cultured. Conditioned media from each donor group was combined with
fresh media and added to recipient cultures for 5 days.
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dose that resulted in significantly altered metabolic activity, as determined by the MTT assay, while
preserving cell viability, was selected for subsequent experiments. A dosage of 250 particles per cell
was selected for future experimentation for both latex and cartilage particles.
In study 2, cells were co-cultured for 5 days with 250 cartilage particles per cell in the presence or
absence of 10 ng/mL of interleukin-1 (IL-1, Life Technologies) or TNF- (Life Technologies, Carlsbad,
CA) (n=6-8/group). These concentrations are previously established for studies of cytokine effects
on joint tissues (Gitter et al. , 1989; Lima et al. , 2008b; Mohanraj et al. , 2014). FLS were also
cultured 250 latex particles per cell to establish a baseline non-biologic particle response. In study
3, designated donor cultures were maintained in media in the presence (FLS + CART) or absence
(FLS only) of 250 cartilage particles per cell for 5 days. In parallel, cell-free cultures with (CART
only) or without particles (media only) were maintained for 5 days under the same conditions.
Conditioned media was removed from the four donor culture groups (media only, CART only, FLS
only, FLS + CART), and particles were removed via filtration with a 0.22 m filter in the particle
groups. This conditioned media was split with fresh growth media and added to the recipient FLS
monolayers for 5 days (n=5-8/group).
3.2.2 Isolation and culture of FLS and cartilage explants
Synovial tissue was harvested from three freshly slaughtered juvenile bovine knee joints (2-4 weeks
old) and digested in collagenase type II (Worthington Biochemical Corporation, Lakewood, NJ)
for 2 hours with stirring at 37°C. Digested cells (FLS) were filtered through a 70μm porous nylon
mesh. Viable cells were counted and plated at a density of 1.76 × 103 cells/cm2. To obtain a pure
cell population, FLS were expanded for two passages in α-Minimal Essential Medium (α-MEM, Life
Technologies) containing 10% fetal bovine serum (FBS), 1% antibiotic-antimycotic and fibroblast
growth factor (FGFFGF)-2 (Life Technologies) (Sampat et al. , 2011; Tan et al. , 2015b). Articular
cartilage explants were cored using a disposable biopsy punch (10 mm diameter, Acuderm® Inc.,
Fort Lauderdale, FL) and cultured in cartilage explant media (Albro et al. , n.d.) supplemented with
1% antibiotic-antimycotic, 1% non-essential amino acids (Sigma-Aldrich, St. Louis, MO), 1 mg/mL
bovine serum albumin (BSA), 50 μg/mL ascorbic acid (Sigma-Aldrich), 0.01 μg/mL hydrocortisone
(Sigma-Aldrich) and 0.002 μg/mL insulin (BD Biosciences, San Jose, CA) until use.
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3.2.3 Creation and characterization of in vitro synovium model
Confluent FLS were trypsinized, counted, re-suspended and plated at a density of 50 x 104 cells/cm2
in α-MEM (10% FBS, 1% antibiotic-antimycotic) supplemented with 50 μg/mL ascorbic acid to
allow the formation of a dense cell monolayer. After 5 days, confluent monolayers were fixed in
4% paraformaldehyde (PFA, Sigma-Aldrich) overnight at 4 °C before being washed in phosphate
buffered saline (PBS, Life Technologies). Cell monolayers were stained to determine the presence
of Type I collagen (rabbit polyclonal anti-collagen I, Abcam, Cambridge, MA), lubricin (rabbit
polyclonal anti-lubricin, Abcam) and DNA (4’,6-Diamidino-2-Phenylindole, Dihydrochloride, DAPI,
Life Technologies).
3.2.4 Particulate preparation and characterization of particles
Cartilage particles were generated aseptically from the superficial and middle zones by manually
abrading cartilage submerged in phosphate buffered saline (PBS) with waterproof 120 grit sandpa-
per (McMaster-Carr, Elmhurst, IL). Potential residual sandpaper particulates were removed gravi-
metrically and via sub-sequent filtration, as was confirmed through microscopic inspection of the
particulate solution. The resulting cartilage particle solution was sequentially filtered with 70μm,
40μm, and 10μm porous nylon mesh filters to achieve a sub-10μm particulate size. An aliquot of
either cartilage particles or 1μm latex particulates (Sigma-Aldrich) was further diluted in PBS,
counted and sized using a Multisizer 4 Coulter Counter (Beckman Coulter, Brea, CA) to determine
the concentration of both the cartilage particulate and latex particle solutions (Oungoulian et al.
, 2013). An average of 4 aliquots was used to determine the particle concentration of the stock
solutions and the average particulate size. Toxicity of sandpaper exposure to the cartilage surface
was evaluated by co-culturing suspended pieces of 120 grit sandpaper with passage 2 FLS plated at
a density of 50 x104 cells/cm2 in α-MEM (10% FBS, 1% antibiotic-antimycotic) supplemented with
50 μg/mL ascorbic acid. Viability and metabolic activity were assessed after 30 minutes, 60 min-
utes and 24 hours using the LIVE/DEAD Viability/Cytotoxicity kit (Life Technologies) and MTT
assay ((3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide, Sigma-Aldrich) (Kupc-
sik, 2011). Cell monolayers were incubated for 4 hours with 0.5 mg/mL MTT in growth media.
The media was replaced and the dye was solubilized in a 1:1 solution of isopropanol and dimethyl
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sulfoxide.
3.2.5 Microscope analysis of cell-particle interactions
To better characterize the interactions between latex and cartilage particles, cartilage particulates
were labeled with 20μM dichlorotriazinylaminofluorescein (DTAF, Sigma-Aldrich)(Oungoulian et al.
, 2013; Krahn et al. , 2006; Wood et al. , 2003). FLS were plated at either a low or high density
overnight before treatment with 250 fluorescently labeled cartilage particles, green-yellow or unla-
beled latex beads (Sigma-Aldrich) per cell for 2 days on glass coverslips. Prior to imaging, synovial
cells were stained with CellTraceTM Calcein Red-Orange AM (Life Technologies) to identify if par-
ticles were internalized or in contact with the cell surface. Alternatively, cells were cultured and
fixed in 4% PFA overnight, permeabilized with 0.1% Triton-X (Sigma-Aldrich) and washed with
PBS. After blocking with 1% BSA in PBS, cells were stained with TRITC-conjugated Phalloidin
(Millipore-Sigma) and counterstained with DAPI. Z-stack images were taken and reconstructed us-
ing a Zeiss LSM700 Confocal microscope (Zeiss, Oberkochen, Germany). For actin-DAPI stained
images with latex particles, non-fluorescent latex beads were used to eliminate the effects of chan-
nel bleed-through. For quantification of cell-particle interactions and spatial characterization, 3
blinded reviewers each counted 170 cells and 108 cells cultured with cartilage and latex particles,
respectively.
3.2.6 Biochemical analysis
Confluent cell sheets and media samples were frozen at -20 °C until use. Frozen monolayers and
cartilage particulates were lyophilized prior to digestion in proteinase K. Samples were analyzed
for DNA, GAG and collagen as described in 2.2.4. GAG and NO release to the the media were
determined as in 2.2.5 Prostaglandin-E2 (PGE2) released into the media was determined using
the PGE2 Parameter Assay Kit (R&D Systems Inc., Minneapolis, MN), respectively. Biochemical
content or media product concentrations of particles alone were subtracted from the measured values
of the resulting synovial sheet with particles to determine the contribution of treated FLS alone.
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Figure 3.2: Collagen I (green, A) and lubricin (green, B) vs. negative (C) staining of a FLS cells
sheet model of synovium. DAPI staining appears blue. Scalebar = 100μm.
3.2.7 Statistical analysis
Data sets were tested for normality and homogeneity using the Kolmogorov-Smirnov Test and Lev-
ene’s test, respectively. Non-normal and non-homogeneous data were adjusted using a log trans-
formation prior to analysis. For MTT dosage studies and conditioned media studies, a one-way
ANOVA with Tukey’s post-hoc test was performed. For cartilage biochemical analyses, a two-way
ANOVA with Tukey’s post-hoc tests with main factors set to cytokine and particle treatment was
utilized. For latex biochemical analyses, student’s unpaired t-test with unequal variances was used.
Statistical analyses were performed in Statistica (Statsoft, Tulsa, OK) and R version 3.3.2 with
α=0.05. Each data point represents the mean and 95% confidence interval.
3.3 Results
3.3.1 Characterization of FLS synovium culture
After 5 days, FLS organized into a multi-layer cell sheet that stained positive for collagen type I
and lubricin (Figure 3.2). Collagen I staining indicated the synthesis of a dense fibrous network
whereas lubricin staining was primarily co-localized intracellularly.
3.3.2 Optimization of particle treatment dose
Latex and cartilage particles had average diameters of 1.05 ± 0.0002μm and 0.85 ± 0.002μm, re-
spectively. Exposure to sandpaper up to 60 minutes had no toxic effects on the FLS as determined
by viability or metabolic activity (not shown). To identify an effective treatment dose of cartilage
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Figure 3.3: MTT assay for assessing the effect of increasing concentrations of cartilage (A) and latex
(B) particles on cellular metabolic activity. Data presented as mean and 95% confidence interval.
* p<0.05 vs. control (0:1 particles: cell), **p<0.05 vs. 100:1 cartilage particles: cell, *** p<0.05
vs. 250:1 cartilage particles: cell. # p<0.05 vs. control 0:1, 500:1, 750:1 and 1000:1 latex particles:
cells, ## p<0.05 vs. 0:1, 100:1, 250:1, and 500:1 latex particles: cells.
particles, dense monolayers were co-cultured with up to 1000 particles per cell (Figure 3.3). In-
creasing the dose of cartilage particles had no effect on cellular viability, as confirmed by increasing
metabolic activity observed in the MTT assay. Metabolic activity significantly increased compared
to controls for all doses ≥ 250 particles per cell (p=0.002; 250:1 vs. 0:1 particles per cell, Figure
3.3A). Thus, a dosage of 250 particles per cell was chosen for future experimentation, as it was the
lowest dose that increased metabolic activity without compromising viability. Only a dose of 1000
latex particles per cell resulted in significantly decreased metabolic activity and viability (p=0.003)
compared to no-particle controls (Figure 3.3B). 250 latex particles per cell resulted in a significant
increase in metabolic activity (p=0.04; vs. 0:1 particles:cells, Figure 3.3B), while maintaining cell
viability. Thus, 250:1 particles:cell was chosen for subsequent experiments. For both latex and
cartilage particles, 250 particles per cell comprised a dose that was <0.002 %v/v.
3.3.3 Characterization of the interaction between particles and FLS
Both latex and cartilage particles were phagocytosed by FLS (Figure 3.4, Figure 3.6A,B). Latex
particles were readily phagocytosed by FLS (73 ± 7%), with 5-20 particles internalized per cell
(Figure 3.6A). Meanwhile, cartilage particles were selectively phagocytosed by FLS, with positive
cells only internalizing 1-5 particles (Figure 3.4A,B). Z-stack reconstructions revealed two potential
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Figure 3.4: (A) Z-stacks of a synovial cell (red) cultured without (CTL) and with (CART) cartilage
wear particles (yellow/green). (B) 3D reconstruction. Top (C) and side (D) views of the 3D
reconstructions of actin staining from the cartilage particles are found on the cell surface (a) and
internalized by the cells (b). Particles indicated by white arrows. Scale bar = 20μm.
mechanisms of action: cartilage particle internalization or attachment to the surface of both dense
monolayers and individual cells (Figure 3.4). 79 ± 7 % of FLS were associated with a particle (either
phagocytosis or surface contact). Of these, 72 ± 11 % of cells had cartilage particles within their
cell boundaries (i.e., as a result of phagocytosis) while 32 ± 5% of the cells had cartilage particles
in contact with the surface. 24 ± 5% of the cells had particles both within the cell boundary and in
contact with the cell. Actin cytoskeleton staining revealed nuclear (internal) and cortical (external)
remodeling of the actin cytoskeleton around cartilage particles (Figure 3.4C,D), compared to only
nuclear (internal) remodeling of latex particulates (Figure 3.6B).
3.3.4 Effect of cytokines and cartilage or latex particles
Exposure to IL-1α or TNF-α had no effect on FLS proliferation (p=0.56, Figure 3.5A), however,
cytokines modulated the total ECM composition of the FLS sheets as well as the release of ECM
components and inflammatory markers to the media. Cytokine treatment had a significant effect
on GAG (p<0.00001) and collagen synthesis (p<0.00001). TNF-α treatment resulted in a decrease
in GAG content (p = 0.003, Figure 3.5B), while both IL-1α (p< 0.00001) and TNF-α (p < 0.00001)
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resulted in a significant decrease in collagen content compared to non-cytokine controls (Figure
3.5C). Overall, cytokine treatment resulted in a significant increase in media GAG (p<0.00001, NO
(p<0.00001), and PGE2 (p<0.00001) when normalized by DNA content (Figure 3.5D,E,F). IL-1α
had the greatest impact on PGE2 synthesis (p=0.0001; vs. no cytokine control), while TNF-α had
the greatest effect on NO synthesis (p=0.0001; vs. no cytokine control). Total GAG synthesis (sum
of FLS GAG + media GAG) was increased in IL-1α (p=0.0003; vs. no cytokine control) and TNF-α
stimulated cultures (p=0.0003; vs. no cytokine control).
Co-culture of FLS with cartilage particulates resulted in a significant increase in DNA content
of the cell sheet (p < 0.00001, Figure 3.5A). The DNA content of the cartilage particles themselves
constituted <1% that of the DNA of the cell monolayer (not shown). Treatment with cytokines did
not have an interactive effect on the proliferative behavior of FLS treated with cartilage particles
(p=0.46, Figure 3.5A). In the absence of cytokine insult, co-culture with cartilage particles had no
effect on GAG content (p=0.09, Figure 3.5B) and resulted in a significant change collagen content
(p<0.00001, Figure 3.5C) of the cell sheet. Cartilage particles and cytokines together significantly
reduced the GAG (p=0.01) and collagen content (p=0.02). Overall, GAG content in the media was
modulated by cytokines and particles together (p<0.00001, Figure 3.5D). NO levels were elevated
as a result of cartilage particle (p=0.00003) and cytokine (p<0.00001) treatments, as well as the
combined cartilage particle and cytokine treatment (p=0.003). Cell sheets treated with TNF-α
had NO levels equivalent to their cartilage particle treated counterparts (p=0.83, Figure 3.5E).
Lastly, cartilage particle treatment had an effect on the release of PGE2 compared to control cells
(p<0.00001). Cytokine and cartilage particles together also resulted in a significant increase in
PGE2 media concentrations compared to non-treated controls (p<0.00001, Figure 3.5F).
Treatment with latex particles alone had no effect on FLS proliferation (p=0.37, Figure 3.6C).
Co-culture with latex particles resulted in a decrease in the overall collagen synthesis by FLS
(p<0.00001, Figure 3.6D). NO synthesis was not altered by culture with latex particles (p=0.39,
Figure 3.6E). PGE2 was detectable only in latex particle treated samples, after pooling. No PGE2
was detected in control samples compared to 27.6±42.4 pg of PGE2/μg of DNA in latex treated
samples (p=0.11).
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Figure 3.5: Analysis of FLS cells sheets cultured ± IL-1 or TNF- and ± cartilage wear particles. The
DNA, ECM synthesis and media NO and PGE2 of the particles alone was subtracted from the total
to determine the final values. DNA (A), FLS cell sheet GAG (B), FLS cell sheet collagen (COL)
(C), media GAG/DNA (D), media NO/DNA (E) and media PGE2/DNA (F). Data presented as
mean and 95% confidence interval. ND= not detected. * p<0.05 vs. non-particle treated control
(CTL) with same cytokine treatment. # p<0.05 vs. - IL/-TNF, ## p<0.05 vs. + IL/-TNF within
CTL or CART treated samples respectively.
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Figure 3.6: (A) Z-stacks of a synovial cell (red) cultured with latex wear particles (yellow). B)
Actin (red)-DAPI (blue) staining showing remodeling of the cytoskeleton around the ingested latex
beads. Scale bar =20μm. Analysis of FLS cell sheets cultured latex particles for DNA (C), FLS cell
sheet COL (D) and media NO/DNA (E), all normalized by corresponding control (CTL) values.
Data presented as mean and 95% confidence interval. * p<0.05 vs. non-particle treated CTL.
3.3.5 Conditioned media study
FLS treated with Media only and CART only conditioned media proliferated to a greater extent
than FLS treated with FLS only conditioned media (p=0.0005) and FLS + CART conditioned
media (p=0.01, Figure 3.7A), respectively. No differences were observed between media only and
CART + media groups (p=0.90) and FLS + media only and CART + media + FLS (p= 0.70,
Figure 3.7A). No differences were detected in GAG synthesis (p=0.17, Figure 3.7B) and collagen
synthesis across all groups (p=0.20, Figure 3.7C). As such, the response of FLS to cartilage particles
appears to require particulate surface binding and/or phagocytosis.
3.4 Discussion
Previous research has identified the deleterious effects of cartilage wear particles on FLS and
suggested that they play an important role in the pathogenesis of OA and degenerative joint
changes(Evans et al. , 1981b). Here, we adopted FLS monolayer cultures as a two-dimensional
synovium model to further characterize the interaction of cartilage particles with FLS. The in vitro
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Figure 3.7: DNA (A), FLS cell sheet GAG/DNA (B), and COL/DNA (C) for the conditioned media
experiment. Data presented as mean and 95% confidence interval. * p<0.05 vs. Media only. #
p<0.05 vs. Particles only.
FLS system was comprised of a dense cell sheet that was a few cells thick and positively expressed
both collagen I and lubricin, similar to the native synovial lining (Smith, 2011; Kiener et al. , 2010;
Ashhurst et al. , 1991). The results of this study demonstrate the inflammatory response of FLS
to sub-10μm cartilage particles cartilage debris in vitro and evaluates two potential mechanisms of
action: phagocytosis and surface contact.
The particulate doses (up to 1000:1 particles per cell) examined and used in this study may
be compared to the range of values used for previous wear particles studies on various adult cell
types involving cartilage (Evans et al. , 1981b), latex (Okafor et al. , 2006), polyethylene (Park
et al. , 2013; Chiu et al. , 2009) and titanium (Haleem-Smith et al. , 2012; Okafor et al. , 2006; Seo
et al. , 2007) that quantified dose in terms of weight/cell (Evans et al. , 1981b; Cameron-Donaldson
et al. , 2004), volume percentage (Haleem-Smith et al. , 2012; Chiu et al. , 2009; Seo et al. , 2007)
and particles per cell (Chang et al. , 2008; Okafor et al. , 2006). Similar to other non-biologic
particles such as titanium, the viability of the synovial sheet cultures was decreased by increasing
concentrations of latex particles (Haleem-Smith et al. , 2012).
Microscopy confirmed that sub-10μm cartilage particles interact with FLS through both phago-
cytosis and surface contact. Both latex control and cartilage particles showed re-arrangement of
the actin cytoskeleton around the wear particulate (Figure 3.4C,D and Figure 3.6B), as has been
previously observed for osteoprogenitors and MSCs (Haleem-Smith et al. , 2012; Okafor et al. ,
2006) treated with titanium particles. Here, we observed a remodeling of the actin cytoskeleton at
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the surface to form a U-shaped organization at the cell- cartilage particulate contact site (Figure
3.4D).
Treatment of the synovium model with IL-1α and TNF-α, commonly utilized cytokines for in
vitro modeling of OA (Goldring, 1999), modulated ECM composition and increased secretion of
inflammatory factors. Specifically, FLS treated with cytokines demonstrated a marked drop in
cell sheet collagen content and increased media concentrations of NO and PGE2, indicative of
an inflammatory response. Previous research on the effect of human FLS cells has shown that
inflammatory cytokines increase cell proliferation, perhaps explaining the thickening of the synovial
capsule observed in OA-associated synovitis (Gitter et al. , 1989; Pulkki, 1986; Nishimoto et al. ,
2000). The previously observed proliferative stimulus provided by these pro-inflammatory cytokines
may have inhibited by the presence of growth factors in FBS used to supplement the culture media
in the present study (Blewis et al. , 2010a; Russell & Hamilton, 2014). Cytokine stimulated FLS
have been shown to produce a number of inflammatory factors involved in OA and RA, including
IL-6, IL-8, NO, and PGE2 (Gitter et al. , 1989; Pulkki, 1986; Nishimoto et al. , 2000; Ribel-Madsen
et al. , 2012) that can lead to matrix degradation, as observed here. PGE2 is known to activate
MMP expression leading to cartilage degeneration (Attur et al. , 2008), reinforcing the role of the
synovium in continued cartilage matrix degradation.
Co-culture of FLS with cartilage particles resulted in proliferation of FLS that was not further
modulated by the addition of inflammatory cytokines (Figure 3.5A). Moreover, exposure to carti-
lage particles alone resulted in increased production of key inflammatory factors (i.e. NO, PGE2)
and thickening of the cell sheet through increased collagen content (Figure 3.5C). These in vitro
findings confirm the results of previous animal model studies showing that cartilage particles alone
can lead to synovitis and increased capsular thickening (Evans et al. , 1984; Chrisman et al. , 1965).
Supplementation of cartilage particle treated FLS cell sheets with inflammatory cytokines did dif-
ferentially modulate the ECM composition, suggesting that the response of cartilage wear particles
may have differing effects on synovial tissue health and cartilage degradation in late stage OA when
cytokine levels are significantly upregulated.
Cells with media only and particle conditioned media proliferated greater than cells treated
with FLS or FLS + Particle conditioned media, likely due to the depletion of nutrients in cell con-
ditioned media. Conditioned media studies with media from cartilage particles alone and cartilage
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particle treated cells showed that the particles themselves are not leaching factors driving the rapid
proliferative or inflammatory response of treated fibroblasts. Accordingly, contact is required for
the mechanisms of action to have an impact on cellular response. Cartilage is composed primarily
of type II collagen and proteoglycan (Buckwalter & Mankin, 1998b), thus particulate binding to
FLS surface receptors via integrins has the potential to activate a number of pathways and increase
expression of MMPs (Guan, 1997). Numerous studies have looked at cellular activation through
ECM binding to FLS integrins (Sarkissian & Lafyatis, 1999) using ECM (collagen, fibronectin,
etc.)-coated beads. These studies have shown that integrin engagement through collagen binding
increases cellular proliferation and decreases collagenase synthesis. These results support the out-
comes reported here for cartilage particle treatment (Figure 3.5). Further, treatment of activated
cells with TNF-α was able to increase collagenase synthesis (Sarkissian & Lafyatis, 1999), observed
via treatment of FLS with cartilage particles and TNF-α (Figure 3.5).
The change in ECM composition and release of products into the media of FLS co-cultured with
latex particles was used as a non-biologic control to isolate the effects of phagocytosis alone on the
observed responses. Latex particles did not affect the proliferation of particle treated FLS, as has
been shown previously in FLS (Werb & Reynolds, 1974) and MSCs (Okafor et al. , 2006). Latex
particulates did induce decreased synthesis of collagen. Previous studies on the effects of sub-15μm
latex particulates in rabbits have shown increased synthesis of collagenase and neutral proteinases
(Greis et al. , 1994; Werb & Reynolds, 1974). These studies have also shown that cells in the same
culture as cells that have phagocytosed latex particulates also synthesize greater concentrations of
collagenase, suggesting that phagocytosis results in the release of an active stimulatory factor.
Cartilage particles induced more proliferation and inflammation than latex particles alone, il-
lustrating the importance of both cell surface contact and presumably activation of integrins in the
response of FLS to cartilage particles. Phagocytosis, cell surface binding and actin reorganization
together may affect how FLS synthesize other molecules beyond the ECM proteins or inflammatory
factors studied here in response to physical stimuli presented to FLS in the synovial joint environ-
ment (e.g. fluid shear or mechanical stretch)(Yanagida-Suekawa et al. , 2013; Sun et al. , 2003; Sun
& Yokota, 2002).
The work presented here provides a platform to study how the synovium responds to cartilage
wear particulates in vivo. Targeting the interaction of cartilage particles by phagocytosis or surface
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binding may provide a means to slow the onset and progression of OA by mitigating the deleterious
effects of cartilage particle-mediated synovitis. Future work will further investigate the exact mech-
anisms (e.g. integrin activation) responsible for rapid FLS proliferation and determine how cellular
activation by cartilage wear particles influences cell-cell communication (Werb & Reynolds, 1974).
These insights may guide the optimization of arthroscopic lavage and debridement techniques to
better address joint pain and inflammation (Attur et al. , 2010; Felson, 2010; Pitta et al. , 2016).
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Chapter 4 Modeling the Synovial Response to Cartilage Wear
Particles
4.1 Fibroblast-like Synoviocytes Interact with Large Particles Through Cell
Attachment
4.1.1 Introduction
The inflamed synovium is characterized by a pannus-like thickening resulting from the rapid prolif-
eration of both fibroblast-like synoviocytes (FLS) and synovial macrophages (SM) (Mathiessen &
Conaghan, 2017; Shibakawa et al. , 2003; Yuan et al. , 2004; Furuzawa-Carballeda et al. , 2008).
Increasing concentrations of both small and large cartilage debris are observed in patients with
increasing severities of osteoarthritis (OA) (Evans et al. , 1981a; Kuster et al. , 1998; Hakshur
et al. , 2011; Mendel et al. , 2010). Overtime, these particles become attached to the surface or
embedded within the synovium. The exact mechanisms by which particles of varying sizes interact
with the synovium remains unknown. In vivo and in vitro studies have shown that these particles
induce synovial hyperplasia, capsular thickening and synovitis (Evans et al. , 1984; Evans et al. ,
1981b; Chrisman et al. , 1965; Hurtig, 1988)(Evans et al. , 1984; Evans et al. , 1981b; Chrisman
et al. , 1965; Hurtig, 1988; Silverstein et al. , 2017). By investigating the interaction of FLS with
large cartilaginous particulates, we can isolate the effects of cell-ECM attachment from particulate
phagocytosis.
Glucocorticoids, such as dexamethasone (DEX), have been shown to have anti-inflammatory
effects both in vivo and in vitro on a number of cell types including chondrocytes and FLS. Specifi-
cally, DEX has been shown to counteract the effects of IL-1 and TNF-α as well as decrease cellular
proliferation (Roach et al. , 2016; DeRijk et al. , 1997; Gitter et al. , 1989; Vento et al. , 1990; Lima
et al. , 2008b). Here, we hypothesize that DEX will be able to suppress cartilage particle mediated
proliferation and inflammation in FLS.
Engagement of the α1β1 or α2β1 integrin subunits (the collagen binding integrins) on FLS results
in proliferation and decreased collagenase synthesis – both of which are observed after cartilage wear
particle treatment of bovine FLS (Silverstein et al. , 2017; Sarkissian & Lafyatis, 1999). Protein
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coated beads or microcarriers (~100-200μm in diameter) are commonly used for the large-scale ex-
pansion of mesenchymal stem cells (MSCs). Microcarrier-based expansion systems are particularly
attractive because they provide a substantial increase in the surface area to volume ratio compared
to traditional cell culture expansion techniques (Rafiq et al. , 2016). Initial cell attachment to
collagen coated microcarriers is mediated through integrin binding, which stimulates cytoskeletal
reorganization and proliferation, thus making them an attractive surrogate system to emulate FLS-
cartilage wear particle attachment (Takai et al. , 2006; Geiger et al. , 2001). Specifically, integrin
activation by cartilage wear particles will be investigate through use of a collagen bead binding
assay (Sarkissian & Lafyatis, 1999) and inhibition of the actin cytoskeleton polymerization with
cytochalasin D (CytoD) (Vasilopoulos et al. , 2007; Carracedo et al. , 2010; Chen et al. , 1994).
Disrupting actin cytoskeleton polymerization and focal adhesion kinase formation will inhibit inte-
grin mediated FLS proliferation and increase FLS collagenase synthesis. Here, we hypothesize that
the cartilage particle mediated synovial inflammation can be treated by suppressing proliferation
with DEX or targeting the activation of integrins.
4.1.2 Methods
4.1.2.1 Isolation and culture of synovial explants, cartilage explants and FLS Syn-
ovial tissue and cartilage explants were harvested from juvenile bovine knee joints (2-4 weeks old).
Synovial tissue was maintained in serum-free media (DMEM, 1% antibiotic-antimycotic, 1% ITS+
premix, 50g/mL L-proline, 0.9 mM sodium pyruvate and 50 g/mL ascorbic acid) until use. Cartilage
explants were cored using with a 10 mm biopsy punch and cultured in a serum-free explant media
until use, as described in 3.2.2. To isolate FLS, synovial tissue was digested with collagenase type
II (Worthington Biochemical Corporation, Lakewood, NJ) for 2 hours with agitation. Digested cells
were filtered through a 40 μm filter, counted and plated at a density of 1.76x103 cells/cm2. Cells
were expanded for two passages as in 3.2.2.
4.1.2.2 Particulate preparation and characterization of particles Cartilage particles
were generated and counted as described previously in 3.2.4. Briefly, particles were created by asepti-
cally abrading the superficial and middle zones with waterproof 120 grit sandpaper (McMaster-Carr,
Elmhurst, IL) in a sterile bath of PBS. To isolate large particles (and remove smaller particulates
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that could be phagocytosed by the cell), the resulting particle solution filtered with a 70 μm nylon
mesh filter. The filter was washed in sterile PBS until the particulates became dislodged from the
filter. Residual sandpaper particulates were removed by gravimetric filtration. Both collagen coated
beads (Solohill Microcarriers, Sigma-Aldrich) and large cartilage particles were counted and sized
using a Multisizer 4 (Beckman Coulter, Brea, CA).
4.1.2.3 Particle dosage optimization To determine the optimal dosage of collagen beads and
large cartilage particles, cells were cultured with increasing concentrations of particles. Due to the
large size, particulate concentrations were set at a starting concentration of 1:30 or 1:32 particles:
cells and a maximum dosage of 1:3 or 1:2 particles per cell for collagen beads and cartilage particles
respectively. After 5 days, changes in cellular viability and metabolic activity were quantified using
the MTT assay as in 3.2.4 .
4.1.2.4 Microscope interactions of tissue-particle and cell-particle interactions Both
collagen coated beads and cartilage particles were labeled with 20μM dichlorotriazinylaminofluores-
cein (DTAF, Sigma-Aldrich) (Oungoulian et al. , 2013; Krahn et al. , 2006). Synovial explants were
cultured with either 50,000 fluorescently labeled collagen beads or cartilage particles for up 5 days.
Concurrently, FLS were plated at a high density overnight before treatment with one fluorescently
labeled collagen bead or cartilage particle for every 30 cells. To visualize the synovial explants
and the FLS, tissues and cells were stained with CellTraceTM Calcein Red-Orange AM (Life Tech-
nologies) to characterize tissue and cell-particle interactions. A Zeiss LSM700 Confocal microscope
(Zeiss, Oberkochen, Germany) was used to take Z-stack images. Images were re-constructed using
the Zeiss Zen software.
4.1.2.5 Particle and inhibitor treatment High density cell sheets were treated with either
1 collagen bead per 32 cells or 1 cartilage particle per 30 cells for 5 days. A sub-group of cartilage
particle treated cells were also treated with 100 nM dexamethasone (DEX) or 0.2 μM CytoD (Roach
et al. , 2016; Rubtsova et al. , 1998; Domnina et al. , 1982). To confirm that the low dose of CytoD
was capable of inhibiting actin polymerization with no effect on cell viability, cells were culture with
0.2 μM CytoD for up to 3 days and stained for viability with Live/Dead Viability/Cytotoxity Kit
(Invitrogen). Cells were fixed and stained with TRITC-conjugated Phalloidin (Millipore-Sigma)
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and counterstained with DAPI to assess actin polymerization (3.2.5).
4.1.2.6 Biochemical analysis Cells treated with collagen beads were trypsinized off the beads,
pelleted and frozen at -20 °C until analysis. A subset of non-treated cells were also collected
after trypsinization. Thus, only DNA could be quantified for these groups. All other groups were
harvested and analyze d for DNA and collagen content as previousy described (2.2.4). Media from
all samples was collected was analyzed for nitric oxdie as described in 2.2.5.
4.1.2.7 Statistical analysis Prior to the analysis, data was analyzed for normality and ho-
mogeneity. Non-normal and non-homogeneous data were adjusted using a log transformation.
Comparisons between controls and collagen particle treated cells were made by Student’s t-test
to determine significant differences (α = 0.05, n=5-6). For cartilage particle studies, a two-way
ANOVA with main factors of particulate treatment and inhibitor treatment was used to determine
significant differences (n=7-8). If statistical differences were observed (α = 0.05), Tukey’s HSD post
hoc test was performed. Data presented as mean and standard deviation. All statistical analyses
were performed in GraphPad Prism 7.
4.1.3 Results
4.1.3.1 Explant particle interactions Collagen beads were 152.5 ± 32.9 μm in diameter,
while cartilage particles were 49.2 ± 15.4 μm in diameter. With time in culture, large particles
became embedded within the synovium. Specifically, cells crawled out of the synovium, attached to
the large beads and particles and continued to proliferate and migrate around the foreign objects
until they were covered by a layer of cells (Figure 4.1, Figure 4.2). With cartilage particles of such
a large size, chondrocytes were still observed within the extracellular (ECM) as indicated by the
nuclear gaps in the protein dye staining (Figure 4.2D). In 2D culture, FLS migrated off of the tissue
culture plastic, and became attached to collagen beads and large cartilage particle (Figure 4.1D,
Figure 4.2E,F).
4.1.3.2 Effect of large collagen beads An increasing dosage of collagen beads resulted in
an increase in MTT absorbance (Figure 4.3A). The lowest tested dosage of 1 bead per 32 cells
was sufficient to observe a significant increase (p=0.009). Increasing the particle dose, and thus
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Figure 4.1: Collagen beads (green) become embedded and enveloped by synovial explants (red). 3D
reconstructions (A,B,C) of tissues containing collagen beads. (D) 3D reconstruction of FLS plated
in 2D culture. FLS (red) migrate from the tissue culture plastic onto the collagen beads (green).
Scalebar = 200 μm.
Figure 4.2: As has been observed clinically, in in vitro culture, cartilage particles (green) become
embedded within synovial explants (red) as shown by 3D reconstructions. Cells migrate out of the
synovium to envelop the large cartilage particles (A,B). Multiple particles can be brought into the
same region of the synovium (C,D) as indicated by *. Scalebar = 200 μm. In 2D culture, FLS
(red) can crawl off tissue culture treated plastic to attach to large cartilage particles. Multiple cells
attach to individual cartilage particles (E,F).
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Figure 4.3: Increasing concentrations of large collagen coated beads increased metabolic activity
of FLS as determined by an increase in normalized absorbance using the MTT assay (A). Culture
with collagen coated beads (COL) increased DNA (B) content and media NO (C). n=3-4 for MTT.
n= 5-6 for DNA and NO assays. Data presented as mean and standard deviation. ^ p<0.05 vs
0:1 particles:cells, ^^ p<0.05 vs 0:1 and 1:32 particles:cells, ^^^ p<0.05 vs 0:1, 1:32, 1:16 and 1:8
particles:cells. * p<0.05 vs. control (CTL).
increasing the available surface area for cells to attach and proliferate, correlated with an increase
MTT. The highest two dosages dosage tested, (1 particle for every 2 or 4 cells) had significantly
greater metabolic activities than all other dosages that were evaluated. Given the increase in growth
surface area, culture of FLS with large collagen coated beads resulted in an increase in cell sheet
DNA content (p=0.0038, Figure 4.3B) and an increase in NO synthesis (p=0.0036, Figure 4.3C) by
FLS compared to controls.
4.1.3.3 Effect of large cartilage particles, DEX and CytoD FLS responded to large car-
tilage particles similarly to large collagen beads. Increasing the dosage of cartilage wear particles
increased the metabolic activity of FLS cell sheets. However, unlike collagen beads, no further
increases in metabolic activity were observed after the initial dose of 1:30 particles to cells. In this
case, adding additional surface area did not increase the metabolic activity (Figure 4.4A).
FLS cultured on tissue culture plastic had a fully developed actin cytoskeleton compared to
those treated with CytoD for the duration of culture. Specifically, control cells formed actin stress
fibers, while FLS cultured with CytoD had disrupted actin cytoskeleton formation (Figure 4.4B,C).
Low doses of CytoD for up to 5 days in culture had no effect on cell viability (data not shown).
Culture with DEX (p<0.0001) and CytoD (p<0.0001) resulted in a significant decrease in DNA
content and collagen content of cell sheets compared to controls (Figure 4.4D). DEX had no effect
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Figure 4.4: Culture with large cartilage particles increases cellular metabolic activity as determined
by an increase in normalized absorbance with the MTT assay (A). FLS cultured on tissue culture
plastic show clear formation of actin stress fibers (red) as indicated by actin-dapi (blue) staining
(B). Treatment with a low dose of cytocholasin D (CytoD) results in the loss of actin stress fiber
formation by FLS (C). DNA (D), collagen (COL,E) content and media NO (F) concentrations are
regulated by cartilage particles, DEX and CytoD. n=3-4 for MTT. n= 7-8 for DNA and NO assays.
Data presented as mean and standard deviation. ^ p<0.05 vs. 0:1 particle: cells, * vs. non-particle
treated controls with same treatment, # p<0.05 vs CTL and ## p<.05 vs DEX within same
particle treatment conditions.
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on collagen content (p=0.28) and NO synthesis (p=0.28). CytoD had decreased collagen content
(but not significantly, p=0.056) and significantly increased NO in the media (p<0.0001) (Figure
4.4E,F).
Culture with cartilage particles alone significantly increased DNA (p=0.0017) and collagen con-
tent (p=0.018) as well as NO synthesis (p<0.00001). Adding DEX (p<0.0001) or CytoD (p<0.0001)
to cartilage particle FLS cell sheets cultured significantly reduced the DNA content to the baseline
for DEX or CytoD only cell sheets (Figure 4.4D). Similarly, collagen content in cartilage particle
treated samples was reduced after DEX (p=0.011) and CytoD (p=0.0025) treatment (Figure 4.4E).
DEX treatment was able to partially counteract the increased NO synthesis by cartilage particle-
treated cells. NO synthesis by FLS treated with DEX and cartilage particles was significantly
lower than particle-treated only FLS (p=0.0139) but still higher than control FLS (p=<0.0001)
and FLS treated with DEX only (p<0.0001). CytoD treatment with cartilage particles resulted in
a synergistic increase in CytoD (4-fold increase in NO compared to CytoD treated FLS, p<0.0001).
4.1.4 Discussion
Synovial explants enveloped large collagen beads and cartilage particles through attachment of cells
to the particle ECM, followed by cell migration and proliferation. Given that the collagen beads
are treated to provide a smooth, optimized surface, primed for cell attachment, the number of cells
that were observed on the surface of the collagen beads was much greater than the number of cell
observed on the surface of large cartilage particles (Chen et al. , 2011; Malda & Frondoza, 2006).
A major limitation of using microcarriers is that it is hard to dislodge cells efficiently from the
particle surface. In this study, trypsin was used to remove cells from the collagen surface. However,
this prevented the characterization of ECM synthesis changes by the cells attached to the collagen
coated surface (Nienow et al. , 2014).
DEX treatment of cartilage particle-treated FLS successfully counteracted the cartilage particle
induced proliferation, collagen synthesis and NO synthesis (Figure 4.4). Intra-articular injections
of DEX have been shown to protect the synovial joint from further cartilage damage in animal
models of PTOA (Huebner et al. , 2013; Huebner et al. , 2014). While DEX does not block the root
cause of the synovial changes, it does successfully treat the downstream effects of the particulates.
DEX is a desirable therapeutic because it can be delivered into the joint space through injections
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or overtime through polymer microspheres (Roach et al. , 2016; Dang et al. , 2011; Lu et al. ,
2011; Raynauld et al. , 2003). Further, initial work has shown that in addition to modulating FLS
proliferation and synthesis, DEX can also decrease macrophage proliferation and retain a healthier
FLS to macrophage ratio in bovine synovial explants (Chapter 2).
Here we also explored role of integrin engagement by inhibiting the actin cytoskeleton poly-
merization. Preventing integrin engagement after FLS binding to cartilage particulates decreased
both proliferation and collagen synthesis by FLS (Figure 4.4). Inhibiting actin polymerization is
not an ideal method for studying integrin engagement as the actin cytoskeleton is involved in a
number of different cellular functions. Previously, it has been observed that disrupting the actin
cytoskeleton with CytoD or latrunculin A results in the upregulation of VCAM-1 and COX-2 by OA
FLS (Chen et al. , 2002), which is known to regulate NO and PGE2 synthesis (Alvarez-Soria et al.
, 2008; Amin et al. , 2000; Fermor et al. , 2002). Future work will look to identify focal adhesions
between cartilage particles and FLS or the synovium as well as to stain for the activation of the β1
integrin subunits (Guan, 1997; Du et al. , 2011). In addition to collagen, cartilage is comprised of a
number of ECM proteins such as proteoglycans. Integrin binding to these proteins, while less well
characterized, may also modulate the response of FLS to cartilage wear particles.
4.2 Cartilage Particles Reduce Mechanosensitivity of Fibroblast-Like
Synoviocytes to Fluid Shear
(work completed with assistance from Eben Estell)
4.2.1 Introduction
Joint articulation can result in stretch of the synovium, as well as shear stress on the synovial lining
from the relative motion of synovial fluid (Schett et al. , 1998). Within the joint space, the primary
cell type of the synovium, fibroblast-like synoviocytes (FLS) are exposed to shear stress resulting
from movement of the synovial fluid with everyday movement (Rattner et al. , 2010). Fluid shear,
is of particular interest, as it has been shown to modulate synovial cell biosynthetic activities, such
as hyaluronan or MMP synthesis (Sun & Yokota, 2002; Sun et al. , 2003; Yanagida-Suekawa et al.
, 2013), and growth factors, such as latent TGF-β3, which is found in the joint space and secreted
by synovium and cartilage in culture (Albro et al. , 2012; Albro et al. , 2013). Previously, it has
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been shown that inflammatory stimuli, such as IL-1 can alter the mechosensitivity of FLS to fluid
shear as well as modulate gap junction communication between cells (Kolomytkin et al. , 2000;
Kolomytkin et al. , 2002; Marino et al. , 2004; Estell et al. , 2017). The number of gap junctions
in OA synovium (4.41 gap junctions per 100 cells) is greater than the number of gap junctions in
normal human synovium (1.00 per 100 cells) (Marino et al. , 2004), suggesting that gap junctions
play a role in altered tissue biosynthesis and mechanosensing in diseased tissues.
4.2.2 Methods
4.2.2.1 Isolation and culture of FLS FLS were isolated from the synovium of 3 freshly
slaughtered juvenile (2-4-week-old) bovine knees by enzymatic digestion with type II collagenase as
described in 3.2.2.
4.2.2.2 Generation and characterization of particles Cartilage particles were generated
aseptically, as described previously (3.2.4). For visual identification of cartilage particles phagocy-
tosed by or on the cell surface of FLS, a subset of the cartilage particles was labeled with 20μM
DTAF as described in 3.2.5.
4.2.2.3 Calcein dye transfer assay Gap junction communication between FLS was assessed
using a previously established double labeling technique (Estell et al. , 2017; Yellowley et al. ,
2000). FLS were cultured overnight and treated with IL-1α (10ng/mL), TNF-α (10ng/mL) or
250 cartilage particles per cell for two days (Silverstein et al. , 2017). A separate set of FLS or
parachute cells were fluorescently labeled with 2μM calcein AM and 4μM 1,1’-Dioctadecyl-3,3,3’,3’-
Tetramethylindocarbocyanine Perchlorate (DiI, Invitrogen) and dropped onto the original cultures.
After incubation for 4 hours, neighboring cells staining positive for transferred calcein AM were
counted for 30 parachute cells across triplicate groups (identified by DiI staining).
4.2.2.4 Fluid shear experiments For fluid shear experiments, FLS were plated overnight
in silicone wells (Grace Bio-Labs) on glass slides. Cells were subsequently treated with cartilage
particles (250 particles per cells) for 48 hours prior to imaging. Controls were maintained in parallel.
To characterize changes in intracellular calcium ([Ca2+]i), cells were labeled with 5μM Fura Red-
AM (Life Technologies). Calcium is an ubiquitous cell signaling molecule that is critical in cell
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Figure 4.5: Representative calcium transient of FLS in response to fluid shear stress. [Ca2+]i
remains at equilibrium until Flow is turned on after 2 minutes. Fluid flow is applied for 2 minutes.
At the onset of flow, [Ca2+]i rises sharply until it reaches the peak magnitude after a slight delay
(peak latency). Eventually [Ca2+]i returns to equilibrium levels. Area Under Curve (AUC, dashed
region) indicates total calcium flux. Fluorescence intensity is normalized to equilibrium values.
Figure adapted from (Estell et al. , 2017). Fura red cells at each stage of the calcium transient
shown in the subset (20x magnification)(Estell et al. , n.d.).
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Figure 4.6: Representative images of calcein dye transfer to quantify gap junction communication
from “parachute cells”. IL and cartilage particle treated cells (CART, B,D) had greater gap junction
communication than control (CTL, A) or TNF(C) groups. Scalebar = 200μm.
signaling. Fluid flow-induced shear stress was applied to cultured FLS using a parallel plate flow
chamber at 0.5 dyne/cm2 (Estell et al. , 2017; Hung et al. , 1997). All experiments were performed
at room temperature in Hank’s Buffered Salt Solution (HBSS) supplemented with 0.5% FBS. After
assembly, chambers were allowed to rest on the microscope stage to permit acquisition of a 2
minute pre-flow baseline. Flow was applied subsequently for 2 minutes, followed by 2 minutes of
post-flow observation. Peak magnitude, peak latency, oscillation period, percent oscillators, percent
responders and mean area under the curve (AUC)were determined from calcium transients using a
custom MATLAB code (Figure 4.5).
4.2.2.5 Statistical analysis Gap junction experiments were analyzed using a one-way ANVOA
with Tukey’s HSD post-hoc test (α=0.05). Calcium signaling experiments to characterize differences
in peak magnitude, AUC, and peak latency were analyzed using Student’s t-test with Welch’s
correction (n>100). Categorical data (percent responding cells) was analyzed with Fisher’s Exact
test. Data presented as mean and standard deviation. All statistical analysis was performed using
GraphPad Prism 7 and MATLAB.
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Figure 4.7: Quantification of dye transfer to surrounding cells to characterize gap junction commu-
nication (n=30). Data presented as mean standard deviation. * p<0.05 vs. CTL, # p<0.05 vs.
IL.
4.2.3 Results
Treatment of FLS with IL and cartilage particles led to a significant increase in gap junction
communication compared to controls cells, as quantified by an increase in calcein transfer (Figure
4.6, Figure 4.7). Control FLS had parachute cell dye transfer to 54 ± 13 cells compared to 81 ±
16 (p<0.001) and 71 ± 16 (p=0.001) cells for IL and cartilage particle treated FLS, respectively.
No differences in the number of parachute dye transferred cells were observed for TNF (61 ± 20.8
parachutes per cell, p=0.30) and control FLS and between TNF and cartilage particle treated FLS
(p=0.15). IL-treated FLS had significantly more parachute dye-transferred cells than TNF treated
FLS (p=0.0001, Figure 4.7).
Treatment with cartilage wear particles significantly reduced the percent of responders to fluid
shear. 52% of control FLS responded to fluid shear, compared to only 33% of cartilage particle
treated FLS (p<0.00001). No differences between control FLS and cartilage particle-treated FLS
were observed for peak magnitude (1.43 ± 0.14 vs. 1.41 ± 0.12 normalized [Ca2+]i, p=0.081),
latency (54.9 ± 25.5 vs. 59.5 ± 22.8 seconds, p=0.089), and oscillation period (92.3 ± 29.6 vs.
103 ± 13.7 seconds, p=0.28). While there were no differences in many of the key characteristics of
the calcium transients between control and cartilage particle-treated FLS, there was a difference in
the AUC. The mean AUC of FLS decreased from 40.1 ± 16.7 to 27.4 ± 12.0 after treatment with
cartilage particles (p<0.0001, Figure 4.8).
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Figure 4.8: Characterization of the response of cartilage particle treated FLS to fluid shear. Percent
responders decreased after particle treatment (CART) (A). No differences were observed in between
control (CTL) and CART groups in terms of peak magnitude, peak latency or osciallation period
(B,C,D). Cartilage particle treatment also reduced the area under the curve of calcium transients
(E). Side and top view of cells counterstained with Fura Red showing cartilage particles (green)
were phagocytosed and on the surface of FLS (F). Data presented as mean and standard deviation
where applicable. n = 195 and 127 for CLT and CART, respectively. * p<0.05 vs CTL.
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4.2.4 Discussion
Gap junctions are present in both the native synovium and passaged FLS (Kolomytkin et al. , 2002).
Previous work has shown increases in gap junction communication by lapine and bovine FLS after
treatment with IL, as was observed in the present study (Estell et al. , 2017; Niger et al. , 2009).
Culture with cartilage particulates lead to an increase in gap junctions and cellular communication
in FLS. It has been reported that increases in gap junction communication are correlated with
inflammation as inhibition of connexin-43 (the gap junction protein) can decrease MMP production
by FLS (Kolomytkin et al. , 2002; Marino et al. , 2004).
An increase in gap junction communication is not necessarily indicative of the response of FLS
to shear stress, as this behavior is likely modulated by individual cells (Estell et al. , 2017). While
similar calcium peaks after application of shear stress were achieved in control and cartilage particle
treated FLS, the AUC was significantly lower after cartilage particle treatment. The total percentage
of responders was also decreased after particle treatment. Thus, the calcium peaks are narrower,
indicating that there is less overall calcium flux in cartilage particle treated cells. Previously we
have observed that sub-10μm particles can be phagocytosed by FLS or be bound to the surface of
the cell. These two mechanisms of interaction result in altered actin cytoskeleton reorganization
(Silverstein et al. , 2017). Mechanoregulation of fibroblasts is highly dependent on the structure
and integrity of the actin cytoskeleton (Wang et al. , 2007). From the literature, murine fibroblasts
calcium signaling is regulated by both phagocytosis and integrin activation. Specifically, it has been
reported that the altered organization of actin filaments through both collagen attachment and
phagocytosis can interfere with Ca2+ entry through integrin-gated channels (Arora et al. , 2011).
Further investigation into the specific integrins that are activated during cartilage particle at-
tachment and phagocytosis are needed to characterize the regulators of the observed decrease in
mechanosensitivity. In particular, it may be important to understand the differential effects of
phagocytosis and collagen binding on FLS function and response fluid shear. By studying the im-
plications of the altered fluid shear mechanosensing on downstream cell and tissue responses such
as cell proliferation, ECM production, and lubricant secretion (Schett et al. , 2001), we may gain
new insights to why clinical procedures such as lavage and synovectomy are effective treatments in
only a subset of patients (Felson, 2010; Pitta et al. , 2016).
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4.3 Cartilage Particulate Mediated Synovial Inflammation is Localized to the
Synovium
4.3.1 Introduction
In OA, inflammation of the synovium leads to the release of increased lubricants and degenerative
enzymes by both FLS and SM (Loeser et al. , 2012; Scanzello et al. , 2011; Attur et al. , 2010;
Wenham & Conaghan, 2010). To emulate this in vitro, a number of studies have co-cultured healthy
or cytokine-treated synovium with chemically or mechanically insulted cartilage (Cook et al. , 2007;
Lee et al. , 2009; Patwari et al. , 2009b; Hardy et al. , 2002; Beekhuizen et al. , 2011). However,
it is believed that both FLS and SM play a role in synovial inflammation and the degeneration of
cartilage, as unstimulated synovial tissue alone can induce OA-like changes in cartilage after just
1 week of culture (Mang et al. , n.d.). Separation of FLS and macrophages in culture studies has
shown that each of these cell types plays a unique role in the regulation of chondrocyte activity
and cartilage degeneration (Huch et al. , 2001; Sun et al. , 2011; Pretzel et al. , 2009; Lee et al. ,
2013; Blasioli et al. , 2014). In addition to mechanical or cytokine insult, joint inflammation can
stem from the interaction of cartilage wear particles with the synovium (Evans et al. , 1981b; Evans
et al. , 1984; Chrisman et al. , 1965; Silverstein et al. , 2017). Here, we applied a tissue engineered
co-culture model system to study the effects of a cartilage particle-mediated model of synovitis on
cartilage.
4.3.2 Methods
4.3.2.1 Isolation and expansion of FLS and chondrocytes Cartilage and synovial tissues
were isolated from three juvenile bovine calf knees (2-4 weeks old). Cartilage was enzymatically
digested with type II collagenase for 11 hours with gentle agitation. The resulting cell suspensions
were filtered through a 40 μm porous mesh. Viable cells were counted and plated at a density of
20 x 103 cell/cm2 or 1.76 x 103 cell/cm2. Chondrocytes were expanded for one passage in DMEM
containing 10% FBS, 1% antibiotic-antimycotic and a growth factor expansion cocktail (1 ng/mL
TGF-β1 and 5 ng/mL bFGF-2) (Francioli et al. , 2007). FLS were isolated and expanded for two
passages as described in 3.2.2
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Figure 4.9: Schematic of experimental design. Chondrocyte pellets were cultured in the top chamber
(I) of Transwell inserts in the presence of media only, cartilage particles (CART) only, FLS, and
FLS + CART in the bottom chamber (II). CART only, FLS only, and FLS + CART were cultured
in the same experimental set up without chondrocyte pellets.
4.3.2.2 Fabrication and culture of chondrocyte pellets Once sufficient cell number was
achieved, confluent chondrocytes were trypsinized, counted and re-suspended at a concentration of
500 x 103 cells/mL. 1 mL of this suspension was aliquoted into sterile screw top microcentrifuge
tubes and pelleted by centrifugation. Individual micropellets were cultured for up to 21 days in
chondrogenic media (CM) (DMEM supplemented with 50 μg/mL l-proline, 100 μg/mL sodium
pyruvate, 100 nM dexamethasone (DEX), and 1% antibiotic-antimycotic). For the first 14 days
of culture, CM was also supplemented with 10ng/mL TGF-β3 (Lima et al. , 2007). Pellets were
harvest after 3, 14 and 21 days.
4.3.2.3 Creation and characterization of cartilage wear particles Carilage particles were
generated from 10mm cartilage explant cores as described in 3.2.4.
4.3.2.4 Co-culture of FLS and chondrocyte pellets FLS were plated at high density and
cultured overnight in DMEM with 10% FBS, 1% antbiotics-antimycotics and 50μg/mL ascorbic-
acid. Pellets were place in Transwell™ inserts above a dish containing no cells, particles only, FLS or
FLS and 250 cartilage particles per cell, as described in 2.2.1and 3.2.1. FLS were also cultured below
an empty Transwell with or without cartilage particles (Figure 4.9). Chamber I was filled with CM
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without DEX. Chamber II was filled with DMEM containing 10% FBS, 1% antbiotics-antimycotics
and 50g/mL ascorbic-acid. FLS and chondrocyte pellets were cultured in the co-culture system for
7 days. Media was replaced in Chamber I every 2 days. Half the media in Chamber II was removed
and replaced with fresh media half-way through culture. Careful effort was made to not remove or
disturb cartilage particulates in Chamber II.
4.3.2.5 Biochemical Analysis After 7 days, pellets and high density FLS cultures were har-
vested, frozen and lyophilized. Media samples were collected during the final week of culture at all
feedings and the terminal time point. Media samples were frozen until later analysis. Dry chondro-
cyte pellets were weighed. Pellets and FLS cell sheets were digested and analyzed for DNA, GAG
and collagen as described in 2.2.4. Culture media was also analyzed for GAG lost to the media and
NO as in 2.2.5.
4.3.2.6 Statistical Analysis Data was tested for normality and homogeneity using the Kolmogorov-
Smirnov Test and Leven’s Test in R version 3.3.2 and log transformed as needed. A two-way ANOVA
with Tukey’s post-hoc tests and main factors set as treatment and culture conditions was used
(α=0.05). Data presented as mean and standard deviation. Statistical analyses were performed in
GraphPad Prism 7.
4.3.3 Results
Chondrocyte pellet dry weight (DW), DNA content, GAG content and collagen content increased
steadily with time in culture. No differences were observed in dry weight or GAG content with co-
culture of any kind. (Figure 4.10) DNA content was not affected by the presence of cartilage wear
particles, however, co-culture with FLS did reduce the total DNA content of the pellets (p=0.04,
Figure 4.10B). Collagen content remained constant in the presence of cartilage particles and FLS
separately. However, culture with cartilage particle treated FLS resulted in decrease collagen by
dry weight compared to all other groups at day 28 (p<0.0001, Figure 4.10D).
FLS treated with cartilage particles proliferated more and had a greater collagen content than
control FLS (p<0.0001). Proliferation of both groups remained unchanged after co-culture with
chondrocyte pellets (Figure 4.11A). However, collagen synthesis decreased in cartilage particle co-
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Figure 4.10: Biochemical characterization of chondrocyte pellets. (A) Dry Weight (DW), (B) DNA,
(C) GAG/DW, (D) collagen (COL)/DW). Dry weight, GAG and collagen content significantly
increased at each time point. DNA content was significantly greater than day 3 in both day 14 and
day 21 pellets (p<0.0001). Day 28 (terminal time point) control pellets had significantly more DNA
than day 3, day 14 and day 21 pellets (p<0.0001). Data presented as mean standard deviation
(n=9-10). * p<0.05 vs. non-particle treated controls (CTL), # p<0.05 vs. non-co-culture pellets,
^ p<0.05 vs. chondrocyte pellets with particles only.
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Figure 4.11: Biochemical analysis of FLS to determine changes in DNA (A) and collagen content
(B) after particles treatment and/or co-culture with cartilage pellets. Data presented as mean
and standard deviation (n=9-10). * p<0.05 vs. non-particle treated control (CTL), # p<0.05 vs.
corresponding co-culture group.
culture FLS compared to cartilage particle treated FLS cultured alone (p<0.0001). No differences
were observed in collagen content between the two co-culture groups (7.583 ± 0.937 μg vs. 10.165
± 3.215 μg, p=0.1029, Figure 4.11B).
No GAG release into the media was detected in either FLS group. The concentration of GAG
in the media was higher in co-culture groups compared to their respective controls (pCTL<0.001,
pCART= 0.02). In both the chondrocyte only and co-culture groups, the presence of cartilage
particles increased media GAG (pCART=0.007, pCO-CULTURE=0.0015, Figure 4.12A). NO release
was greater in the FLS cell sheets treated with cartilage wear particles (0.338 ± 0.087 μM vs.
0.511 ± 0.171 μM, p=0.0012). There were no differences in media NO between chondrocyte pellets
culture alone (8.542 ± 1.427 μM) and pellets in co-culture with FLS (9.260 ± 1.123 μM) or FLS
and cartilage particles (10.196 ± 1.083 μM). However, the media NO was greater in co-culture with
FLS and cartilage particles compared to pellets cultured with particle only (p=0.04, Figure 4.12B).
4.3.4 Discussion
As was observed in our explant co-culture in Chapter 2, co-culture with cartilage and FLS had no
effect on DW, GAG or collagen content (Figure 4.10). Decreased cell proliferation was observed
in pellets co-cultured with FLS only. In our explant culture and in co-culture of encapsulated OA
chondrocytes with FLS monolayers, a similar phenomenon was observed in the cartilaginous tissues
only(Huch et al. , 2001). In the FLS monolayers, only collagen synthesis in cartilage particles groups
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Figure 4.12: Analysis of GAG (A) and NO (B) released into the media. Data presented as mean
and standard deviation (n=9-10). * p<0.05 vs. CTL for each group, # p<0.05 vs. non-co-culture,
^ p<0.05 vs. chondrocyte pellets with particles only.
was decreased, suggesting the potential protective effects of chondrocyte co-culture on the synovium.
A similar phenomenon was observed for proteoglycan content after IL-1 stimulation in a similar co-
culture model utilized by Huch et. al. (Huch et al. , 2001). Cartilage particle treatment resulted in
increased media GAG in both chondrocyte pellet only and co-culture groups. Chondrocyte pellets
undergo remodeling throughout culture and release MMPs into the media as part of the remodeling.
These MMPs likely broke down some of the cartilage particles in the chamber below, leading to the
increase in media GAG in these groups. The results of this study suggest that cartilage particulate
inflammation is localized to the synovial tissue only, as no breakdown of the cartilage pellets was
observed. Comparing these results to those observed in bovine synovial explants where an increase
in media GAG and media NO were observed in co-culture groups, these changes are driven by the
resident macrophages of the native synovium.
71
Part II
Pre-Clinical Model of Osteoarthritis Using Cells
Derived from a Canine Animal Model
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Chapter 5 Transient expression of the diseased phenotype of
osteoarthritic chondrocytes in engineered cartilage
5.1 Introduction
Post-traumatic osteoarthritis (PTOA) often develops after injury to diarthrodial joints, such as
the knee. To gain greater insights to the etiology and progression of cartilage damage in PTOA,
researchers have adopted a number of in vivo and in vitro models that can successfully mimic
aspects of the disease. Animal models of PTOA, including surgical destabilization of the knee
joint, allow the researcher to address the full spectrum of pathologic changes observed in clinical
PTOA (Gregory et al. , 2012; Marshall & Chan, 1996; Kuroki et al. , 2011). Specifically, in the
meniscal-release (MR) model, development of osteoarthritic-like conditions is accelerated, and can
be reproducibly generated over the period of a few months rather than years (as in humans). Further,
a canine animal model provides for assessment in a clinically relevant species in which the anatomy,
physiology, and biomechanics of the knee joint, as well as medical, surgical, and post-operative
management strategies are similar to humans (Altman et al. , 1984; Ng et al. , 2010; Pond & Nuki,
1973).
In vitro culture provides opportunities for studying the biologic behavior of OA tissue and
cells under more controlled conditions than in vivo. In this context, tissue explants offer ideal
culture models as they maintain chondrocytes in their native extracellular matrix. The feasibility
of culturing human OA cartilage explants, however, depends on the severity of OA, where possibly
only irregular and fragile fragments and slivers of tissue may be harvestable. Therefore, the ability
to isolate and expand chondrocytes from limited tissue quantities and subsequently culture them
under conditions that maintain their OA phenotype is desirable.
Tissue engineering culture models can provide a platform to study diseased chondrocytes. Tra-
ditional tissue engineering approaches for disease modeling include mechanical overload (Tan et al. ,
2010b; Patwari et al. , 2001) or cytokine insult (Kuroki et al. , 2005; Goldring & Berenbaum, 2004a)
of healthy chondrocytes in 2D or 3D culture. Patient-specific culture models have been developed
using cells derived from an individual’s cartilage (healthy or OA) or stem cells differentiated toward
the chondrocyte phenotype. Mesenchymal stem cells may be derived from healthy or OA sources in-
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cluding bone marrow, adipose tissue, or synovium, as well as from iPSCs to produce disease-specific
models of OA (Willard et al. , 2014; Sampat et al. , 2011; Diekman et al. , 2010; Murphy et al. ,
2002; Li et al. , 2012). However, these methods require the differentiation of cells to a chondrogenic
phenotype. Studies utilizing OA chondrocytes may have an advantage as they are derived directly
from the pathologic joint.
In the current study, our model system outlines the derivation of cells from pathologic cartilage
with a well-defined history of joint injury, canine knee joints that have undergone MR surgery and
subsequent development of PTOA, and use of these cells in a 3D tissue engineering culture model.
Pellet culture has long been used to optimize culture conditions prior to the use of 3D hydrogels
and provides analogous results (O’Connell et al. , 2015). While previous research has characterized
the behavior of human OA chondrocytes under numerous culture conditions, many of these studies
do not provide a normal chondrocyte comparison (Hsieh-Bonassera et al. , 2009), are limited by
statistical matching power (age and gender) (Li et al. , 2012; Dehne et al. , 2009) or use cells
with age-related loss of chondrogenic capacity (Dehne et al. , 2009; Barbero et al. , 2004). Due
to these differences, the reported synthesis capabilities of OA chondrocytes compared to healthy
chondrocytes has been varied, with some groups reporting reduced (Dorotka et al. , 2005; Tallheden
et al. , 2005) and others reporting comparable or increased levels of matrix synthesis (Li et al. ,
2012; Dehne et al. , 2009) in both 2D and 3D culture.
This study aims to characterize the persistence of the disease phenotype in long-term culture
(up to 4 weeks) using a well-established micropellet culture system. The maintenance of the OA
phenotype is determined by micropellet production of de novo proteoglycan and collagen production
as well as via micropellet release into the media of OA chemokines and cytokines observed previously
to be elevated in the synovial fluid of dogs post-MR. As studies of OA cells in the literature are
often limited to gene expression, this study, using an established 3D tissue engineering culture model
with protein analysis and immunoanalysis, addresses a knowledge gap in our understanding of OA
phenotype stability in culture. Moreover, insights gained from this study may help to establish a
more biomimetic research platform for the study of OA through the incorporation of OA cells.
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5.2 Materials and methods
5.2.1 Induction of canine OA
MR surgery was performed on the knees of six adult research bred hound dogs (5 males, 1 fe-
male, 1-year-old (13–16m), >20 kg) as described previously (Luther et al. , 2009) (Figure 5.1).
The procedure was approved by the University of Missouri’s Institutional Animal Care and Use
Committee (IACUC #7332). This PTOA model is created using arthroscopic guidance and instru-
mentation so as to avoid the known joint health effects of open arthrotomy (Farr et al. , 2015).
Dogs were pre-medicated intramuscularly (IM) with xylazine (0.5mg/kg), morphine (0.5mg/kg),
and glycopyrrolate (0.005mg/kg); induced intravenously (IV) with propofol (6mg/kg); intubated
and maintained with isoflurane (1–2.5%) for the duration of the surgery based on veterinary medicine
standard of care. After surgery, heart rate (), respiratory rate (RR), and rectal temperature were
monitored until the dog was considered stable, alert, and sternal. Pain was assessed by monitoring
HR, RR, the patient’s attitude and vocalizations, appetite, reaction to palpation of the surgical site
and recorded for appropriate decision making and pain-relieving measures.
All dogs were assessed at least twice daily (morning and afternoon/evening) for the first 72
hours post-operatively. Dogs received two post-operative doses of morphine (0.5mg/kg IM or SQ).
Each dose of morphine was given within 6 hours of the preceding dose (including the pre-operative
dose). Tramadol (2–4mg/kg bid) was started the evening of surgery, no longer than 6 h following
the second post-operative dose of morphine. Two doses in total were given with approximately 12
hours between the first dose and second dose of Tramadol. Assessment of pain was performed and
recorded immediately prior to administration of each dose of the analgesic agents. The dogs were
housed in an AAALAC approved facility in 18–25 square foot cages (64–72°F) with one dog per
cage. The dogs were given a 12-hours light/12-hours dark cycle, unlimited water from spout, dry
dog food once a day and Nylabone Chews and Kong Dog Toys in the cage for enrichment.
After 12 weeks, the dogs were euthanized and the cartilage was grossly examined for OA changes
(Figure 5.1). No adverse events were noted. As in our previous work with the canine MR model,
insult to the joint via radial transection of the medial meniscus resulted in primarily unicompart-
mental (medial) disease. This was characterized by cartilage erosion and degradation due to the
changes in femoral and tibial articular cartilage contact pressures and areas by 12 weeks. Associated
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Figure 5.1: Gross images of six donor canine knees 12 weeks post-surgery and prior to cartilage
sample harvesting.
synovitis, effusion, and clinical signs of slowly progressive lameness have also been noted (Luther
et al. , 2009).
5.2.2 Tissue harvest and isolation of chondrocytes
Cartilage slivers were obtained from the limbs of dogs (Dog 219, 220, 221, 223, 224, 249) 12 weeks
post-MR surgery for induction of OA with contralateral limbs serving as normal controls (Figure
5.1). Tissues were enzymatically digested using collagenase type IV (Worthington Biochemical
Corporation, Carlsbad, CA) for 8 hours with stirring at 37°C after which cell suspensions were
filtered through a 70 μm porous mesh and sedimented by centrifugation (Ng et al. , 2010).
5.2.3 Creation and culture of micropellets
After two passages in Dulbecco’s Modified Eagle’s Media (DMEM, Life Technologies, Carlsbad,
CA) containing 10% fetal bovine serum (FBS, Atlanta Biologicals, Norcross, GA), 1% antibi-
otic–antimycotic (Invitrogen Corporation, Carlsbad, CA), and a growth factor expansion cocktail (1
ng/ml TGF-β1, 5 ng/ml FGF-2, and 10 ng/ml platelet derived growth factor, PDGF-ββ) (Invitrogen
Corporation) )(Francioli et al. , 2007; Alegre-Aguaron et al. , 2014), confluent chondrocytes were
trypsinized, counted and re-suspended (Ng et al. , 2010). Chondrocytes from dogs 219, 223, and 249
were pooled by disease condition, normal (non-operated) or OA (MR surgery) (similar to previously
utilized bovine cell culture protocols (Ng et al. , 2010; Hsieh-Bonassera et al. , 2009; Mauck et al.
, 2000)), while chondrocytes from 220, 221, and 224 remained separated by dog and disease state
to study effects of donor variability. Briefly, 1ml of a 500,000 cells/ml suspension was aliquoted
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into 1.5ml sterile screw-top tubes and pelleted by centrifugation. Individual micropellets were cul-
tured for 28 days with media changes every 2–3 days in 1ml of chondrogenic medium comprised
of DMEM containing 50µg/ml l-proline (Sigma–Aldrich, St. Louis, MO), 100 µg/ml sodium pyru-
vate (Sigma–Aldrich), 1% ITS+premix (BD Biosciences, San Jose, CA), 100 nM dexamethasone
(Sigma–Aldrich), 1% antibiotic–antimycotic, (Invitrogen), 50µg/ml ascorbic acid (Sigma–Aldrich),
and continuously supplemented with 10 ng/ml TGF-β3 (R&D Systems, Minneapolis, MN) (Ng et al.
, 2010). Media samples were collected at each feeding (n=5). Micropellets were harvested, weighed
and frozen at −20°C at days 0, 14, and 28 for biochemical analysis (n=5), or fixed in acid formalin
ethanol for histology and immunohistochemistry (n=2).
5.2.4 Biochemical analysis
Frozen samples were lyophilized, and the dry samples were digested prior to analysis for DNA, GAG
and collagen as described in 2.2.4. Micropellet culture media were also assayed with the DMMB
blue dye-binding assay to determine GAG lost to the media. Total GAG was determined as the
sum of micropellet GAG at each time point and accumulated media GAG. GAG, total GAG, and
collagen contents were each normalized to micropellet DNA.
5.2.5 Histological analysis
Acid-formalin ethanol fixed samples were embedded in paraffin wax (Fisher Scientific, Waltham,
MA) and sectioned to a thickness of 8µm. Sections were subsequently stained with alcian blue
(pH=1.0, Sigma–Aldrich) and picrosirius red (Sigma–Aldrich) to determine GAG and collagen
distribution, respectively. Immunohistochemistry was performed to determine the distribution of
collagen Type II (rabbit polyclonal anti-collagen type II, EMD Millipore, Billerica, MA (Kelly et al.
, 2004). Distribution of the staining intensity through the center (horizontal diameter) of each
sample was analyzed in ImageJ (NIH). Grayscale values were normalized to the maximum grayscale
value across the cross-section.
5.2.6 Media chemokine and cytokine analysis
A 25 μl aliquot was taken from each of the media samples from pooled donor pellet groups at days
0, 14, and 28 for chemokine and cytokine analysis (n=5). Each aliquot was analyzed in duplicate
using a Luminex multiplex canine cytokine and chemokine immunoassay (Millipore Corporation,
St. Louis, MO) on the xMAP platform (Qiagen Inc, Valencia, CA) for interleukin (IL)-6, IL-8,
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(KCKC)-like protein, and Monocyte Chemoattractant Protein-1 (MCP-1) (Garner et al. , 2011). A
multiplex human MMP immuoassay (R&D Systems) based on the xMAP assay platform which has
been previously shown to react with canine samples (Breshears et al. , 2010), was used to analyze the
media samples for five matrix metalloproteinases (MMP): MMP-1, MMP-2, MMP-3, MMP-9, and
MMP-13 as described in (Garner et al. , 2011). For the xMAP assays, media samples were mixed
with antichemokine, anticytokine, or anti-MMP monoclonal antibody-charged 5.6µm polystyrene
microspheres. Streptavidin-phycoerythrin and a biotinylated polyclonal secondary antibody were
added following overnight incubation at 4°C with the polystyrene microspheres (Garner et al. , 2011;
Breshears et al. , 2010). The median fluorescence intensity was used to determine the concentration
(pg/ml) of each chemokine and cytokine.
5.2.7 Statistical analysis
A two-way ANOVA with repeated measures with Fisher’s Least Significance Difference (LSD) post
hoc tests (α=0.05) was performed with main factors set as time and disease condition, and donor
as the repeated measure. Biochemical properties served as the dependent variable. A separate set
of two-way ANOVA tests with main factors set as time and disease state were used for chemokine
and cytokine data. Data are reported as the mean± standard deviation of 4–5 samples per time
point and group. All statistical tests were performed in Statistica (Tulsa, OK).
5.3 Results
5.3.1 Effects of disease state and donor on ECM synthesis
The average cell yield was 172× 103± 85× 103 cells/gram of tissue. Two passages led to a ∼200-
fold increase in cell number during expansion. There were no observed differences in the DNA
content of the chondrocyte pellets, regardless of time, donor, or disease state (not shown, p=
0.46). Accordingly, pellet extracellular matrix synthesis was normalized by DNA content to identify
biosynthesis changes. Across all biochemical analyses, there were no statistical differences between
donors within the same disease state. Pellet GAG was significantly different with respect to disease
(p=0.004), time (p=0.0001), and as a function of time and disease (p=0.009). No significant
differences were detected as a function of donor. More specifically, by day 28, pellet GAG was
significantly greater in OA pellets from dog 220 (p=0.01), and 224 (p=0.001) and with trending
increases in pellets synthesized by dog 221 (p=0.15) and pooled dogs (p=0.23) compared to normal
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chondrocyte pellets (Figure 5.2A). Total pellet GAG was significantly different between disease
states (p=0.005), time (0.0001), time and disease (p=0.0001) and donor and disease (p=0.032) at
day 28. Thus, while there are no intra-disease differences between donors alone there exist disease-
dependent differences in total GAG synthesis. At day 28, total GAG synthesis was significantly
greater in OA pellets from dog 220 (p=0.003), dog 224 (p=0.0002), and pooled dogs (p=0.03)
(Figure 5.2B). Overall, pellet collagen was only significant with respect to disease (p=0.03) and
time (p=0.005). By day 28, collagen content was significantly higher in OA chondrocyte pellets
synthesized by dog 224 (p=0.03) and pooled groups (p=0.04) and trending toward increases in
pellets synthesized by dog 220 (p=0.14) compared to normal controls for each dog (Figure 5.2C).
The results of the biochemical data were supported by histology and immunohistochemistry.
After 28 days of culture, alcian blue staining of pellets for GAG was relatively uniform across all
dog donors and disease states (Figure 5.2D). Picrosirius red pellets had a dense ring of collagen
staining around the edges with locally intense staining in the center of pellets prepared from the
pooled dogs (Figure 5.2E). Collagen II staining was observed throughout pellets synthesized by
normal and OA chondrocytes. Brighter immunostaining of collagen II was observed for OA pellets
from pooled donors (Figure 5.2F).
5.3.2 Chemokine and cytokine expression profiles vary with culture duration and
disease state
MMP, chemokine, and cytokine expression levels were evaluated in media from pooled donor pellets
at days 0, 14, and 28. Concentration of MMP-1 and MMP-3 increased with time in culture for both
normal (pMMP1<0.00001, pMMP3<0.00001) and OA chondrocyte pellets (pMMP1=0.01, pMMP3<
0.00001) (Figure 5.3A and C). Conversely, MMP-2 concentrations decreased with time in culture
(pN=0.002, pOA<0.00001) (Figure 5.3B). MMP-9 levels remained constant during pellet culture
for normal chondrocytes, but decreased with culture time for OA pellets (p<0.001) (Figure 5.3D).
Media concentration of MMP-13 remained constant (Figure 5.3E). While trends were mostly similar
between the two groups, expression of MMP1 (pD0=0.02, pD14<1× 10−5, pD28=0.01) (Fig. 3A)
and MMP-2 (pD0<1× 10−5, p14<1× 10−5, pD28=0.01) (Figure 5.3B) were significantly elevated
in OA pellet media at all time points. MMP-9 media expression was significantly decreased in OA
pellets only at day 28 (p=0.01) (Figure 5.3D). MMP-3 concentrations were slightly elevated in OA
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Figure 5.2: Pellet GAG (A), total GAG (sum of pellet GAG and media GAG) and pellet collagen
(C) normalized by DNA content as a function of donor and culture time. All groups significant to
day 0. Representative histological and immunohistological staining for pooled donor chondrocyte
pellets. Alcian blue (GAG) (D), picrosirius red (collagen) (E) and collagen type II (F) staining of
pellets formed from normal and osteoarthritis chondrocytes and cultured for 28 days. Graphs show
grayscale intensity across the diameter normalized to the maximum intensity of the histological
section. *p<0.05 versus day 14, #p<0.05 versus normal. All groups significant to day 0. n=4–6
Scale bar= 1mm.
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Figure 5.3: MMP concentrations from culture media of pooled donor pellets synthesized from normal
or osteoarthritic chondrocytes. *p<0.05 versus Day 0, **p<0.05 versus Day 14, #p<0.05 versus
normal. n=5.
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Figure 5.4: Chemokine and cytokine concentrations from culture media of pooled donor pellets
synthesized from normal or OA chondrocytes. *p<0.05 versus Day 0, **p<0.05 versus Day 14,
#p<0.05 versus normal. n=5.
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pellets compared to their normal counterparts at days 14 and 28 (pD14=0.17, pD28=0.21) (Figure
5.3C). No differences were observed between disease states for MMP-13 pellets (p=0.64, Figure
5.3E).
No significant differences were observed as a function of culture time or disease state in the me-
dia concentration of IL-6 (p=0.57, Figure 5.4A). Concentrations of IL-8 (Figure 5.4B), KC (Figure
5.4C) and MCP-1 (Figure 5.4D) (pIL8-N=2× 10−5, pIL8-OA=1× 10−6 pKC-N<1× 10−5, pKC-OA<
1× 10−5, pMCP1-N=0.0004, pMCP1-OA=0.009) all significantly decreased with culture time. Mean-
while, the concentration of KC was significantly elevated in normal pellet groups at days 0 and 14
(pD0=2× 10−6, pD14<1× 10−6), but was significantly lower in OA pellet groups by day 28 (p<1
× 10−5) (Figure 5.4C). Finally, MCP-1 levels were slightly elevated in OA groups at day 14 (pD14
=0.10) (Figure 5.4D).
5.4 Discussion
Biochemical analysis of the cartilage micropellets revealed no differences among donors for pellets
fabricated from either normal or OA chondrocytes. Overall, pellet GAG, total GAG, and pellet
collagen was significantly increased with time in culture and more elevated in OA chondrocyte
pellets (Figure 5.2). Specifically, the biochemical composition between pellets from normal and
OA chondrocytes became significantly different at day 28, suggesting that an underlying difference
between the chondrocytes derived from healthy and pathologic tissue exists in our 3D culture system
with time. Interestingly, we observed a greater ECM content for the pooled pellet group relative to
the ECM content of each individual donor that was pooled. This finding may suggest an interactive
effect between cells of different donors. We have previously noted a similar effect of pooling for
canine chondrocyte-seeded agarose constructs (Ng et al. , 2010). These results support previous
reports that OA chondrocytes can have an increased metabolic activity due to cellular attempts to
balance of catabolic and anabolic pathways, even though the disease is characterized by a loss of
ECM (Goldring, 2000; Sun et al. , 2011).
The differences between normal and OA chondrocytes are also captured by the time-dependent
changes of key chemokines, cytokines, and matrix metalloproteinases in the micropellet culture me-
dia. Previously, through analysis of the synovial fluid of naturally occurring canine OA and induced
canine OA, we have identified IL-8 as highly sensitive and MCP-1 as highly specific biomarkers in
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canine OA. Analysis of canine synovial fluid 12 weeks post-MR surgery showed a trending increase
in MCP-1 expression and a significant increase in IL-8 expression compared to baseline and non-
operated contralateral controls (Garner et al. , 2011). A similar evaluation of dogs found that in
naturally occurring (not surgically induced) canine OA, MCP-1 was significantly higher pre-surgery
(lavage and stabilization of the cruciate ligament) compared to post-surgery and normal dogs. Sim-
ilarly, IL-8 and KC were significantly higher pre-surgery compared to normal dogs and decreased
with surgery (although not significantly). While MMP expression was below the resolution of the
assay in the induced canine OA synovial fluid aspirate, evaluation of dogs with naturally occurring
OA had no changes in MMP-2 and MMP-3 synovial fluid expression before and after surgery and
compared to healthy dogs (Garner et al. , 2011).
In this study, culture media profiles from OA chondrocyte micropellets paralleled a subset of
the synovial fluid markers measured in spontaneously occurring OA and MR dogs (Garner et al. ,
2011). Significantly increased expression of MMP-1 and MMP-2 was observed in OA micropellet
culture media at all time points. Elevated MMP-3 concentrations were detected at days 14 and
28. OA research has included investigation into a number of different MMPs, including MMP-1,
MMP-2, and MMP-3 which target collagen, gelatin fragments, and proteoglycans, respectively (Li
et al. , 2012; Yoshihara et al. , 2000). These MMPs are typically up-regulated in early stage OA
and post-traumatic OA (Sun et al. , 2011; Alam et al. , 2011; Monibi et al. , 2016; Catterall et al.
, 2010). Additionally, these markers are highly expressed by OA and cytokine stimulated healthy
chondrocytes in 2D and 3D cell culture (Li et al. , 2012; Fan et al. , 2005; Flannery et al. , 1999).
Observed increases in MMP-3 expression are closely linked to elevated expression of MCP-1 and IL-
8 (Yuan et al. , 2001; de Bruin et al. , 2005). In this study, increased MMP-1, -2, and -3 expression
resulted in increased loss of GAG to the media. The observed deviations from the MR animal model
may be exacerbated by in vitro culture conditions. There were no observed differences in MMP-13
expression detected in the micropellet media, suggesting that both normal and OA chondrocytes
did not undergo hypertrophic differentiation during time in culture (Goldring et al. , 2011). This
may also be the result of a loss of MMP-13 expression during cell expansion in 2D as this has
been observed by others (Markway et al. , 2013; Diao et al. , 2013). In previous canine studies, no
measurable amounts of MMP-9 or MMP-13 were detected in synovial fluid samples (Garner et al.
, 2011).
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Similar to the results of previous canine OA biomarker studies, the results of this study identi-
fied time-dependent differences in IL-8, KC, and MCP-1 media concentrations. IL-8, a neutrophil
chemoattractant, is elevated in rheumatoid arthritis and constitutively expressed by OA synovio-
cytes (Seitz et al. , 1994; Remick et al. , 1992). Expression of IL-8 in OA chondrocytes can be
regulated by cytokines in vitro and induce chondrocyte hypertrophy, which is commonly seen in
OA (Remick et al. , 1992). Similarly, MCP-1 attracts mononuclear cells such as monocytes and
memory T cells and is frequently associated with rheumatoid arthritis. Studies have shown that
MCP-1 expression is elevated by OA chondrocytes and can be regulated by IL-1β in vitro (Yuan
et al. , 2001; Seitz et al. , 1994). More recently, these markers, in addition to MMP-1 and IL-6, were
confirmed as biomarkers for OA in human patients undergoing knee arthroplasty (Monibi et al. ,
2016). Likewise, our in vitro model exhibits higher media concentrations of both IL-8 at day 0 and
significantly greater concentrations of IL-8 at day 14 with elevated levels of MCP-1 (Garner et al. ,
2011). The delayed increase in MCP-1 expression may be related to the clinically observed positive
correlation between MCP-1 and IL-8 expression (Monibi et al. , 2016). At day 28, no differences
in media concentrations of either IL-8 or MCP-1 are detected between normal and OA micropellet
cultures.
Like IL-8, KC is a murine protein and a member of the CXC cytokines family and is a neutrophil
chemoattractant. In the dog, mouse antibodies against KC are capable of detecting a KC-like
proteins in fluids such as synovial fluid (Garner et al. , 2011). Up-regulation of KC may also
encourage chondrocyte hypertrophy (Merz et al. , 2003). Clinical results have demonstrated that
variations in KC expression may be useful for identifying differences between cruciate disease and
other types of OA, as changes were only observed in dogs suffering from OA after ACL transection
(Garner et al. , 2011). Here, we observed decreased expression of KC in OA chondrocyte pellets at
day 0, but significantly elevated levels at day 14 with no differences by day 28. This result suggests
that in our in vitro model, KC expression is regulated by related factors such as IL-8, as they show
similar expression trends.
Using chondrocytes isolated from pathologic cartilage harvested from an animal model of OA,
as done in this study, decouples donor age and gender from disease specific results. Unlike human
studies, the canine animal model allows for a donor matched healthy tissue control, the contralateral
limb. Further, by using chondrocytes isolated from an animal model of OA, we are able to reduce
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the effects of donor to donor variability that are frequently observed in OA chondrocytes obtained
from human clinical samples. The ability to control these variables allows us to design studies that
look at cellular alterations in OA relatively free of contaminating variables. Using cells derived
from animal models also allows for the flexibility to study OA pathology as a function of age as OA
can be induced in juvenile or adult animals. Although animal models may not fully capture the
naturally occurring disease states, these options may provide insights on early intervention strategies
for mitigating the effects of OA.
Taken together, our OA chondrocyte pellet data indicate that for at least a period of 2 weeks in
3D cell culture, OA chondrocytes exhibit a memory of their disease phenotype. These findings are
encouraging and consistent with the literature findings showing increased and correlated synovial
fluid expression of MMP-1, IL-8, KC, and MCP-1 in human and canine OA(Garner et al. , 2011;
Monibi et al. , 2016). These results may further suggest that epigenetic changes in the diseased joint
promote memory of the OA phenotype for at least 2 weeks, even after cells have been isolated from
the OA tissue. Accordingly, as this OA phenotype wanes with increasing time in culture, there may
be techniques available to preserve the disease phenotype, including growth factor treatment for the
minimization of de-differentiation(Hsieh-Bonassera et al. , 2009; Loeser et al. , 2003), stimulation
with mechanical loading(Lima et al. , 2008a; Jeon et al. , 2012) or oxygen tension(Markway et al.
, 2013; Schrobback et al. , 2012), administration of pro-inflammatory cytokines(Li et al. , 2012;
Fan et al. , 2005), and co-culture with synovium(Cook et al. , 2007; Patwari et al. , 2009a) or
immune cells(Sun et al. , 2011). This preliminary work provides a baseline from which more optimal
protocols may be developed to preserve the OA phenotype in culture, for studies of cellular changes
associated with PTOA, or perhaps to convert the cells to a more “normal” phenotype as a cell source
for therapeutic applications(Dehne et al. , 2009; Patwari et al. , 2009a).
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Part III
Translation to a Clinically Relevant Human
Model
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Chapter 6 Disease Dependent Reponse of Human Fibroblast-like
Synoviocytes to Pro-inflammatory Stimuli
6.1 Introduction
Synovitis is observed in a majority of both early and late stage osteoarthritis (OA) patients, impli-
cating the key role of the synovium in disease progression (Attur et al. , 2010; Wenham & Conaghan,
2010). In the inflamed synovium, the resident cell types, fibroblast-like synoviocytes (FLS) and syn-
ovial macrophages (SM) release pro-inflammatory factors, that further stimulate synovial cells and
chondrocytes to produce more cytokines and degradative enzymes, leading to cartilage degenera-
tion. Histological changes to the synovium include a pannus-like thickening and increased cellularity
(Wenham & Conaghan, 2010; Mathiessen & Conaghan, 2017; Scanzello & Goldring, 2012). In addi-
tion to these changes in tissue composition, surgeons have also observed cartilage particles attached
to and embedded within the synovium (Lloyd-Roberts, 1953; Evans & Mears, 1981). Patients,
even with mild synovitis, present with pain and stiffness caused by fibrotic shortening. Given that
changes to the synovial lining precede cartilage damage (Hugle & Geurts, 2016), it is important to
understand the role different pro-inflammatory mediators have on the synovium before and during
the progression of disease.
Cartilage particles are generated as the result wear between two surfaces, resulting in continued
tissue degradation. Trauma to the synovial joint, such as meniscal tear, ACL rupture or cartilage
trauma, disrupt the overall biomechanics of the knee joint. These injuries can cause the release
of tissue and cartilaginous debris as well as joint instability and surface roughness (Scanzello &
Goldring, 2012; Scanzello et al. , 2011)(Stachowiak et al. , 1997; Forster & Fisher, 1999; Temple
et al. , 2007). Numerous studies have observed increasing concentrations of both small and large
cartilage particles in the synovial fluid of patients with increasing grades of OA (Kuster et al. ,
1998; Podsiadlo et al. , 1997; Hotchkiss et al. , 1982).
In vivo, following the injection of cartilage wear particles into the knee joints of rabbits, dogs
and horses, animals quickly developed synovitis that was followed by the gradual onset of the
capsular, fibrotic thickening of the synovium and changes to cartilage thickness and subchondral
bone. However, unlike more traditional animal models of OA, such as ACL transection or DMM,
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total joint changes after cartilage particulate injections took 6-12 months to fully progress compared
to 12 weeks or less (Evans et al. , 1984; Chrisman et al. , 1965; Hurtig, 1988; Garner et al. , 2011;
Kuroki et al. , 2011). In vitro, cartilage particles have been shown to stimulate enhanced proteinase
activity, cellular proliferation, collagen synthesis and nitric oxide production. Characterization of
the interaction of small cartilage particles with FLS has implicated this occurs through phagocytosis
and integrin activation via cell-ECM attachment (Evans et al. , 1981b; Silverstein et al. , 2017).
To better understand synovial inflammation and to isolate the contribution of FLS to the release
of degradative factors by the synovium, it is important to be able to study inflammatory response
of FLS in the absence of immune cells. Most work studying the response of FLS to inflammatory
stimuli has been done using rheumatoid arthritis (RA) or OA FLS. In response to IL-1, diseased FLS
have increased synthesis of lubricant molecules, cytokines, chemokine and MMPs. However, these
studies lack comparisons to healthy control cells and fail to look at cellular ECM synthesis (Kiener
et al. , 2010; Blewis et al. , 2010a; Furuzawa-Carballeda et al. , 2008). Using cells from healthy and
OA donor tissues allows for the evaluation of cells in their own de novo matrix. OA chondrocytes
isolated from a meniscal release canine animal model are capable of transiently retaining their
disease phenotype after passaging and pellet culture as determined through secretion of MMPs,
cytokines and chemokines (Silverstein et al. , 2016). Similarly, cells derived from healthy and
inflamed synovium maintain altered gene expression patterns for up to 5 passages (Winchester
et al. , 1993; Neumann et al. , 2010).
In this study, we investigated the role of chemical (cytokines) and physical (cartilage particles)
pro-inflammatory mediators on the healthy and OA human FLS phenotypes. Using healthy cells
can provide insight to the response and phenotype of FLS to the stimuli at the onset of disease,
while OA FLS can provide insight into how the phenotype shifts persists with additional stimuli in
late stage OA.
6.2 Materials and methods
6.2.1 Experiment design
Study 1 optimized the treatment dosage of cartilage particles. Particle concentrations up to 500
particles per cell were cultured for 6 days with confluent FLS monolayers derived from 4 different
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Figure 6.1: Schematic of the experimental study design. In study 1, FLS were cultured for 5 days
with increasing concentrations of latex or cartilage particulates (up to 500:1 particles: cells). In
study 2, FLS from healthy and OA donor tissue were cultured with 10ng/mL IL-1 and TNF- or 250
cartilage wear particles per cell for 5 days. Acellular cartilage particle only groups were cultured in
parallel.
OA donors to determine a dosage that would result in a measurable cell response. Using the MTT
assay (3.2.4), the lowest particle dose that significantly increased metabolic activity was identified
for each donor. From the four donors, 250 particles per cell, was selected for future experiments to
ensure that as many donors as possible would respond to the cartilage particle stimuli. In study 2,
FLS from normal (healthy) and OA donors were treated for 6 days with one of three inflammatory
stimuli: 10ng/mL IL-1β (IL), 10ng/mL TNF-α (TNF) or 250 cartilage particles per cell (Figure 6.1.
6.2.2 Isolation and expansion of human FLS
Human synovial tissues from 15 patients with OA were obtained as discarded specimens following
total knee arthroplasty, with approval of the Columbia University Institutional Review Board (IRB
AAAQ2703). Healthy synovial tissue was obtained the synovial plica of one patient undergoing
arthroscopic surgery to repair a torn ACL and from a patient undergoing total hip arthroplasty
after fracture (IRB AAAQ2703). An additional healthy donor cell line was purchased from Cell
Applications Inc. (San Diego, CA) (Table 3). Upon retrieval, surgical waste tissues were digested
in collagenase type II within a few hours of collection (Worthington Biochemical Corporation,
Lakewood, NJ) for 2-3 hours with shaking at 37 °C. Digested cells (FLS) were filtered through
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a 40 μm porous nylon mesh (Corning Inc, Corning, NY). Viable cells were counted and plated
at a density of 2.64 × 103 cells/cm2. Cell were expanded α-Minimal Essential Medium (α-MEM,
Life Technologies, Carlsbad, CA) containing 10% FBS, 1% antibiotic-antimycotic and bFGF-2 as
described in 3.2.2 to remove contaminating cells types and to achieve sufficient cell number(Sampat
et al. , 2011; Alegre-Aguaron et al. , 2014). At passage 3 to create dense synovial sheets, confluent
FLS were trypsinized, counted, suspended and plated a density of 125 x 104 cell/cm2 and cultured
as described in DMEM containing 10% FBS, 1% antibiotic-antimycotic and 50 μg/mL ascorbic acid
.
6.2.3 Analysis of cell surface markers
To ensure that cells isolated from the surgical waste tissue were indeed FLS and to evaluate the re-
moval of contaminating cell populations (e.g. macrophages, endothelial cells, etc.), expression of sur-
face markers on cultured FLS were analyzed. Cell were expanded for up to 5 passages in α-Minimal
Essential Medium (α-MEM, Life Technologies) containing 10% FBS, 1% antibiotic-antimycotic and
1 ng/mL bFGF-2 (Life Technologies). Prior to flow cytometry (FACS), FLS were cultured to 60-80%
confluency, trypsinized and re-suspended in FACS buffer compromised of phosphate buffered saline
(PBS, Life Technologies) containing 1% bovine serum albumin (BSA, Sigma-Aldrich) and fluores-
cein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC) or peridinin chlorophyll
protein complex (PerCP) label antibodies. Antibodies again CD11b (integrin alpha M, R&D Sys-
tems, Mineapolis, MN), CD14 (R&D Systems), CD31 (Platelet endothelial cell adhesion molecule,
PECAM-1, R&D Systems), and CD45 (lymphocyte common antigen, LCA, R&D Systems) were
used as negative indicators. CD11b and CD14 are immune cell markers; CD34 and CD45 are
hematopoetic cell markers; CD31 is an endothelial marker. Antibodies against MSC and synovial
tissue markers CD73 (5’-nucleotidase, R&D Systems), CD90 (Thy-1, Biolegend), CD105 (endoglin,
R&D Systems) and CD106 (vascular cell adhesion molecule 1, VCAM-1, R&D Systems) were also
used. Antibody concentrations were optimized using primary human peripheral blood monocytes
or human FLS to validate negative and positive markers, respectively. The lowest concentration
that yielded a clear separation between negatively and positively stained cells was used for further
experimentation. Prior to analysis, 1 x 105 cells were incubated in the dark at room temperature for
30 minutes after which they were washed and suspended in 0.4 mL FACS buffer. Cell fluorescence
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Table 3: Summary of normal and healthy synovial tissue donors. * indicates purchased cell line.
92
was evaluation by flow cytometry using a Fortessa Flow Cytometer (Becton Dickinson, Franklin
Lakes, NJ). The data was analyzed in FlowJo 9.9.5 (FlowJo LLC, Ashland, Oregon).
6.2.4 Creation of human cartilage wear particles
Expired cartilage tissue grafts were obtained from the Musculoskeletal Transplant Foundation (Edi-
son, NJ) and stored at 4 °C until use. As described in 3.2.4, cartilage samples were submerged in
sterile PBS and manually abraded with waterproof 120 grit sandpaper (McMaster-Carr, Elmhurst,
IL). Effort was made to ensure that no bone was abraded during the cartilage wear process. Po-
tential residual sandpaper particulates were removed gravimetrically and via sub-sequent filtration
with 70μm, 40μm, and 10μm porous nylon mesh filters to achieve a sub-10μm particulate size. An
aliquot of the resulting solution was diluted in PBS and counted and sized using a Multisizer 4 Coul-
ter Counter (Beckman Coulter, Brea, CA) to determine the concentration as described previously
(3.2.4).
6.2.5 Biochemical analysis
After 6 days of culture, confluent monolayers and media samples were harvested and analyzed for
DNA and collagen as described in 2.2.4. Nitric oxide (NO), hyaluronan (HA) and prostaglandin-E2
(PGE2) released into the media was determined using the Greiss Reagent for nitrite quantification
(Life Technologies), Hyaluronan Quantikine ELISA and the PGE2 Parameter (R&D Systems Inc.,
Minneapolis, MN), respectively. For all biochemical measurements on particle treated samples, the
measured value of the cartilage particles alone was subtracted out to determine the contribution
of the FLS alone. For collagen content of particle treated samples, the % collagen recovered was
calculated as the amount of collagen measured divided by the amount of collagen in the cartilage
particles added to the system.
6.2.6 Luminex analysis
A 25μl aliquot was taken from the pooled media of each healthy and OA donors from each of
the experimental conditions. Each aliquot was analyzed in duplicate using a Luminex multiplex
human cytokine and chemokine immunoassay kit (EMD Millipore, St. Louis, MO) for IL-6, IL-8,
and Monocyte chemoattractant protein-1 (MCP-1) or a Luminex multiplex human MMP assay kit
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(R&D Systems) for MMP-1-1, -3, -9, -10,and -13. For the xMAP assays, media samples were mixed
with antichemokine, anticytokine, or anti-MMP monoclonal antibody-charged 5.6 μm polystyrene
microspheres. Streptavidin-phycoerythrin and a biotinylated polyclonal secondary antibody were
added following incubation at room temperature for 2 hours with the polystyrene microspheres.
The median fluorescence intensity was used to determine the concentration (pg/mL) of each MMP,
chemokine and cytokine.
6.2.7 Statistical analysis
Data sets were tested for normality and homogeneity using the Kolmogorov-Smirnov Test and
Levene’s test in R (version 3.3.2). Non-normal and non-homogeneous data were adjusted using a
log transformation prior to analysis. For MTT dosage studies, a one-way ANOVA with Tukey’s HSD
post-hoc test was performed. For DNA, collagen and NO measurements, the average of each donor
(n=7-8 samples/ donor) was calculated. A two-way ANOVA for disease and experimental treatment
with Fisher’s Least Significance Difference test was utilized due to the lack of availability of healthy
FLS donors. For analysis of DNA content of the high-density cell monolayers, due to the variability
in baseline proliferation with the normal donors, data was normalized to the DNA content of the
controls. To determine the differences in DNA content between healthy and OA monolayers and %
collagen recovered in healthy and OA cartilage particle treated monolayers, a t-test with Welch’s
correction was used. Prior to media analysis for HA, PGE2, chemokines, cytokines and MMPs,
replicates from each individual donor and experimental group were pooled to provide one data
point per donor per condition. A two-way ANOVA for disease and experimental treatment with
Fisher’s LSD test was used to test for significant differences between disease state and experimental
groups. The lowest point on the curve for ELISAs and Luminex was used when samples were below
the range of the standard curve for statistical analysis. All statistical analyses were performed in
GraphPad Prism 7 with α=0.05. Each data point represents the mean and standard deviation.
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Figure 6.2: OA cells grew around foci during passage 0 (A) that disappeared with passaging. After
3 passages, healthy and OA FLS had a similar fibroblast morphology (B). Scale bar = 200m. (C)
Doubling time of healthy FLS (N) remained then same with passaging, while the doubling time of
FLS changed with passage number. Healthy (Donor NA and donor NB) and cell line (donor NC)
were run in duplicate. N=15 donors for OA FLS. Data presented as mean and standard deviation.
# p<0.05 vs healthy FLS at the same passage number. * p<0.05 vs. passage 1 (P1). ** p<0.05
vs. P3.
6.3 Results
6.3.1 Cell proliferation with passaging
Duirng passage 0 (P0), OA FLS formed cell clusters or foci (Figure 6.2A), which was not observed
in healthy FLS. By passage 3 and for all additional passages, all healthy and OA FLS had a normal
fibroblastic morphology (Figure 6.2B). Healthy FLS had consistent doubling time of just under 2
days across all 5 passages. OA FLS had the greatest doubling time at P1 (3.09 ± 0.319 days), that
was also significantly longer that healthy FLS at P1 (p = 0.0068). The doubling time of OA FLS
decreased during P2 and P3 to match that of the healthy FLS. However, the doubling time slowed
down again at P4 and P5 due to donor variability (Figure 6.2C).
6.3.2 Analysis of cell surface markers
All cells isolated from surgical debris had positive expression of key synovial cell surface mark-
ers (CD73, CD90, CD105, and CD106) throughout all passages. Negative expression (<5%) of
hematopoietic and immune cell markers (CD11b, CD14, CD34 and CD45) was observed at all pas-
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Table 4: Percentages of positive surface markers and CD31 shown as mean percentage and SD for
up to 5 passages (P1-P5). Healthy (Donor NA and donor NB) and cell line (donor NC) were run in
duplicate. N=15 donors for OA FLS. Statistically significant differences represented as: # p<0.05
vs. OA FLS at the same passage, ! vs. healthy FLS at the same passage, * vs. P1, $ vs. P2, ^ vs.
P3.
sages. In the cell line, expression of all surface markers remained stable with stable with passaging.
Healthy FLS had a significant increase in CD90 and CD105 expression with passaging. OA FLS
had relatively stable expression of all surface markers except for a transient increase in CD105 after
3 passages and an overall decrease in CD106 with passaging. In OA cells and the purchased cell line
only, there was some positive expression of CD31. The percentage of CD90 and CD105 was lower
in OA derived FLS compared to the purchase cell line at all passages (Table 4). P3 cells were used
for all subsequent studies.
6.3.3 Optimization of cartilage particle dosage
Human cartilage particulates generated from allografts had an average diameter of 0.887 ± 0.004μm.
The dose response of FLS to particles was highly donor specific. Of the four donor (66.2 ± 9 years
old, 50% male) used to determine the dose, one donor showed a significant increase in metabolic
activity at a concentration of 25 particles per cell (Figure 6.3D), two donors showed a significant
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Figure 6.3: MTT assay for assessing the effect of increasing concentrations of cartilage particles on
passage 3 OA FLS from 4 different donors. A) 56 year old female. B) 68 year old female. C) 65
year old male. D) 78 year old male. Data presented as mean and SD (n=3-4/group). * p<0.05 vs.
control (0:1 particles: cell), ** p<0.05 vs. 25:1 particles: cell, *** vs. 50:1 particles:cell, **** vs.
100:1 particles:cell.
increase in metabolic activity at a concentration of 100 particles per cell (Figure 6.3A.B) and one
donor showed a significant increase in metabolic activity at a concentration of 250 particles per cell
(Figure 6.3C). Thus, a dosage of 250 particles per cell was adopted for future experiments, to ensure
that a high enough dosage in to elicit a response in as many donors as possible was used.
6.3.4 Biochemical analysis
No differences were observed in cell proliferation (as determined by DNA content) between healthy
and OA FLS (2.82 ± 1.55 g vs. 1.662 ± 0.23 μg of DNA, p=0.33, Figure 6.4A). Disease (p=0.027),
inflammatory treatment (p<0.0001) and the interaction of disease and treatment (p=0.034) all had
significant effects on the proliferation and the DNA content of cell sheets. IL treatment significantly
decreased the proliferation of healthy FLS and had no effect on OA FLS (p=0.038) while TNF had
no effect (p=0.71). In OA cells, both IL (p=0.21) and TNF (p=0.12) had no effect on prolifera-
tion (Figure 6.4B). A population of FLS lost their fibroblastic phenotype with cytokine treatment.
Specifically, all healthy donors developed a rounded cell morphology after IL treatment, while this
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was observed in only a small subset of OA FLS treated with IL and both healthy and OA FLS
treated with TNF (Figure 6.4C). Accordingly, OA FLS cell sheets treated with IL had greater DNA
content than healthy FLS.
Collagen synthesis was modulated by disease state (p=0.02) and treatment (p=0.002). Healthy
FLS synthesized a greater amount of collagen compared to OA FLS (p=0.0039). IL (p=0.002) and
TNF (p=0.023) significantly reduced collagen synthesis in healthy FLS. Meanwhile, similar trends
were observed in OA FLS. However, due to the decreased overall synthesis, no differences were
detected in collagen synthesis after cytokine treatment (Figure 6.4D). To determine the effect of
cartilage particles on collagen synthesis, the % collagen recovered was measured from the collagen
content of acellular cartilage particle controls. Similar to baseline levels, healthy FLS treated had a
higher % collagen recovery than OA FLS (100.5 ± 7.99% vs. 83.09 ± 14.79%, p=0.032, Figure 4E).
HA and NO release to the media were modulated by treatment (pHA<0.0001, pNO<0.0001) and
the interaction of disease and treatment (pHA<0.0001, pNO=0.0004). HA synthesis (p=0.007) and
NO (p=0.006) production was much greater in healthy control FLS as compared to OA control FLS.
IL and TNF significantly treatment increased the concentrations of HA and NO in the media for
by both healthy and OA FLS (Figure 6.4F,G). However, OA FLS showed higher sensitivity IL and
TNF as the total HA released when normalized by DNA content and compared to baseline synthesis
was much greater in cytokine treated OA FLS compared to healthy FLS. Healthy cells had a 3-fold
and 2-fold increase in HA synthesis after IL and TNF treatment compared to 13-fold and 12-fold
increase in OA FLS. NO release after IL (p=0.13) and TNF (p=0.16) treatment was elevated in OA
FLS compared to corresponding healthy FLS groups, although not significantly. No differences in
HA synthesis were observed after co-culture with cartilage wear particles in both healthy and OA
(Figure 6.4F). NO synthesis normalized by DNA content was elevated in healthy FLS after cartilage
particle treatment, although not significant (3.052 ± 1.839 vs. 6.015 ± 2.37M/μg, p=0.13). After
cartilage particle treatment, NO production was significantly elevated compared to controls for in
OA FLS (1.130 ± 0.502 vs. 2.964 ± 0.824 μM/μg, p<0.001), however NO was significantly less than
corresponding cell treated with IL and TNF (Figure 6.4G).
PGE2 synthesis was relatively low in CTL and CART samples for both healthy and OA FLS,
with many donors having values that were below the resolution of the assay. However, PGE2
synthesis was significantly elevated by both healthy and OA FLS after IL and TNF stimulation. In
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Figure 6.4: Analysis of healthy (N) and OA FLS cell sheets culture ± IL-1 or TNF- and ± cartilage
wear particles. The DNA, ECM synthesis and media NO of the particles alone was subtracted
from the total to determine the final values. (A) DNA content of N and OA FLS. (B) DNA
content of FLS cell sheets normalized to control. (C) Some healthy FLS and OA FLS developed a
rounded morphology in response to IL-1. Scalebar = 200m. (D) Collagen synthesis normalized to
DNA content. (E) Percent collagen content of cartilage wear particle recovered in cartilage particle
treated cell sheets after 6 days of culture. (F) Media concentration of HA released into the media
normalized by DNA content. (G) Media NO released normalized by DNA content. Data presented
as mean ± SD of all donors (n=3 for N, n=13 for OA). The mean was calculated as the average of
n=6-8 for each donor/group. * p<0.05 vs. control (CTL). ** p<0.05 vs. IL and TNF. # p<0.05 N
FLS.
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Figure 6.5: Media chemokine and cytokine concentrations of healthy (N) and OA FLS cell sheets
normalized by DNA after treatment with ± IL-1β (IL) or TNF-α (TNF) and ± cartilage wear
particles (CART). Replicates from each donor was pooled prior to analysis. Data presented as
mean ± SD (n=3 for healthy FLS, n=12 for OA FLS).* p<0.05 vs. control (CTL). ** vs. IL and
TNF. # versus normal.
both cases, media concentrations of PGE2 was significantly greater after IL (79996 ± 60964 and
57530 ± 22357 pg/μgDNA) treatment than TNF treatment (35518 ± 56234 and 23266 ± 24085
pg/μg DNA). No disease dependent differences were observed in PGE2 production.
6.3.5 Media chemokine and cytokine analysis
Disease (p<0.001) and treatment (p<0.001) had a significant effect on IL-6, IL-8 and MCP-1 pro-
duction. Media concentrations of IL-6 (p=.048) and IL-8 (p=0.015) were significantly elevated in
OA FLS samples compared to healthy FLS samples. Treatment with cytokine or cartilage wear
particles increased the concentration of IL-6 and IL-8 regardless of cell type. The magnitude of
the responses was greater in OA cells compared to healthy FLS. Further, OA FLS were much more
sensitive to cytokines than wear particles (Figure 6.5A,B). MCP-1 levels in the media remained un-
changed between healthy and OA FLS. In healthy FLS, MCP-1 levels were elevated after cytokine
treatment, although not significant (pIL=0.34, pTNF=0.65). In OA FLS, cytokines significantly
increased the MCP-1 media concentration compared to untreated controls and cartilage particle
treated samples (Figure 6.5C).
6.3.6 Media MMP analysis
Across all MMPs, disease (p<0.001) and inflammatory treatment (p<0.00001) had significant effects
on MMP expression, but not the interaction of the two factors (6.6). Baseline MMP concentrations
normalized by DNA of MMP-1 (p<0.00001) and MMP-3 (p=0.036) were significantly elevated in
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OA FLS compared to healthy FLS. MMP-10 was elevated in OA cells (232.1 ± 125.3 pg/μg vs.
460.5 ± 246.3 pg/μg, p=0.067). IL and TNF treatment significantly increased the concentration of
MMP-1,-3, -10, and -13 production by both healthy and OA FLS (Figure 6.6A,B,D). IL and TNF
significantly increased MMP-9 in OA FLS, while only TNF had an effect on healthy FLS. However,
MMP-9 was elevated after IL treatment in healthy cells (65.95 ± 32.0 pg/μg vs. 377.6 140.1 pg/μg,
Figure 6.6C). Accounting for baseline MMP expression, healthy FLS had greater increases (65.5 and
1223 fold increase) in MMP-1 after IL and TNF treatment compared to OA FLS (28.7 and 52.51
fold increase). On the other hand, OA FLS had greater increases in MMP-3, MMP-9, MMP-10,
and MMP-13 after cytokine treatment compared to healthy FLS (Figure 6.6).
MMP-3 (p=0.0097) and MMP-10 (p=0.001) concentrations normalized by cell sheet DNA were
significantly elevated in OA FLS treated with cartilage wear particles (Figure 6.6B,D). Given that
co-culture with cartilage wear particles resulted in a significant increase in DNA, total media con-
centrations were also evaluated to determine difference in MMP production and characterize the
total change in MMP. However, in terms of total MMP media concentration, cartilage particles also
significantly increased MMP release in MMP-9 (214 ± 99 pg/mL vs. 634 ± 318 pg/mL, p=0.0055)
and MMP-13 (1846 ± 899 pg/mL vs. 3194 ± 852 pg/mL, p=0.0048) (Figure 6.6C,E). In healthy
FLS, only MMP-10 was elevated after particle treatment (629 ± 339 pg/mL vs. 1574 ± 455 pg/mL,
p = 0.049).
6.4 Discussion
Synovitis is observed in the majority of patients of OA, even at the earliest stages of disease. FLS, the
predominant cell type found in the synovium, play a key role in the regulation of the environment
in both healthy and OA joints. The present study shows that both cartilage wear particles and
inflammatory cytokines (IL-1 and TNF-) can modulate FLS behavior and ECM synthesis as well
as stimulate FLS from both healthy and OA joints to releases chemokines, cytokines, MMPs and
other inflammatory mediators in the absence of immune cells in an arthritic environment (Bartok
& Firestein, 2010; Bustamante et al. , 2017).
Passaging and subsequent FACS analysis of human FLS derived from surgical tissues confirmed
that the isolated cells were indeed FLS. During P0, OA FLS exhibited an invasive phenotype marked
by the development of foci that was lost with passaging (Lafyatis et al. , 1989). This contributed to
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Figure 6.6: Media MMP concentrations of healthy (N) and OA FLS cell sheets after treatment with
± IL-1 or TNF- and ± cartilage wear particles. Replicates from each donor was pooled prior to
analysis. Data presented as mean ± SD (n=3 for healthy FLS, n=12 for OA FLS). * p<0.05 vs.
control (CTL). ** vs. IL, *** vs. IL and TNF. # versus normal. ^ p<0.05 vs. CTL in terms of
total MMP media concentration not normalized by DNA content.
the significant increase in doubling time as cells proliferated in isolated clusters rather than spread
out throughout the available tissue culture treated surface area (Figure 6.2). Isolated OA FLS had
a spindle shaped fibroblastic morphology that becomes more homogenous with passaging. Both
healthy and OA cell exhibited positive expression of key synovial markers and negative expression
of immune and hematopeoetic cell markers (Sampat et al. , 2011; Alegre-Aguaron et al. , 2014;
Manferdini et al. , 2016; Hatakeyama et al. , 2017; Hermida-Gomez et al. , 2011)(Table 4). The
healthy FLS from the cell line had significantly lower expression of CD106 than freshly isolated
cells from healthy and OA donor tissues, indicative of a differently sub-population of FLS that is
from the sub-intimal layer rather than the intimal layer of the synovium (Bartok & Firestein, 2010;
Wilkinson et al. , 1993). This is also supported by the slightly lower percentage of CD90 cells in
non-cell line FLS (O’Brien et al. , 2017). OA FLS and cells line FLS have a small sub-population
of CD31 positive cells. These cells have been previously shown to be removed with passaging.
However, increased starting concentrations of endothelial cells in OA tissue (Szekanecz et al. , 1995;
Haywood et al. , 2003) or in the sub-intima (cell line) (Deligne et al. , 2015) with the addition of
FGF to the passaging media may be responsible for the maintenance of this sub-type (Ashraf et al.
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, 2010).
As has been shown previously by our group in juvenile bovine FLS, human FLS (both healthy
and OA) proliferated in response to increasing dosages of cartilage wear particles and had no increase
in proliferation after TNF treatment (Silverstein et al. , 2017). While synovial hyperplasia is driven
by both FLS and macrophages, it is possible that FLS proliferation is driven by cartilage particle
mediated intergrin engagement (Sarkissian & Lafyatis, 1999; Lowin & Straub, 2011). Interestingly,
IL treated healthy FLS developed a rounded morphology and reduced proliferation in healthy FLS
(Figure 6.3C). While most papers report increases in proliferation with IL and TNF, this may
be a donor, disease or culture model dependent phenomenon. Studies reporting increases in FLS
proliferation with IL typically use FLS derived from OA or RA with pooled cell sources plated at
low density (Gitter et al. , 1989; Nishimoto et al. , 2000; Blewis et al. , 2010b), while those observing
a mixed response have used FLS from non-arthritic patients (Pulkki, 1986). Additionally, while the
presence of serum may play an additional role in magnifying these effects (Russell & Hamilton,
2014), it is more representative of the mix of proteins and growth factors (e.g. TGF-β, insulin-like
growth factor and bFGF) present in synovial fluid (Honsawek et al. , 2012; Tavera et al. , 1996;
Albro et al. , 2012; Denko et al. , 1996; Zheng et al. , 2006). Healthy FLS had more collagen
synthesis than OA FLS, as was also observed after treatment with cartilage wear particles (Figure
6.3D,E). However, treatment with IL and TNF reduced collagen synthesis to the levels of OA FLS,
as has been observed in a similar model with juvenile bovine FLS (Silverstein et al. , 2017) and in
RA FLS (Rinaldi et al. , 2001).
Previous studies have reported that IL and TNF treatment increase the synthesis of HA by FLS.
OA FLS had greater release of HA after cytokine stimulation compared to healthy FLS. However,
the type of HA released by the two cell types might be of differing molecular weights that correlate
with changes in HA composition in synovial fluid between early and late stage of OA (Blewis
et al. , 2010b; Kosinska et al. , 2015). Interestingly, OA control FLS had a lower baseline level
of HA synthesis compared to healthy cells, which may be related to the overall observed decrease
in anabolic activity of OA FLS compared to healthy FLS. Surprisingly, treatment of healthy and
OA FLS with cartilage particles had no effect on HA release into the media, even though HA is a
component of cartilage (Roughley & Lee, 1994).
NO is a catabolic factor produced by FLS that promotes cartilage degradation and inflammation
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and is upregulated in OA and is also indicative of increased matrix turnover, and upregulation of
MMPs (Abramson et al. , 2001; Abramson, 2008). In low grade synovitis, NO and PGE2 contribute
to the inflammatory cascade and stimulate FLS and chondrocytes to synthesize various MMPs
(MMP-1,-3, -9, and -13)(Sellam & Berenbaum, 2010). In OA, NO synthesized by FLS can result in
the inhibition of aggrecan and collagen synthesis by chondrocytes (Goldring & Berenbaum, 2004b).
Thus, given that healthy FLS had greater overall biosynthesis (collagen and HA), the baseline levels
of NO were elevated in healthy FLS. However, the increase in NO after cytokine and cartilage particle
treatment was greater in OA FLS, indicative of an increased sensitivity to OA stimuli (Figure 6.4G).
Increases in PGE2, a factor involved in inflammation and the degradation of cartilage were only
observed after cytokine stimulation, with IL being a much more potent stimulant of PGE2 (Gitter
et al. , 1989; Attur et al. , 2008).
The cytokines IL-6 and IL-8 have been found to be strong biomarkers of OA (Nguyen et al. ,
2017; Bay-Jensen et al. , 2016; Kaneko et al. , 2000). IL-6 is pro-inflammatory cytokine upregulated
in inflamed tissues and synthesized by immune cells, endothelial cells, and FLS, that is believed
to stimulate MMP production in FLS and chondrocytes (Blasioli & Kaplan, 2014). IL-8, which
can be produced by immune cells, FLS and chondrocytes, is a neutrophil chemoattractant that is
responsible for increases in MMP-13 as well as the accumulation of neutrophils in the synovium
(Takahashi et al. , 2015). IL-6 and IL-8 are upregulated in both early and late stage of OA, with
the concentrations both cytokines increasing with the stage of disease (Wanner et al. , 2013) and
patient pain (Leung et al. , 2017). In human synovial fluid, elevated levels of IL-6 and IL-8 have
also been correlated with the size, adhesion and roughness of cartilage (Wang et al. , 2014). In the
present culture model, IL-6 and IL-8 was significantly elevated in OA FLS compared to healthy
FLS, mimicking the native synovial environment. In both healthy and OA FLS, cytokines resulted
in a much larger increase in IL6 and IL8 compared to cartilage particle treatment, however, particles
alone were capable of increasing synthesis of these cytokines (Figure 6.5).
MCP1 is also a biomarker of late stage OA, which is synthesized by a variety of synovial joint
cells including chondrocytes, monocytes, macrophages and FLS (Garner et al. , 2011; Conti et al.
, 2002; Endres et al. , 2010; Li & Jiang, 2015). OA chondrocytes have higher baseline expression
of MCP-1 compared to healthy chondrocytes and expression of MCP-1 can be further modulated
with IL-1(Sandell et al. , 2008). However, expression of MCP-1 by healthy and OA FLS has not
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been well characterized. Here, we observed no differences in baseline MCP-1 expression between
healthy and OA FLS. IL and TNF were able to modulate MCP-1 in OA FLS only (Figure 6.5C)
(Seitz et al. , 1994).
MMP concentrations have also been identified as potential biomarkers of synovial inflammation
both in early and late stage OA. In particular, research has been focused on MMP-1, MMP-3, MMP-
9, MMP-10 and MMP-13. Increasing concentrations of MMP-1 and MMP-3, which target collagen
and proteoglycans (Yoshihara et al. , 2000), in serum and synovial fluid have been measured in early,
intermediate, and late stage OA compared to healthy controls (Bay-Jensen et al. , 2016; Heard et al.
, 2012; Li et al. , 2014). Differences in MMP-9 and -13, which target type II and IV collagen (Zeng
et al. , 2015; Goldring, 2012), synovial fluid concentrations have also been reported between healthy
or early stage OA patients and patients with Grade 4 OA (Heard et al. , 2012). MMP-10, which
degrades proteoglycans and promotes collagenolysis (Barksby et al. , 2006), expression has also been
shown to be increased in OA synovium and cartilage tissue (Davidson et al. , 2006). In the culture
model presented here, only MMP-1 and MMP-3 were elevated in OA control FLS compared to
healthy controls. This may be due to a loss of the invasive phenotype with passaging, as indicated
by MMP-1,-3 and -10 synthesis (Tolboom et al. , 2002). Additionally, it has been observed that
MMP-13 expression is lost with passaging in human chondrocytes (Silverstein et al. , 2016; Markway
et al. , 2013; Diao et al. , 2013). Cartilage particle treatment induced increased synthesis of MMP-3
and MMP-10 and a total media concentration increase of MMP-9 and MMP-13. However, cytokine
treatment substantially increased expression of all MMPs compared to controls and cartilage particle
treatments.
This work examines the response of healthy and OA FLS to different pro-inflammatory stimuli
in a biomimetic culture model allowing for the evaluation of disease cells in their de novo patho-
logic matrix. Here, we chose only to look at FLS to focus specifically on the primary resident cell
type of the synovium to isolate the role these cells play in synovial inflammation and the release of
degradative factors. OA FLS were much more sensitive to OA stimuli than their healthy counter-
parts, supporting the hypothesis that OA FLS retain their inflammatory memory and contribute to
the degenerative cascade of late stage OA. Interestingly, the response of both healthy and OA FLS
was much greater in response to cytokines compared to cartilage particles. This is the opposite of
what was observed in a juvenile bovine model (Silverstein et al. , 2017). Future work will look at
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additional numbers of healthy human donors to strengthen statistical power.
The results presented here suggest that cartilage wear particles induce local synovial inflamma-
tion that more closely resembles the early stage of osteoarthritis. Meanwhile, the healthy cytokine
treated FLS mimic the synovial response after severe trauma to the synovial joint, such as cartilage
damage or other tissue injury. OA FLS can be used to model the contributions of the cartilage
particles and cytokines to the continued inflammation of the synovium leading to the further degra-
dation of cartilage. This simple model can be expanded to include SM, which have phagocytic
capabilities, and thus may interact differently with cartilage wear particles than FLS. Given that
the interaction of cartilage particulates with FLS and resulting increases in cytokine and MMP
production is likely mediated by integrin engagement, therapeutics that target these changes and
interactions may provide insight on new technique to delay the onset of OA.
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Chapter 7 Conclusions and Future Directions
7.1 Conclusions
This dissertation develops and characterizes physiologic culture models of OA to evaluate cells
of the synovial joint, specifically fibroblast-like synoviocytes (FLS) and chondrocytes, to better
understand changes that both synovium and cartilage undergo with the onset of OA. Each part of
this dissertation built upon the previous chapters and aimed to take the insights from basic science
and pre-clinical cell culture models and apply them to clinically derived cells. The key findings of
each major study in this dissertation are summarized in the context of the applications of how these
models can be used to develop patient and disease specific culture models of OA for the development
and testing of new therapeutics.
7.1.1 Characterizing the response of synovium to chemical and physical
pro-inflammatory mediators
In Part Iof this dissertation, we looked at the response of the synovium and FLS to pro-inflammatory
mediators. The synovium has recently gained attention as a key contributor to the progression of
osteoarthritis (OA), as the onset of synovitis precedes cartilage damage (Hugle & Geurts, 2016)
and is observed in 50% of patients presenting with early stage OA and in nearly all patients with
late stage OA (Wenham & Conaghan, 2010; Attur et al. , 2010). Previous studies examining the
effects of interleukin-1 or tumor necrosis factor-α on synovial capsule tissue or FLS have focused
primarily on the effects of this tissue on cartilage and the release of inflammatory mediators rather
than on changes to the tissue or resident cell behavior. While the role of cartilage wear particles
in synovial inflammation and in disease progression has long been accepted, the exact effects of
cartilage particles on FLS and mechanisms by which FLS interact with cartilage wear particles
remain poorly understood. We aimed to fill this gap by using explant culture (Chapter 2) to
provide a basic understanding of the synovial response to pro- and anti-inflammatory compounds
and by developing a simple synovial cell culture model that could mimic the response of synovial
tissues without the inclusion of synovial macrophages (SM, Chapter 3).
In Chapter 2, we utilized a juvenile bovine synovial explant model to study the effects of IL-1
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and dexamethasone (DEX) on the cellular and ECM composition of the synovium. Given that
the synovium is in frequent cross talk with cartilage in healthy and pathologic knees, we also
looked at the effects of cartilage co-culture on the synovium. Here, we found that the cellular
composition of the synovium begins normal (~5% SM, 95% FLs), but that regardless of culture
conditions macrophages overtake the culture. Treatment with IL-1 enhanced this effect, while
treatment with DEX counteracted this response. DEX had no negative effects on the synovium and
in fact allowed the tissues to maintain close to day 0 properties. This confirms that DEX is beneficial
to the synovium, eliminating concerns that DEX may stimulate chondrogenic differentiation of FLS
(Beane & Darling, 2012; Langenbach & Handschel, 2013). Different from earlier co-culture studies
(Cook et al. , 2007; Lee et al. , 2009; Patwari et al. , 2009a; Fell & Jubb, 1977), we found that
in our serum-free culture media (Bian et al. , 2008; Bian et al. , 2010), the effects of cytokines
on cartilage were not enhanced in the presence of synovium. However, media GAG and NO were
greater in co-culture controls, an effect that was eliminated by DEX. Similarly, we confirmed that
DEX is chondroprotective against the effects of IL-1 and that this is extended to co-culture as well.
These results suggest that DEX is a potentially a promising therapeutic intervention as it provides
a protective benefit to both the synovium and cartilage.
Chapters 3 and 4 looked at characterizing the interaction cartilage wear particles with FLS. We
chose to first study the effects of sub-10m cartilage particles as these are observed in late stage
OA (Tew & Hackett, 1981; Mendel et al. , 2010) and capable of interacting with FLS through both
phagocytosis (Greis et al. , 1994; Olson et al. , 1988) and cell surface contact. Microscopy confirmed
our hypothesis that small cartilage particles were ingested by FLS and also remained bound to the
cell surface in both single cell and high-density culture. Reorganization of the actin cytoskeleton
for both phagocytosis and cell surface contact implicated that cartilage particles would likely effect
downstream cell signaling, motivating the work in Chapter 4.
In our original studies (Chapter 3), we found that cartilage particles induce synovial inflam-
mation and proliferation. By using small latex beads as a control, we determined that the most
prevalent changes were likely due to cell-cartilage ECM interactions. On the other hand, in Chapter
4.1 the use of large collagen coated beads confirmed our hypothesis that ECM binding is responsible
for the observed proliferation and NO synthesis. To determine if integrin activation was partially re-
sponsible for the response of FLS to cartilage particles, FLS cultured with large particles were treated
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with cytochalasin D (CytoD) to inhibit actin polymerization, the formation of focal adhesions and
ultimately integrin activation. The successful inhibition of proliferation by CytoD motivates further
work into the exact integrins involved in this signaling pathway to provide new insights on the
contribution of cartilage particles to synovial dysregulation. Alternatively, we showed that DEX
can be used to achieve the same effects and may be a candidate treatment for intervention against
early stage particle mediated synovitis.
Chapter 4 also investigates the downstream effects of cartilage particles on FLS mechanosensing
(Chapter 4.2) and cartilage co-culture (Chapter 4.3). FLS exhibit decreased Ca2+ signaling in
response to fluid shear. This result suggests that particulates embedded in the synovium decrease
the response of the synovium to physical stimulation, which likely has implications for the regulation
and maintenance of synovial fluid. Particle-stimulated FLS had minimal effects on cartilage pellets
in co-culture, suggesting that particle media inflammation may be localized to the synovium or
require macrophages in order to result in total joint changes.
7.1.2 Phenotype persistence of disease cells in culture
In Part II of this dissertation work, we sought to develop a OA culture model using pathologic
chondrocytes derived from an OA animal model as a culture model. This culture model is partic-
ularly attractive as is allows for the decoupling of age and gender effects as well as donor matched
normal (healthy) controls. In Chapter 5, we demonstrated that OA chondrocytes retain their dis-
eased phenotype with two passages in the presence of growth factors that promote retention of the
chondrogenic phenotype (Ng et al. , 2010; Francioli et al. , 2007). We found that OA chondro-
cytes exhibited increased biosynthesis compared to healthy controls in pellet culture, indicative of
a definitive shift in the metabolic activity of these diseased cells (Fan et al. , 2005; Goldring, 2012).
Here, we demonstrated the use of Luminex technology to determine the persistence of the diseased
phenotype by comparing the media concentrations of clinical relevant synovial fluid biomarkers such
as IL-6, IL-8, MCP-1, KC and MMP-1,-2,-3, -9 and -13 (Cook et al. , 2007). The Luminex screen for
OA biomarkers revealed that OA chondrocytes maintained elevated expression of several biomark-
ers for up to two weeks in culture. These results demonstrate that cells derived from a pathologic
joint can be expanded and used to create diseased tissues in vitro. The ability to engineer patho-
logic cartilage tissue using OA chondrocytes will provide new platforms to test and validate disease
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modifying drugs for OA (Willard et al. , 2014; Vandenburgh, 2010).
7.1.3 Translation to clincally relevant human models
To study the response of normal (healthy) and pathologic cells to chemical and physical pro-
inflammatory stimuli, in Part III of this dissertation we sought to translate findings from our bovine
synovial model and pathologic canine animal model to a clinically relevant human cell model based
on cells derived from clinical samples of varying OA disease state. Comparing the results of Chapter
3 and 6, we observed species dependent responses of FLS to pro-inflammatory stimuli. This finding
is consistent with previous work showing that the observed chondrocyte behavior in basic science
or pre-clinical models (bovine or canine cells) does not always correlate with the response of human
cells (Giannoni et al. , 2005).
For these studies, OA synovium was obtained from patients undergoing total knee arthroscopy.
Healthy synovium was obtained from the synovial plica of a patient undergoing ACL repair as well
as from a patient undergoing total hip arthroscopy after fracture. Unlike the studies performed in
Chapter 5, for these studies we were interested in the behavior of clinical samples from different
stages of disease. To ensure that the cells isolated from the clinical samples were a pure population of
FLS, flow cytometry was done for up to 5 passages to characterize the cell types. We confirmed that
both healthy and OA FLS had positive expression of MSC markers, as FLS have been previously
identified as having a similar epitope to MSCs (Shirasawa et al. , 2006). Further, we confirmed
previous findings that trypsininzation and passaging removed the non-FLS cell types that reside
within the synovium from the culture (De Bari et al. , 2001; Tan et al. , 2015b; Manferdini et al. ,
2016). In OA FLS, some endothelial cells expression (~10%) remained across all 5 passages.
Previously it has been observed that cells derived from healthy and inflamed synovium maintain
altered gene expression patterns for up to 5 passages (Winchester et al. , 1993; Neumann et al. ,
2010). The same response of cartilage particles in juvenile bovine FLS (Chapter 3) was translated
to both healthy and OA FLS demonstrated proliferation in response to cartilage wear particles
(Chapter 4). Unlike the canine OA chondrocyte study in Chapter 5, OA FLS showed increased
baseline catabolic activity relative to normal FLS as determined by increased secretion of cytokines
and MMPs and a decreased baseline anabolic activity as demonstrated through decreased collagen,
HA, and NO synthesis.
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However, human FLS were more sensitive to cytokine stimulation than their bovine counter-
parts and less sensitive to the presence of cartilage particles. In Chapter 3, the IL-1α isoform was
investigated, as our lab has shown this isoform to be more effective on juvenile bovine cells (Lima
et al. , 2008b). In Chapter 6, the IL-1β isoform was used as this has been used by other groups for
adult canine and human cells (Tan et al. , 2015a; Gitter et al. , 1989; Blewis et al. , 2010b). The
increase in media cytokines and media MMPs increased much more compared to baseline in OA FLS
compared to healthy FLS. Cartilage particles induced a much smaller fold change in cytokine and
MMP production in both healthy and OA FLS, indicative a more localized inflammatory response.
These results mimic the in vivo effects of cartilage particles injected into the joint of animal models
where localized synovitis is observed after just one injection. In contrast to more aggressive animal
models of OA where joint destabilization is introduced (Gregory et al. , 2012; Marshall & Chan,
1996; Kuroki et al. , 2011; Evans et al. , 1984; Elmesiry et al. , 2014; Pond & Nuki, 1973; Venable
et al. , 2008), full-scale joint changes arising from cartilage particle injection take 6-12 months to
present.
The findings of Chapter 6 confirm that FLS, the predominant synovial cell component, play
a role in synovial inflammation and cartilage degradation in OA and are capable of synthesizing
inflammatory factors in the absence of SM. The use and culture of healthy FLS present the oppor-
tunity to study the role of synovium at the earliest stages of disease, such as after joint trauma
resulting in the release of debris into the joint space. Synovial tissue is relatively easy to obtain
by closed needle or arthroscopic biopsy (Bresnihan, 2003). Thus, patient OA FLS can be easily
harvested and expanded using the model developed here to screen for patient specific responses
to particular therapeutic (e.g. corticosteroids vs. viscosupplementation) rather than relying on
anecdotal observations in the clinic.
7.2 Future Directions
The work of this dissertation presents biofidelic culture models of OA using a range of cell types
and different stimuli. Moving forward, this work can be extended to a number of avenues including
further mechanistic investigations, the development of therapeutic interventions and expansion to
more complex and physiologic models of the synovium. A brief overview of these research areas as
well as preliminary data for these new research areas is included below.
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7.2.1 Mechanistic interactions of cartilage wear particles with fibroblast-like
synoviocytes
While Chapters 4.1 and 4.2. began to investigate the mechanisms behind the interaction of FLS,
more work is needed to understand the specific integrins involved in FLS-cartilage particle at-
tachment. This can be done through studies targeted inhibition of particular integrin subunits or
through staining for focal adhesion kinase and cartilage ECM specific integrin subunits (Guan, 1997;
Du et al. , 2011). While cartilage particles decrease FLS mechanosensitivity, it is unclear if this
observation is rooted in particulate phagocytosis or particulate binding. Surrogates such as small
latex particles or collagen coated beads were used for biochemical analyses and can also be applied
to fluid shear models. Future work will also include analysis of spent media from fluid shear studies
to determine differences in MMP and lubricant synthesis (Sun et al. , 2003; Schett et al. , 1998).
Given the variety of shapes and sizes of cartilage particles present in the synovial fluid of OA
patients, future work can look to characterize the role of particle shape and topography on FLS-
cartilage particulates attachment. Techniques such as SEM and AFM can be used to visualize
surface roughness, shape and mechanical properties of particles. Integrin signaling based on ECM
stiffness has been shown to dictate numerous cell functions including actin organization, differenti-
ation and cell fate (Ross et al. , 2013; McBeath et al. , 2004; Engler et al. , 2006). Accordingly, as
cartilage stiffness decreases with disease (Bank et al. , 2000), cartilage debris from healthy or OA
patients may dictate a disease specific response.
7.2.2 Development of clinical interventions
With the aim of approaching treatment of OA as a disease of the total joint, we are developing
strategies to delivery DEX via PLGA microspheres via a synovial patch (Roach et al. , 2016). This
patch would be fabricated from a vitrified collagen embedded with DEX-loaded PLGA microspheres
(Figure 7.1). The vitrification process allows for control of the mechanical properties and fibril
structures (Guo et al. , 2013), providing another mechanism by which we can control the slow release
of DEX into the joint space (Haga et al. , 2012). Vitrified collagen gels are being optimized for
ocular surface reconstruction (Zhou et al. , 2014; Calderon-Colon et al. , 2012) and skin regeneration
(Takezawa et al. , 2004). For our application, vitrified collagen is a potentially good candidate
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Figure 7.1: Schematic of the envision synovial patch. The patch contain DEX releasing PLGA
micropheres would be attached to synovial lining. Inset, confocal microscope reconstruction of FLS
(orange) and flourescently labled DEX microspheres (blue). Adapted from (Roach, 2017).
scaffold as it is of a similar material composition to the native synovium and can be kept dry at
room temperature until use.
Clinically, this patch could be stitched into the synovium via arthroscopy, at earliest the pre-
sentation of synovitis, before synovial changes cause cartilage degeneration. Given that juvenile
bovine FLS do not necessarily respond to inflammatory factors similarly to human FLS, we inves-
tigated the effects of DEX on FLS derived from OA patients. From the work outlined in Chapters
2, we have shown that DEX can modulate the response of both juvenile bovine synovial tissue to
IL through maintenance of a healthier ratio of FLS and through inhibition of the inflammatory
cascade. Further, in Chapter 4, we showed that DEX was able to prevent particle mediated juvenile
bovine FLS proliferation and inflammation.
In a preliminary study, using the same donors and model system described in Chapter 6, we saw
that overall DEX had no effect on proliferation (Figure 7.2A). However, in some OA donors, DEX
stimulated FLS proliferation, while other donors experienced a more expected decreased proliferation
(Figure 7.2C). DEX also decreased HA content (Figure 7.2B), suggesting that is may be able to
inhibit increased biosynthesis of activated FLS in synovitis (Blewis et al. , 2010b). Lastly, as was
observed in juvenile bovine FLS, DEX was able to decrease NO synthesis by OA FLS as well
as cartilage particle stimulated OA FLS (Figure 7.2C). For both HA and NO synthesis, DEX
differentially modulated the changes in HA and NO synthesis in CTL and cartilage particle-treated
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Figure 7.2: Effects of dexamethasone (DEX) on OA FLS. (A,D) DNA content, (B,E) hyaluronan
(HA)/DNA and (C,F) nitric oxide (NO)/DNA of OA FLS treated with DEX, caritlage wear particles
(CART), or DEX and CART. (A,B,C) Data presented as mean and standard deviation of 12 donors.
(D,E,F) Each data point represents the average of 8 replicates per donor. * p<0.05 vs. CTL, **
p<0.05 vs. DEX, *** p<0.05 vs. CART.
OA FLS in a donor depended manner (Figure 5.2E,F). In particular, some cartilage particle-treated
donors saw a minimal decrease in NO after DEX treatment while others saw a dramatic drop to
below baseline NO synthesis.
The donor variability observed here maybe the first steps in better understanding the clinical
response to corticosteroids and viscosupplementation. The success of corticosteroid injections and
viscosupplementation has been quite variable, with no clear predictors of successful patient response
(Hirsch et al. , 2013; Berthelot et al. , 2013; Boutefnouchet et al. , 2017). In the future, patient
specific culture models can be used to predict patient responses to different therapeutics, such as a
DEX releasing synovial patch.
7.2.3 Tissue engineered model of synovium to the study the study inflammatory
and anti-inflammatory mediators
In addition to regulating ECM, inflammation and synovial fluid composition, the synovium serves
as a thin barrier that governs transport into and out of the joint space (Blewis et al. , 2010a).
It is responsible for regulating the residence time of endogenous soluble factors in the joint space
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Figure 7.3: Gross images of a synovium explant (A) and tissue engineered (TE) synovium. Scalebar
= 5mm. Live/Dead staining of a synovium explant (C) and TE synovium construct (D). Scalebar
= 100μm.
and mediating transport of pharmacological agents such as corticosteroids that are used clinically
to reduce joint pain and inflammation (Gerwin et al. , 2006). While there are many techniques
that can be used to quantify the transport of water, ions and solutes across tissues, they utilize
culture testing chambers or wells that require sized contiguous tissue specimens (Albro et al. , 2009;
Chahine et al. , 2009).
With a long-term goal of exploring differences in synovium transport properties that may accom-
pany osteoarthritis (OA), one would naturally perform experiments on harvested synovium from
normal and OA patients. However, the ability to harvest synovium specimens suitable for such
testing from clinical patients is challenging and impractical, as it is difficult to harvest large intact
pieces of human synovial tissue free from fat and other connective tissues (Kjelgaard-Petersen et al. ,
2015). To address this technical limitation, a tissue engineered synovium would allow for evaluation
of the effects of these pro-and anti-inflammatory mediators on the composition of the synovium and
the transport properties of the synovium.
In this preliminary study performed in coordination with Rob Stefani, we have shown that FLS
embedded within a matrigel matrix showed viability and cellularity similar to synovium explants
after 14 days of culture (Figure 7.3). Similar to native synovium, FLS were able to self-assemble
at the surface of the matrigel, forming a layer representative of the intimal layer of the synovium
(Figure 7.5)(Kiener et al. , 2010). Matrix synthesis led to increased opacity of the TE synovium
constructs similar to that of the native synovium. FLS were able to significantly proliferate and
synthesize collagen during time in culture. After 14 days, the TE synovium reached a DNA content
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Figure 7.4: Histology of tissue engineered and native synovium showing similar ECM content and
lining layer organization. PR = Picrosirius Red. H&E = Hematoxylin and Eosin. Scalebars = 2
mm and 0.25 mm (right, zoomed in).
of 0.32 ± 0.03% and collagen content of 10.82 ± 2.0% by dry weight. As observed in Chapter 2,
the typical composition of bovine synovial explants is quite variable, but has a significantly greater
collagen content than our engineered synovial tissues (~5 fold greater). The desorption rate was
significantly higher in native synovium for the 10 kDa dextran but not 70 kDa (Figure 7.4A). The
permeability of the TE synovium to both 10 and 70 kDa dextran was significantly decreased after
treatment with pro-inflammatory cytokine and/or steroid (Figure 7.4B). Similar to the native
synovium, large cartilage wear particles are remodeled into the matrigel matrix after only a few
days of culture (Figure 7.6).
These preliminary results summarize the potential of this tissue engineered synovium model to
explore the role of the synovium in maintenance of joint healthy and pathology. Unlike the 2D
culture model utilized in Chapter 3 and 4, 3D culture can be used to model and mimic the unique
structure of the synovium that plays an important role in its function. Future work looks to further
optimize the parameters of the culture system (i.e. pre-culture duration, scaffold material) to en-
hance collagen synthesis in order to improve mechanical strength and tissue integrity. Additionally,
more detailed characterization of the composition of the tissue engineered synovium is needed to
determine if it expresses key synovial markers such as collagen types I and IV, lubricin, cadherin-11
and VCAM-1 (Kiener et al. , 2010; Bartok & Firestein, 2010; Smith, 2011; Valencia et al. , 2004).
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Figure 7.5: Dextran Absorbance/Desorbance Assay for day 14 tissue engineered synoium vs. syn-
ovial explant after 24 hours (A). Permeability of tissue engineered synovim is regulated by inflam-
matory agents and steroids. * p<0.05 vs. IL-1 only. n=4-6.
Figure 7.6: Tissue engineered synovium remodels to incorporate cartilage wear particles. FLS (red).
Cartilage particles (green).
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Other applications of a tissue engineered synovium include the ability to study the individual
responses of FLS and SM to inflammatory and anti-inflammatory mediators. Further, we can use
this system to study the role of SM in healthy tissue maintenance and inflammation in a controlled
manner that is not possible with synovial explants (e.g., both cell types present in their native
organization) or in 2D culture (e.g., SM are lost with culture time) (Donlin et al. , 2014; Watanabe
et al. , 2017). Healthy as well as early and late stage OA synovial tissue composition can be
replicated in a 3D culture model by changing the ratio of or spatial separation of SM and FLS
within the engineered synovial tissue (O’Brien et al. , 2017; Zhou et al. , 2015; Holt et al. , 2010),
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